<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22608626</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0072-9752</ISSN><JournalIssue CitedMedium="Print"><Volume>106</Volume><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>Handbook of clinical neurology</Title><ISOAbbreviation>Handb Clin Neurol</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>251-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/B978-0-444-52002-9.00015-2</ELocationID><Abstract><AbstractText>Bipolar disorder is a serious disorder of mood that is associated with considerable psychosocial and economic morbidity. Even though it is more common than previously thought, it has until relatively recently been somewhat neglected in terms of research when compared to disorders such as schizophrenia and major depression. Recent advances in the fields of nosology, epidemiology, and molecular genetics in particular have begun to unravel some of the complexity of this disorder and the next few years are likely to witness substantial changes to the ways in which the broad spectrum of bipolar disorders is diagnosed and managed.</AbstractText><CopyrightInformation>Copyright © 2012 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Cardiff University, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitham</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Ghaemi</LastName><ForeName>S Nassir</ForeName><Initials>SN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Handb Clin Neurol</MedlineTA><NlmUniqueID>0166161</NlmUniqueID><ISSNLinking>0072-9752</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="N">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010551" MajorTopicYN="N">Personality</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22608626</ArticleId><ArticleId IdType="pii">B978-0-444-52002-9.00015-2</ArticleId><ArticleId IdType="doi">10.1016/B978-0-444-52002-9.00015-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28498954</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-5111</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>01</Day></PubDate></JournalIssue><Title>The international journal of neuropsychopharmacology</Title><ISOAbbreviation>Int J Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.</ArticleTitle><Pagination><MedlinePgn>670-680</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ijnp/pyx032</ELocationID><Abstract><AbstractText>Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.</AbstractText><CopyrightInformation>© The Author 2017. Published by Oxford University Press on behalf of CINP.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solé</LastName><ForeName>Brisa</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiménez</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torrent</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinares</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnin</LastName><ForeName>Caterina Del Mar</ForeName><Initials>CDM</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Imma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varo</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grande</LastName><ForeName>Iria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valls</LastName><ForeName>Elia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salagre</LastName><ForeName>Estela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Moreno</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Aran</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>André F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Barcelona Bipolar Disorders Program, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Drs Sole, Jimenez, Torrent, Reinares, del Mar Bonnin, Torres, Varo, Grande, Valls, Salagre, Sanchez-Moreno, Martinez-Aran, and Vieta); Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil (Dr Carvalho).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Neuropsychopharmacol</MedlineTA><NlmUniqueID>9815893</NlmUniqueID><ISSNLinking>1461-1457</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">cognitive impairment</Keyword><Keyword MajorTopicYN="Y">cognitive remediation</Keyword><Keyword MajorTopicYN="Y">functional remediation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28498954</ArticleId><ArticleId IdType="pii">3813906</ArticleId><ArticleId IdType="doi">10.1093/ijnp/pyx032</ArticleId><ArticleId IdType="pmc">PMC5570032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2006 Jul;93(1-3):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16677713</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2008 Jun;42(7):526-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17681545</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2017;86(1):31-46</Citation><ArticleIdList><ArticleId IdType="pubmed">27884012</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2016 Oct;70(10 ):424-433</Citation><ArticleIdList><ArticleId IdType="pubmed">27233969</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 Aug;75(8):864-76</Citation><ArticleIdList><ArticleId IdType="pubmed">25099527</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychology. 2009 Sep;23(5):551-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19702409</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychol. 2014 Oct 10;2(1):41</Citation><ArticleIdList><ArticleId IdType="pubmed">25566387</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2016 Apr;194:9-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26800305</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2012;8:55-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22347797</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2017 Jan;210(1):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27284082</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25661911</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Mar;156:46-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24439829</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:54-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26343306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Aug;12(5):557-67</Citation><ArticleIdList><ArticleId IdType="pubmed">20712758</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2015 Sep;41(5):1095-104</Citation><ArticleIdList><ArticleId IdType="pubmed">25616505</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">24906790</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):192-202</Citation><ArticleIdList><ArticleId IdType="pubmed">25156468</ArticleId></ArticleIdList></Reference><Reference><Citation>MedGenMed. 2006 Aug 23;8(3):46</Citation><ArticleIdList><ArticleId IdType="pubmed">17406176</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2014 Aug;164:130-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24856566</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2011 Mar;12(2):119-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20854181</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2016 Jan 30;235:7-12</Citation><ArticleIdList><ArticleId IdType="pubmed">26707783</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):156-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19505727</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2006;75(2):72-84</Citation><ArticleIdList><ArticleId IdType="pubmed">16508342</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2015 Mar;76(3):e342-50</Citation><ArticleIdList><ArticleId IdType="pubmed">25830456</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2014 Oct;44(14):3083-96</Citation><ArticleIdList><ArticleId IdType="pubmed">25065409</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2008 Oct 30;161(1):28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">18752854</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2004 Aug;29(8):1538-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15127079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Feb;113(1-2):1-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18684514</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2016 Oct;26(10):1638-48</Citation><ArticleIdList><ArticleId IdType="pubmed">27511320</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2015 Jul 25;19(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">26209859</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2012 Apr;27(3):223-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21570263</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2016 Oct;26(10):1541-61</Citation><ArticleIdList><ArticleId IdType="pubmed">27593623</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2010 Jun;13(5):617-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20392298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2009 Jan 17;373(9659):234-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19150704</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2015 Aug 28;11:2265-70</Citation><ArticleIdList><ArticleId IdType="pubmed">26356034</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2017 Jan;19(1):3</Citation><ArticleIdList><ArticleId IdType="pubmed">28097635</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychologia. 2009 Aug;47(10):2015-28</Citation><ArticleIdList><ArticleId IdType="pubmed">19467352</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):214-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25172270</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Jan;55(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9435759</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Ther. 2015 Nov-Dec;22(6):477-86</Citation><ArticleIdList><ArticleId IdType="pubmed">25383489</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2013 Nov;23(11):1337-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23643344</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar;2(2):115-122</Citation><ArticleIdList><ArticleId IdType="pubmed">28299368</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Aug;170(8):852-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23511717</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 Jun;75(6):e587-93</Citation><ArticleIdList><ArticleId IdType="pubmed">25004200</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2016 Oct;176(2-3):500-5</Citation><ArticleIdList><ArticleId IdType="pubmed">27317360</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2017 Apr;78(4):423-432</Citation><ArticleIdList><ArticleId IdType="pubmed">28002661</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Sep;71(9):1234-42</Citation><ArticleIdList><ArticleId IdType="pubmed">20361907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 May;14(3):227-38</Citation><ArticleIdList><ArticleId IdType="pubmed">22548896</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2014 Oct;57:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">25016347</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2008;32(4):675-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18199480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Jun;16(4):422-31</Citation><ArticleIdList><ArticleId IdType="pubmed">24725166</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Jan;73(1):103-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22152405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2012 Feb;200(2):135-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22297310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Nov;14(7):697-706</Citation><ArticleIdList><ArticleId IdType="pubmed">23107220</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Feb;136(3):650-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22051075</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 Sep;128(3):149-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23617548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 May;16(3):217-29</Citation><ArticleIdList><ArticleId IdType="pubmed">24219657</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2016 Aug;26(8):1338-47</Citation><ArticleIdList><ArticleId IdType="pubmed">27139077</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2010 Feb;196(2):92-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20118450</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2016 Aug;175(1-3):72-78</Citation><ArticleIdList><ArticleId IdType="pubmed">27117677</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Jul;73(7):e899-905</Citation><ArticleIdList><ArticleId IdType="pubmed">22901360</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2016 Oct 11;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">27677983</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2016 May;133(5):386-98</Citation><ArticleIdList><ArticleId IdType="pubmed">26719018</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2015 Dec 17;11:3111-25</Citation><ArticleIdList><ArticleId IdType="pubmed">26719696</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Mar 1;173:146-53</Citation><ArticleIdList><ArticleId IdType="pubmed">25462409</ArticleId></ArticleIdList></Reference><Reference><Citation>J ECT. 2013 Sep;29(3):170-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23519225</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2009 Winter;15(4):309-19</Citation><ArticleIdList><ArticleId IdType="pubmed">19889129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Psychiatry. 2015 Jun;2(6):483-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26360429</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 Dec;75(12):1347-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25099079</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2013 Nov;74(11):1076-83</Citation><ArticleIdList><ArticleId IdType="pubmed">24330893</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med. 2012 Aug 14;10:91</Citation><ArticleIdList><ArticleId IdType="pubmed">22891797</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2016 Jan;208(1):87-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26541692</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2016 Sep;134(3):187-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27500779</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2011 Aug;130(1-3):106-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21641776</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 May;25(5):599-656</Citation><ArticleIdList><ArticleId IdType="pubmed">25836356</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharmacol. 2010 Jan 10;626(1):87-96</Citation><ArticleIdList><ArticleId IdType="pubmed">19836378</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2016 Mar 12;17 (1):136</Citation><ArticleIdList><ArticleId IdType="pubmed">26969299</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2016 Jul 29;17:371</Citation><ArticleIdList><ArticleId IdType="pubmed">27472964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2016 Apr 9;387(10027):1561-72</Citation><ArticleIdList><ArticleId IdType="pubmed">26388529</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2017 Mar;27(3):248-260</Citation><ArticleIdList><ArticleId IdType="pubmed">28119083</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Dec;17 Suppl 2:41-55</Citation><ArticleIdList><ArticleId IdType="pubmed">26688289</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2016 Aug;134(2):91-103</Citation><ArticleIdList><ArticleId IdType="pubmed">27097559</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2017 Apr;27(4):350-359</Citation><ArticleIdList><ArticleId IdType="pubmed">28126401</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2016 Oct;17 (7):535-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26068130</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2008 Jun;38(6):771-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17922938</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Mar 23;340:c869</Citation><ArticleIdList><ArticleId IdType="pubmed">20332511</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2014 Feb;13(1):28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">24497240</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2008 Nov;18(11):787-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18725178</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 12;10(6):e0127955</Citation><ArticleIdList><ArticleId IdType="pubmed">26070195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Dec;17(8):849-58</Citation><ArticleIdList><ArticleId IdType="pubmed">26667520</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2008 Jul;23(7):693-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18172910</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2012;81(4):250-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22678229</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2013 Nov;74(11):1101-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24330897</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Mar 20;146(1):132-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22840617</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2008 Oct;32(8):1426-38</Citation><ArticleIdList><ArticleId IdType="pubmed">18582942</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2016 Nov 15;205:378-386</Citation><ArticleIdList><ArticleId IdType="pubmed">27573491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 May;16(3):270-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24286629</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2012 Dec 1;72(11):943-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22770649</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):451-67</Citation><ArticleIdList><ArticleId IdType="pubmed">23873090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Psychiatry. 2017 Mar;4(3):208-217</Citation><ArticleIdList><ArticleId IdType="pubmed">28185899</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2012 Apr;125(4):266-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22211280</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2009 Dec;120(6):456-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19416126</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Pract. 2011 Nov;17(6):410-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22108398</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2009 Jun;29(3):291-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19440086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 May;75(5):e450-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24922497</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Nov;70(11):1588-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19689922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2016 May;18(3):288-99</Citation><ArticleIdList><ArticleId IdType="pubmed">27112120</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2014 Nov-Dec;22(6):342-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25377607</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2010 Oct;16(5):298-307</Citation><ArticleIdList><ArticleId IdType="pubmed">19895584</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2016 Jan;46(2):291-301</Citation><ArticleIdList><ArticleId IdType="pubmed">26387583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Jan 15;208:621-627</Citation><ArticleIdList><ArticleId IdType="pubmed">28029429</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Sep 15;64(6):468-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18534556</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2017 Apr;47(5):866-876</Citation><ArticleIdList><ArticleId IdType="pubmed">27894373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Nov;9(7):671-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17988356</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2012 Oct;66(6):514-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23066769</ArticleId></ArticleIdList></Reference><Reference><Citation>Postgrad Med. 2010 Nov;122(6):107-16</Citation><ArticleIdList><ArticleId IdType="pubmed">21084787</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2015 Mar 30;226(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">25618475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Psiquiatr Salud Ment. 2017 Apr - Jun;10 (2):67-69</Citation><ArticleIdList><ArticleId IdType="pubmed">28341435</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Aug;70(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19758523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28503106</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>04</Month></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Depression and Mania in Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>353-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X14666160606210811</ELocationID><Abstract><AbstractText Label="BACKGROUND">Episode duration, recurrence rates, and time spent in manic and depressive phases of bipolar disorder (BD) is not well defined for subtypes of the disorder.</AbstractText><AbstractText Label="METHODS">We reviewed the course, timing, and duration of episodes of mania and depression among 1130 clinically treated DSM-IV-TR BD patients of various types, and compared duration and rates as well as total proportion of time in depressive versus manic episodes during 16.7 average years at risk.</AbstractText><AbstractText Label="RESULTS">As expected, episodes of depressions were much longer than manias, but episode-duration did not differ among BD diagnostic types: I, II, with mainly mixed-episodes (BD-Mx), or with psychotic features (BD-P). Recurrence rates (episodes/year) and proportion of time in depression and their ratios to mania were highest in BD-II and BD-Mx subjects, with more manias/year in psychotic and BD-I subjects. In most BD-subtypes, except with psychotic features, there was more time in depressive than manic morbidity, owing mainly to longer depressive than manic episodes. The proportion of time in depression was highest among those who followed a predominant DMI course, whereas total time in mania was greatest in BD with psychotic features and BD-I. and with an MDI course.</AbstractText><AbstractText Label="CONCLUSIONS">Subtypes of BD patients differed little in episode-duration, which was consistently much longer for depression. The findings underscore the limited control of bipolar depression with available treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tondo</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The International Consortium for Psychotic &amp; Mood Disorders Research, McLean Hospital, Belmont, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lucio Bini Mood Disorders Centers, Cagliari and Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vázquez</LastName><ForeName>Gustavo H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>The International Consortium for Psychotic &amp; Mood Disorders Research, McLean Hospital, Belmont, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Palermo University, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldessarini</LastName><ForeName>Ross J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>The International Consortium for Psychotic &amp; Mood Disorders Research, McLean Hospital, Belmont, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049671" MajorTopicYN="N">History, 18th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">cycle length</Keyword><Keyword MajorTopicYN="Y">depression</Keyword><Keyword MajorTopicYN="Y">duration of episodes</Keyword><Keyword MajorTopicYN="Y">mania</Keyword><Keyword MajorTopicYN="Y">polarity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>03</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28503106</ArticleId><ArticleId IdType="doi">10.2174/1570159X14666160606210811</ArticleId><ArticleId IdType="pii">CN-15-353</ArticleId><ArticleId IdType="pmc">PMC5405618</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Psychiatry. 2013 Nov;170(11):1249-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24030475</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweiz Arch Neurol Psychiatr (1985). 1995;146(1):5-16</Citation><ArticleIdList><ArticleId IdType="pubmed">7792568</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1976 Jan;33(1):117-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1108832</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(2-3):199-203</Citation><ArticleIdList><ArticleId IdType="pubmed">3114828</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(2-3):205-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3628828</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1975 Nov-Dec;16(6):517-24</Citation><ArticleIdList><ArticleId IdType="pubmed">1192716</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmakopsychiatr Neuropsychopharmakol. 1980 Jul;13(4):156-67</Citation><ArticleIdList><ArticleId IdType="pubmed">6108577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Jun 1;178:71-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25797049</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Oct;126(1-2):299-302</Citation><ArticleIdList><ArticleId IdType="pubmed">20427091</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2014 May;129(5):383-92</Citation><ArticleIdList><ArticleId IdType="pubmed">24152091</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1997 Nov;54(11):993-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9366655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Oct;151(1):105-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23827534</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1991 Sep;148(9):1237-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1883005</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1989 Nov-Dec;17(3):237-41</Citation><ArticleIdList><ArticleId IdType="pubmed">2529291</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Feb;10(1 Pt 2):163-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18199235</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Clin North Am. 1999 Sep;22(3):547-64</Citation><ArticleIdList><ArticleId IdType="pubmed">10550855</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 May;127(5):355-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23121222</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jul;93(1-3):13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16650901</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2012 Apr;125(4):293-302</Citation><ArticleIdList><ArticleId IdType="pubmed">22188017</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1990 Dec;147(12):1627-33</Citation><ArticleIdList><ArticleId IdType="pubmed">2244640</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2008 Aug;118(2):106-15</Citation><ArticleIdList><ArticleId IdType="pubmed">18397362</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2134-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14638583</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2005 May-Jun;13(3):155-78</Citation><ArticleIdList><ArticleId IdType="pubmed">16020028</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24174890</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1958-5969</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Dialogues in clinical neuroscience</Title><ISOAbbreviation>Dialogues Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>The relationship between borderline personality disorder and bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>155-69</MedlinePgn></Pagination><Abstract><AbstractText>It is clinically important to recognize both bipolar disorder and borderline personality disorder (BPD) in patients seeking treatment for depression, and it is important to distinguish between the two. Research considering whether BPD should be considered part of a bipolar spectrum reaches differing conclusions. We reviewed the most studied question on the relationship between BPD and bipolar disorder: their diagnostic concordance. Across studies, approximately 10% of patients with BPD had bipolar I disorder and another 10% had bipolar II disorder. Likewise, approximately 20% of bipolar II patients were diagnosed with BPD, though only 10% of bipolar I patients were diagnosed with BPD. While the comorbidity rates are substantial, each disorder is nontheless diagnosed in the absence of the other in the vast majority of cases (80% to 90%). In studies examining personality disorders broadly, other personality disorders were more commonly diagnosed in bipolar patients than was BPD. Likewise, the converse is also true: other axis I disorders such as major depression, substance abuse, and post-traumatic stress disorder are also more commonly diagnosed in patients with BPD than is bipolar disorder. These findings challenge the notion that BPD is part of the bipolar spectrum.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Theresa A</ForeName><Initials>TA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Dialogues Clin Neurosci</MedlineTA><NlmUniqueID>101238198</NlmUniqueID><ISSNLinking>1294-8322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001883" MajorTopicYN="N">Borderline Personality Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>En los pacientes que buscan un tratamiento para la depresíón es importante, clínicamente, reconocer tanto el trastorno bipolar como el trastorno de personalidad borderline (TPB) y es primordíal poder distinguirlos. Las investigaciones que consideran que el TPB debe ser íncluido como parte del espectro bípolar llegan a distintas conclusiones. Se revisó la pregunta más estudiada acerca de la relación entre el TPB y el trastorno bipolar: ¿cuál es su concordancía diagnóstica? Entre los estudíos se encontró que aproxímadamente el 10% de los pacientes con TPB tenía un trastorno bipolar I y otro 10% tenía un trastorno bipolar II. Asimismo, aproxímadamente el 20% de los pacíentes bípolares II fue diagnostícado con TPB, en cambio sólo el 10% de los bípolares I tuvo ese díagnóstico. A pesar de que las cifras de comorbilidad son considerables, cada trastorno es díagnostícado en ausencía del otro en la gran mayoría de los casos (80% a 90%). En los estudios que examínan en general los trastornos de personalidad, los pacientes bipolares fueron díagnostícados más comúnmente con otros trastornos de la personalidad que con el TPB. Asimismo, lo inverso también es verdadero: otros trastornos del eje I como la depresión mayor, el abuso de sustancías y el trastorno por estrés postraumático también fueron díagnostícados con mayor frecuencia en pacientes con TPB que en el trastorno bípolar. Estos hallazgos ponen en tela de juícío la idea que el TPB es parte del espectro bípolar.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Il est important de reconnaître cliniquement le trouble bipolaire et la personnalité « borderline » (PBL) chez les patients demandant un traitement antidépresseur, et de les distinguer l'un de l'autre. Pour la recherche, l'appartenance de la PBL au cadre des troubles bipolaires a donné lieu à des conclusions divergentes. Nous analysons la question la plus étudiée sur la relation entre la PBL et le trouble bipolaire: leur concordance diagnostique. Dans les études, environ 10% des patients ayant une PBL sont atteints de trouble bipolaire 1 et 10% de trouble bipolaire II. De même, environ 20% des patients bipolaires II souffrent de PBL alors que seulement 10% des patients bipolaires I ont une PBL. Les taux de comorbidité sont importants mais chaque maladie est néanmoins diagnostiquée en l'absence de l'autre dans la grande majorité des cas (80 à 90%). Dans les études s'intéressant aux troubles de la personnalité de manière plus large, les autres troubles de la personnalité ont été plus fréquemment diagnostiqués chez les patients bipolaires. L'inverse est également vrai: les autres troubles de l'axe I comme la dépression majeure, les abus de substance et les états de stress post-traumatique sont plus fréquemment rencontrés chez les patients PBL que chez les patients bipolaires. Ces résultats remettent en question la notion de l'appartenance de la PBL au cadre bipolaire.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">bipolar spectrum</Keyword><Keyword MajorTopicYN="N">borderline personality disorder</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24174890</ArticleId><ArticleId IdType="pmc">PMC3811087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biol Psychiatry. 2007 Sep 15;62(6):553-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17217923</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 1999 May;187(5):313-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10348089</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 Dec;155(12):1733-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9842784</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Aug;61(8):549-55</Citation><ArticleIdList><ArticleId IdType="pubmed">10982196</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1994 Aug;31(4):281-94</Citation><ArticleIdList><ArticleId IdType="pubmed">7989643</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 1994 Jan-Feb;28(1):57-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8064641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Dec;67(1-3):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11869772</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Sep;59 Suppl 1:S5-S30</Citation><ArticleIdList><ArticleId IdType="pubmed">11121824</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1998 Mar-Apr;39(2):72-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9515191</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005;66 Suppl 1:13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15693747</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 1993 Jun;3(2):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8364346</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2010 Sep-Oct;51(5):486-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20728005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Oct;3(5):253-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11903208</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 1989;25(1):63-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2505303</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Aug;61(8):807-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15289279</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2004 Jun;38(6):433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15209835</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2002 Mar;47(2):125-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11926074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Psychopharmacol. 2004 Jul;19(5):355-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15252830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Psychoanal Assoc. 1986;34(4):863-93</Citation><ArticleIdList><ArticleId IdType="pubmed">3819306</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1985 Feb;142(2):207-12</Citation><ArticleIdList><ArticleId IdType="pubmed">3970245</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2007 Feb;9(1):40-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17257513</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2000 Mar-Apr;41(2):106-10</Citation><ArticleIdList><ArticleId IdType="pubmed">10741888</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 1999;10(4):175-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10690579</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2004 May-Jun;12(3):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15371068</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">12507741</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Jul;109(1-2):83-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18082895</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2012 Apr;46(4):327-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22508593</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2008 Jun 30;159(3):300-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18445508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Apr;79(1-3):297-303</Citation><ArticleIdList><ArticleId IdType="pubmed">15023511</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1990 Aug;147(8):1043-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2197883</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1983 Dec;40(12):1319-23</Citation><ArticleIdList><ArticleId IdType="pubmed">6651467</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Apr;165(4):468-78</Citation><ArticleIdList><ArticleId IdType="pubmed">18281407</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2011 Feb;10(1):45-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21379356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Jun;65(1):3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11426507</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1999 Jul-Aug;40(4):245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10428182</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1983 Jan;40(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">6849616</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 May;188:423-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16648528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Apr;7(2):192-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15762861</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2002 May;69(1-3):31-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12103449</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2006 Dec;194(12):967-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17164638</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2003 Jan-Feb;44(1):35-43</Citation><ArticleIdList><ArticleId IdType="pubmed">12524634</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2001 Nov-Dec;35(6):307-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11684137</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2003 Jan-Feb;44(1):28-34</Citation><ArticleIdList><ArticleId IdType="pubmed">12524633</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jun;62(6):617-27</Citation><ArticleIdList><ArticleId IdType="pubmed">15939839</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 1988 Jun;33(5):336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">3409151</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2000 Sep-Oct;41(5):339-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11011829</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Nov;157(11):1873-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11058490</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Jul;87(1):17-23</Citation><ArticleIdList><ArticleId IdType="pubmed">15967232</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1999 Nov;60(11):752-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10584763</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1996 Dec;153(12):1598-606</Citation><ArticleIdList><ArticleId IdType="pubmed">8942457</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Disord. 2003 Dec;17(6):550-61</Citation><ArticleIdList><ArticleId IdType="pubmed">14744080</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Jun 30;188(1):40-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21131058</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 1989;25(1):68-70</Citation><ArticleIdList><ArticleId IdType="pubmed">2505304</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 May;165(5):631-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18347003</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Jul;69(7):1033-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18557663</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Nov;66(11):1432-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16420081</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2010 Oct;167(10):1194-201</Citation><ArticleIdList><ArticleId IdType="pubmed">20713498</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1988 Aug;45(8):733-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3395201</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol. 1994 Jul;50(4):656-65</Citation><ArticleIdList><ArticleId IdType="pubmed">7983218</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol. 1992 May;48(3):320-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1602021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1998 Sep;50(2-3):163-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9858076</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1985 Feb;142(2):192-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3970243</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Apr;69(4):533-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18426259</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2002 Mar;47(2):195-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11926084</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Feb;64(2):161-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12633125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2001;62 Suppl 14:5-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11469675</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2004 May-Jun;12(3):133-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15371067</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1992 Sep;161:344-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1393303</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rep. 2004 Aug;95(1):121-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15460367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jun;92(2-3):141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16529822</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1988 Oct;78(4):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3227970</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1991 Dec;23(4):217-21</Citation><ArticleIdList><ArticleId IdType="pubmed">1791267</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2004;65 Suppl 15:5-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15554789</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Jan 10;144(1-2):72-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22858216</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Feb;158(2):295-302</Citation><ArticleIdList><ArticleId IdType="pubmed">11156814</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Oct;61(10):804-8; quiz 809</Citation><ArticleIdList><ArticleId IdType="pubmed">11078046</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Mar;51(3):225-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8122959</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Med Res. 2012 Oct;4(5):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23024731</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2001 Jan;52(1):51-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11141528</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Feb;61(2):134-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10732661</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1988 Jul;153:44-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3224249</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Q. 2012 Dec;83(4):449-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22392448</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1989 Aug;46(8):682-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2751402</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Sep;71(9):1212-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20361913</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Apr;73(4):437-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22579144</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1989 Mar-Apr;30(2):149-56</Citation><ArticleIdList><ArticleId IdType="pubmed">2920550</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1982 Oct;139(10):1360-1</Citation><ArticleIdList><ArticleId IdType="pubmed">7124998</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2011 Aug;68(8):791-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21810644</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr J Univ Ott. 1990 Mar;15(1):22-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2326383</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1983 Jun;140(6):695-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6846626</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Oct;64(10):1201-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14658969</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2006 Oct;60(5):611-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16958946</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Disord. 2010 Dec;24(6):763-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21158598</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Jul;163(7):1126-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16816211</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr J Univ Ott. 1982 Sep;7(3):190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6758006</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2012 Jun;46(6):506-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22510555</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1990 Nov-Dec;31(6):499-510</Citation><ArticleIdList><ArticleId IdType="pubmed">2265534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2007 Oct;68(10):1533-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17960968</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Oct;156(10):1570-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10518168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1985 Feb;46(2):41-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3968045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Mar;66(3):339-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15766300</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 1998 Apr;32(2):276-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9588307</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1997 Mar-Apr;38(2):102-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9056129</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1984 Apr;45(4):150-3</Citation><ArticleIdList><ArticleId IdType="pubmed">6715286</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1992 Nov-Dec;33(6):397-406</Citation><ArticleIdList><ArticleId IdType="pubmed">1451453</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2000 Oct;102(4):256-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11089725</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):68-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16019119</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 1986;328:61-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3463140</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1993 May;162:641-50</Citation><ArticleIdList><ArticleId IdType="pubmed">8149116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Apr;5(2):115-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12680901</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1979 Aug;135:168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">497620</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Nov 1;82(3):373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15555688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1995 Aug 18;34(4):269-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8550952</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 Nov;128(5):376-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23379930</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Jul;163(7):1173-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16816221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Dec;5(6):436-42</Citation><ArticleIdList><ArticleId IdType="pubmed">14636367</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1022-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18313825</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1981 Apr;38(4):381-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6260053</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1998 Mar-Apr;39(2):63-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9515190</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2005 Mar;50(4):234-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15898463</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 2009;26(4):382-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19195006</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1991 Mar;83(3):206-13</Citation><ArticleIdList><ArticleId IdType="pubmed">2031465</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Feb;152(2):232-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7840357</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23271744</PMID><DateCompleted><Year>2013</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>345</Volume><PubDate><Year>2012</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>e8508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.e8508</ELocationID><ELocationID EIdType="pii" ValidYN="Y">bmj.e8508</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Ian M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Neuroscience and Psychiatry Unit, University of Manchester, Manchester M13 9PT, UK. ian.anderson@manchester.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2013;346:f510</RefSource><PMID Version="1">23364059</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2013;346:f530</RefSource><PMID Version="1">23393129</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008487" MajorTopicYN="N">Medical History Taking</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016742" MajorTopicYN="N">Preconception Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23271744</ArticleId><ArticleId IdType="doi">10.1136/bmj.e8508</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29956510</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0342-9601</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>9</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Medizinische Monatsschrift fur Pharmazeuten</Title><ISOAbbreviation>Med Monatsschr Pharm</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: clinical overview.</ArticleTitle><Pagination><MedlinePgn>363- 9</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a severe psychiatric disorder, characterized by depressive, manic and mixed episodes. The illness affects about 1-2 % of the population. Bipolar I disorders affect both genders equally, whereas bipolar II disorders seem to occur more frequently in women. The classification of the different subtypes of bipolar disorders is done depending on the severity and frequency of the episodes. Other subtypes beside bipolar I and bipolar II disorder are rapid cycling (more than 4 episodes of mania, depression, hypomania or mixed state in one year) and cyclothymia (hypomanic and subdepressive symptoms over a two year period). Besides a thorough psychiatric and neurological examination, further clinical tests should be performed in order to exclude differential diagnosis (psychiatric as well as neurological and somatic diseases). 
The course of the illness is often negatively affected by the high frequency of psychiatric and somatic comorbidities. After all the prognosis of bipolar disorder is depending on the individual course of the illness. Notably comorbidities and psychotic symptoms seem to have a negative influence on the prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Juliane K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Leweke</LastName><ForeName>F Markus</ForeName><Initials>FM</Initials></Author></AuthorList><Language>eng</Language><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Klinik bipolarer Erkrankungen.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Monatsschr Pharm</MedlineTA><NlmUniqueID>7802665</NlmUniqueID><ISSNLinking>0342-9601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003527" MajorTopicYN="N">Cyclothymic Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29956510</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26172568</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2327-6924</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of the American Association of Nurse Practitioners</Title><ISOAbbreviation>J Am Assoc Nurse Pract</ISOAbbreviation></Journal><ArticleTitle>Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses.</ArticleTitle><Pagination><MedlinePgn>530-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/2327-6924.12275</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This review article provides an overview of the frequency, burden of illness, diagnosis, and treatment of bipolar disorder (BD) from the perspective of the advanced practice nurses (APNs).</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">PubMed searches were conducted using the following keywords: "bipolar disorder and primary care," restricted to dates 2000 to present; "bipolar disorder and nurse practitioner"; and "bipolar disorder and clinical nurse specialist." Selected articles were relevant to adult outpatient care in the United States, with a prioritization of articles written by APNs or published in nursing journals.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">BD has a substantial lifetime prevalence in the population at 4%. Because the manic or depressive symptoms of BD tend to be severe and recurrent over a patient's lifetime, the condition is associated with significant burden to the individual, caregivers, and society. Clinician awareness that BD may be present increases the likelihood of successful recognition and appropriate treatment. A number of pharmacological and nonpharmacological treatments are available for acute and maintenance treatments, with the prospect of achieving reduced symptom burden and increased functioning for many patients.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">Awareness of the disease burden, diagnostic issues, and management choices in BD has the potential to enhance outcome in substantial proportions of patients.</AbstractText><CopyrightInformation>©2015 The Authors. Journal of the American Association of Nurse Practitioners published by Wiley Periodicals, Inc. on behalf of American Association of Nurse Practitioners.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Medical Services, Centerstone of Indiana, Bloomington, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Bethany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Indiana University School of Nursing, Columbus, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNew</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Services, Centerstone of Indiana, Bloomington, Indiana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Assoc Nurse Pract</MedlineTA><NlmUniqueID>101600770</NlmUniqueID><ISSNLinking>2327-6886</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009722" MajorTopicYN="Y">Nurse Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057184" MajorTopicYN="Y">Practice Patterns, Nurses'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011568" MajorTopicYN="N">Psychiatric Nursing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Primary care</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">managed care</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">nurse practitioners</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26172568</ArticleId><ArticleId IdType="pmc">PMC5034840</ArticleId><ArticleId IdType="doi">10.1002/2327-6924.12275</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Psychiatry. 2013 Nov;170(11):1249-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24030475</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2007 Nov;13(7 Suppl):S178-88</Citation><ArticleIdList><ArticleId IdType="pubmed">18041879</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2003;17(7):491-511</Citation><ArticleIdList><ArticleId IdType="pubmed">12751919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Feb;15(1):1-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23237061</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurse Pract. 2010 Feb;35(2):36-45</Citation><ArticleIdList><ArticleId IdType="pubmed">20087150</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Jun;71(6):e14</Citation><ArticleIdList><ArticleId IdType="pubmed">20573324</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2009 Jun 16;119(23):3028-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19528344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 May;12(3):264-70</Citation><ArticleIdList><ArticleId IdType="pubmed">20565433</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Mar;66(3):323-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15766298</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Psychiatry. 2013 Sep;70(9):931-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23863861</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Pharmacol. 2013 Jul 25;4:91</Citation><ArticleIdList><ArticleId IdType="pubmed">23898295</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2012 May 23;12:47</Citation><ArticleIdList><ArticleId IdType="pubmed">22620289</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Board Fam Med. 2012 May-Jun;25(3):283-90</Citation><ArticleIdList><ArticleId IdType="pubmed">22570391</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1996 May 15;39(10):896-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8860192</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2013 Jul;27(7):515-29</Citation><ArticleIdList><ArticleId IdType="pubmed">23749421</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Orthopsychiatry. 1996 Jan;66(1):17-31</Citation><ArticleIdList><ArticleId IdType="pubmed">8720638</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Apr;107(1-3):53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17822779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Oct;6(5):368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15383128</ArticleId></ArticleIdList></Reference><Reference><Citation>Manag Care Interface. 2006 Sep;19(9):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17017312</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Mar;60(3):261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12622659</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Jan;112(1-3):30-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18486237</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Manag Care. 2007 Nov;13(7 Suppl):S164-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18041877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005;7 Suppl 4:21-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15948764</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2004 Apr;65(4):478-84</Citation><ArticleIdList><ArticleId IdType="pubmed">15119909</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2006 Jul;57(7):937-45</Citation><ArticleIdList><ArticleId IdType="pubmed">16816277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Jun;10(4):511-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18452447</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry J. 2013;2013:548349</Citation><ArticleIdList><ArticleId IdType="pubmed">24236281</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Sep;62(9):996-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">16143731</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 1998;7(2):83-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9614597</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2007 Aug 16;7:40</Citation><ArticleIdList><ArticleId IdType="pubmed">17705840</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2013 Dec;28(12):1648-56</Citation><ArticleIdList><ArticleId IdType="pubmed">23835789</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Assoc Nurse Pract. 2015 May;27(5):280-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25691013</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Saf. 2004 May;3(3):221-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15155150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Sep;14(6):672-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22938169</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Res Treat. 2012;2012:684725</Citation><ArticleIdList><ArticleId IdType="pubmed">22319648</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychosom Med. 2005 Jan-Feb;67(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15673617</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Feb;161(2):217-22</Citation><ArticleIdList><ArticleId IdType="pubmed">14754766</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2000 Dec;20(6):607-14</Citation><ArticleIdList><ArticleId IdType="pubmed">11106131</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2011 Jul;199(1):57-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21593515</ArticleId></ArticleIdList></Reference><Reference><Citation>Prim Care Companion J Clin Psychiatry. 2010;12(Suppl 1):4-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20628500</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Hypertens (Greenwich). 2008 May;10(5):348-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18453793</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2011 Feb;72(2):156-67</Citation><ArticleIdList><ArticleId IdType="pubmed">21034686</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2007 Feb;10(1):123-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16787554</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Mar 23-30;271(12):918-24</Citation><ArticleIdList><ArticleId IdType="pubmed">8120960</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009;70 Suppl 3:5-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19570496</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Nurse Pract. 2006 Aug;18(8):368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16907698</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2009 Jan;43(3):230-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18590916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Jan 30;375(9712):385-95</Citation><ArticleIdList><ArticleId IdType="pubmed">20092882</ArticleId></ArticleIdList></Reference><Reference><Citation>Prim Care Companion CNS Disord. 2011;13(4):null</Citation><ArticleIdList><ArticleId IdType="pubmed">22132354</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546</Citation><ArticleIdList><ArticleId IdType="pubmed">15816786</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Oct;66(10):1205-15</Citation><ArticleIdList><ArticleId IdType="pubmed">16259532</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 2010;43(3):5-14</Citation><ArticleIdList><ArticleId IdType="pubmed">21150842</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Spectr. 2010 Feb;15(2 Suppl 3):4-7; discussion 17</Citation><ArticleIdList><ArticleId IdType="pubmed">20414158</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2009 Aug;47(8):826-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19584762</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2009 Jan;194(1):4-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19118318</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2012 Nov 21;12:204</Citation><ArticleIdList><ArticleId IdType="pubmed">23171304</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2006 Jul;6(7):1077-86</Citation><ArticleIdList><ArticleId IdType="pubmed">16831120</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jul;162(7):1351-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15994719</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacopsychiatry. 2011 Jan;44(1):21-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21031345</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 May;127(5):355-64</Citation><ArticleIdList><ArticleId IdType="pubmed">23121222</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2006 Dec;26(6):600-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17110817</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Jan;97(1-3):171-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16860396</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2014 Feb;171(2):169-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24170221</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Fam Physician. 2012 Mar 1;85(5):483-93</Citation><ArticleIdList><ArticleId IdType="pubmed">22534227</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2009;10(2):85-116</Citation><ArticleIdList><ArticleId IdType="pubmed">19347775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2011 Mar;129(1-3):79-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20888048</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Methods Psychiatr Res. 2004;13(2):93-121</Citation><ArticleIdList><ArticleId IdType="pubmed">15297906</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 May;64(5):543-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17485606</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2011 Sep;14(8):1029-49</Citation><ArticleIdList><ArticleId IdType="pubmed">21733231</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Jan;170(1):102-10</Citation><ArticleIdList><ArticleId IdType="pubmed">23288387</ArticleId></ArticleIdList></Reference><Reference><Citation>Issues Ment Health Nurs. 2012 Jan;33(1):8-14</Citation><ArticleIdList><ArticleId IdType="pubmed">22224961</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1994 Sep 1;331(9):591-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8047085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Gen Psychiatry. 2009 Feb 18;8:7</Citation><ArticleIdList><ArticleId IdType="pubmed">19226463</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Drugs. 2007;21(9):727-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17696573</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Oct;151(1):54-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23769606</ArticleId></ArticleIdList></Reference><Reference><Citation>Dialogues Clin Neurosci. 2007;9(3):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17969869</ArticleId></ArticleIdList></Reference><Reference><Citation>Prim Care Companion J Clin Psychiatry. 2010;12(Suppl 1):17-22</Citation><ArticleIdList><ArticleId IdType="pubmed">20628502</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Nov;60(11):1079-88</Citation><ArticleIdList><ArticleId IdType="pubmed">14609883</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2007 Jan;115(1):12-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17201861</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):106-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19903574</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2011 Sep;62(9):1032-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21885581</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Nov;157(11):1873-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11058490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2013 May 11;381(9878):1672-82</Citation><ArticleIdList><ArticleId IdType="pubmed">23663953</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Health Syst Pharm. 2009 Feb 15;66(4):358-65</Citation><ArticleIdList><ArticleId IdType="pubmed">19202045</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2014 Feb;171(2):160-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24170180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fam Med. 2010 Mar-Apr;8(2):160-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20212303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31273693</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2011</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Bipolar Disorder: Its Etiology and How to Model in Rodents.</ArticleTitle><Pagination><MedlinePgn>61-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-4939-9554-7_4</ELocationID><Abstract><AbstractText>Characterized by the switch of manic and depressive phases, bipolar disorder was described as early as the fifth century BC. Nevertheless up to date, the underlying neurobiology is still largely unclear, assuming a multifactor genesis with both biological-genetic and psychosocial factors. Significant process has been achieved in recent years in researching the causes of bipolar disorder with modern molecular biological (e.g., genetic and epigenetic studies) and imaging techniques (e.g., positron emission tomography (PET) and functional magnetic resonance imaging (fMRI)). In this chapter we will first summarize our recent knowledge on the etiology of bipolar disorder. We then discuss how several factors observed to contribute to bipolar disorder in human patients can be manipulated to generate rodent models for bipolar disorder. Finally, we will give an overview on behavioral test that can be used to assess bipolar-disorder-like behavior in rodents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Freund</LastName><ForeName>Nadja</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University, Bochum, Germany. nadja.freund@ruhr-uni-bochum.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juckel</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University, Bochum, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067290" MajorTopicYN="N">Behavior Rating Scale</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012377" MajorTopicYN="N">Rodentia</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Behavioral test</Keyword><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Environmental manipulation</Keyword><Keyword MajorTopicYN="Y">Etiology</Keyword><Keyword MajorTopicYN="Y">Genetic models</Keyword><Keyword MajorTopicYN="Y">Rodent models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31273693</ArticleId><ArticleId IdType="doi">10.1007/978-1-4939-9554-7_4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25536097</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1539-736X</ISSN><JournalIssue CitedMedium="Internet"><Volume>203</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of nervous and mental disease</Title><ISOAbbreviation>J Nerv Ment Dis</ISOAbbreviation></Journal><ArticleTitle>Borderline personality disorder and bipolar disorder: what is the difference and why does it matter?</ArticleTitle><Pagination><MedlinePgn>3-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/NMD.0000000000000225</ELocationID><Abstract><AbstractText>Borderline personality disorder (BPD) and bipolar disorder (types I and II) are frequently confused because of their symptomatic overlap. Although affective instability is a prominent feature of each, the pattern is entirely different. BPD is characterized by transient mood shifts that occur in response to interpersonal stressors, whereas bipolar disorder is associated with sustained mood changes. These disorders can be further distinguished by comparing their phenomenology, etiology, family history, biological studies, outcome, and response to medication. Their distinction is of great clinical importance because misdiagnosis can deprive the patient of potentially effective treatment, whether it is psychotherapy for BPD or medication for bipolar disorder. On the basis of a comprehensive literature review, guidelines for differential diagnosis are suggested, and priorities for further research are recommended. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paris</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>*Department of Psychiatry, Jewish General Hospital and McGill University School of Medicine Montreal, Quebec, Canada; and †Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, University of Iowa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Donald W</ForeName><Initials>DW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Nerv Ment Dis</MedlineTA><NlmUniqueID>0375402</NlmUniqueID><ISSNLinking>0022-3018</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Nerv Ment Dis. 2015 Jan;203(1):8-12</RefSource><PMID Version="1">25536098</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Nerv Ment Dis. 2015 Jan;203(1):13-4</RefSource><PMID Version="1">25536099</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001883" MajorTopicYN="N">Borderline Personality Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25536097</ArticleId><ArticleId IdType="doi">10.1097/NMD.0000000000000225</ArticleId><ArticleId IdType="pii">00005053-201501000-00002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29412851</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3147</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>03</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Older Age Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>95-110</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0193-953X(17)30102-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psc.2017.10.008</ELocationID><Abstract><AbstractText>Further understanding of older age bipolar disorder (OABD) may lead to more specific recommendations for treatment adjusted to the specific characteristics and needs caused by age-related somatic and cognitive changes. Late-onset mania has a broad differential diagnosis and requires full psychiatric and somatic work-up, including brain imaging. Research on pharmacotherapy in OABD is limited. First-line treatment of OABD is similar to that for adult bipolar disorder (BD), with specific attention to vulnerability to side effects and somatic comorbidity. Because findings in younger adults with BD cannot be extrapolated to OABD, more research in OABD is warranted.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dols</LastName><ForeName>Annemiek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Old Age Psychiatry, GGZinGeest and VUmc University Medical Center, Amstelveenseweg 589, 1081 JC, Amsterdam, The Netherlands; Mental Health Program, Amsterdam Public Health Research Institute, Van der Boechorstsstraat 7, 1081 BT, Amsterdam, The Netherlands; Mood, Anxiety and Psychosis Program, Amsterdam Neuroscience, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands. Electronic address: a.dols@ggzingeest.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beekman</LastName><ForeName>Aartjan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Old Age Psychiatry, GGZinGeest and VUmc University Medical Center, Amstelveenseweg 589, 1081 JC, Amsterdam, The Netherlands; Mental Health Program, Amsterdam Public Health Research Institute, Van der Boechorstsstraat 7, 1081 BT, Amsterdam, The Netherlands; Mood, Anxiety and Psychosis Program, Amsterdam Neuroscience, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands; Department of Psychiatry, GGZinGeest and VUmc University Medical Center, Amstelveenseweg 589, 1081 JC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="Y">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">Cognition</Keyword><Keyword MajorTopicYN="Y">Late life</Keyword><Keyword MajorTopicYN="Y">Physical health</Keyword><Keyword MajorTopicYN="Y">Somatic comorbidity</Keyword><Keyword MajorTopicYN="Y">Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29412851</ArticleId><ArticleId IdType="pii">S0193-953X(17)30102-8</ArticleId><ArticleId IdType="doi">10.1016/j.psc.2017.10.008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30327338</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-960X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Evidence-based mental health</Title><ISOAbbreviation>Evid Based Ment Health</ISOAbbreviation></Journal><ArticleTitle>Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective.</ArticleTitle><Pagination><MedlinePgn>177-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/eb-2018-102912</ELocationID><Abstract><AbstractText>Bipolar disorder (BPD) is a potentially lifelong condition characterised by extreme changes in mood that may begin in childhood and cause substantial impairment. Over the past decades, BPD has been the focus of increased attention mainly due to controversies surrounding its prevalence, diagnosis and treatment in children and adolescents. This report addresses these controversies by reviewing the extant evidence base, providing clinicians with a summary of the literature on diagnosis, phenomenology and treatment of paediatric BPD. The debate regarding diagnosing children with BPD based on severe irritability and aggression is mostly resolved. The current data support utilising the diagnostic criteria based on episodic changes of mood polarity. Therefore, longitudinal course of illness should be explored in detail when diagnosing BPD. Given high rates of genetic predisposition for BPD, assessment of youth should focus on obtaining accurate family history of this condition. Additionally, there has been a substantial increase in randomised placebo-controlled clinical trials evaluating pharmacological agents for mood stabilisation in children and adolescents, which we summarise in this review. Despite significant progress being made in the field of paediatric BPD, more research is needed in the areas of phenomenology, pathophysiology, course and treatment of this condition in youth.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Findling</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stepanova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youngstrom</LastName><ForeName>Eric A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Andrea S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Evid Based Ment Health</MedlineTA><NlmUniqueID>100883413</NlmUniqueID><ISSNLinking>1362-0347</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">child &amp; adolescent psychiatry</Keyword><Keyword MajorTopicYN="N">depression &amp; mood disorders</Keyword></KeywordList><CoiStatement>Competing interests: RLF has received research funding for grant/research support and/or as a consultant from the following commercial organisations: Aevi, Akili, Alcobra, Amerex, Am Acad CAP, American Psychiatric Press, Bracket, Epharma Solutions, Forest, Genentech, Guilford Press, Ironshore, Johns Hopkins U Press, KemPharm, Lundbeck, Merck, NIH, Neurim, Nuvelution, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Teva, Touchpoint, Tris, Validus, WebMD. ES and ASY have received research funding from PsychNostics, LLC, and Supernus Pharmaceuticals. EAY has consulted about psychological assessment with Pearson, Janssen, Joe Startup Technologies and Western Psychological Services; he has received royalties from the American Psychological Association and Guilford Press.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>06</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30327338</ArticleId><ArticleId IdType="pii">eb-2018-102912</ArticleId><ArticleId IdType="doi">10.1136/eb-2018-102912</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31093646</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-5111</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>08</Month><Day>01</Day></PubDate></JournalIssue><Title>The international journal of neuropsychopharmacology</Title><ISOAbbreviation>Int J Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>467-477</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ijnp/pyz018</ELocationID><Abstract><AbstractText>People with bipolar disorder frequently experience persistent residual symptoms, problems in psychosocial functioning, cognitive impairment, and poor quality of life. In the last decade, the treatment target in clinical and research settings has focused not only on clinical remission, but also on functional recovery and, more lately, in personal recovery, taking into account patients' well-being and quality of life. Hence, the trend in psychiatry and psychology is to treat bipolar disorder in an integrative and holistic manner. This literature review offers an overview regarding psychosocial functioning in bipolar disorder. First, a brief summary is provided regarding the definition of psychosocial functioning and the tools to measure it. Then, the most reported variables influencing the functional outcome in patients with bipolar disorder are listed. Thereafter, we include a section discussing therapies with proven efficacy at enhancing functional outcomes. Other possible therapies that could be useful to prevent functional decline and improve functioning are presented in another section. Finally, in the last part of this review, different interventions directed to improve patients' well-being, quality of life, and personal recovery are briefly described.</AbstractText><CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of CINP.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonnín</LastName><ForeName>Caterina Del Mar</ForeName><Initials>CDM</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinares</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Arán</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiménez</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sánchez-Moreno</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solé</LastName><ForeName>Brisa</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montejo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bipolar and Depressive Disorders Unit, Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Neuropsychopharmacol</MedlineTA><NlmUniqueID>9815893</NlmUniqueID><ISSNLinking>1461-1457</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">functional outcome</Keyword><Keyword MajorTopicYN="Y">psychotherapy</Keyword><Keyword MajorTopicYN="Y">quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>02</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>04</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31093646</ArticleId><ArticleId IdType="pii">5475185</ArticleId><ArticleId IdType="doi">10.1093/ijnp/pyz018</ArticleId><ArticleId IdType="pmc">PMC6672628</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2014 May;160:50-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24709022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):16-24</Citation><ArticleIdList><ArticleId IdType="pubmed">17391346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Feb;14(1):6-18</Citation><ArticleIdList><ArticleId IdType="pubmed">22329468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Eval Clin Pract. 2018 Aug;24(4):869-878</Citation><ArticleIdList><ArticleId IdType="pubmed">29665163</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Mar 01;210:280-286</Citation><ArticleIdList><ArticleId IdType="pubmed">28068616</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1999 Jul;29(4):869-78</Citation><ArticleIdList><ArticleId IdType="pubmed">10473314</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2017 Aug 1;20(8):670-680</Citation><ArticleIdList><ArticleId IdType="pubmed">28498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Psychiatry. 2018 Nov 29;9:641</Citation><ArticleIdList><ArticleId IdType="pubmed">30555363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Aug;11(5):453-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19624385</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2016 Jul;42 Suppl 1:S44-52</Citation><ArticleIdList><ArticleId IdType="pubmed">27460618</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2017;16(6):638-651</Citation><ArticleIdList><ArticleId IdType="pubmed">28017130</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2013 Sep;128(3):179-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23379960</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Sep;164(9):1340-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17728418</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2008 Sep;42(11):956-61</Citation><ArticleIdList><ArticleId IdType="pubmed">18076906</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2009;42(3):148-56</Citation><ArticleIdList><ArticleId IdType="pubmed">19276630</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Nov;152(11):1635-40</Citation><ArticleIdList><ArticleId IdType="pubmed">7485627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Feb;136(3):650-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22051075</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pract Epidemiol Ment Health. 2007 Jun 07;3:5</Citation><ArticleIdList><ArticleId IdType="pubmed">17555558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17391354</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Sep;125(1-3):74-81</Citation><ArticleIdList><ArticleId IdType="pubmed">20034673</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2010;32 Suppl 1:S94-S104</Citation><ArticleIdList><ArticleId IdType="pubmed">20883145</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2018 Dec 1;241:436-445</Citation><ArticleIdList><ArticleId IdType="pubmed">30145515</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2018 May;20(3):228-237</Citation><ArticleIdList><ArticleId IdType="pubmed">29121444</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2009 Mar;35(2):347-61</Citation><ArticleIdList><ArticleId IdType="pubmed">19176470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):93-102</Citation><ArticleIdList><ArticleId IdType="pubmed">17391353</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Dec 15;142(1-3):13-21</Citation><ArticleIdList><ArticleId IdType="pubmed">22840620</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2011 May;41(5):971-82</Citation><ArticleIdList><ArticleId IdType="pubmed">20810001</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Apr;60(4):402-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12695318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2017 Dec;19(8):614-626</Citation><ArticleIdList><ArticleId IdType="pubmed">28895274</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2017 Mar;249:268-274</Citation><ArticleIdList><ArticleId IdType="pubmed">28135597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Jun;10(4):511-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18452447</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):214-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25172270</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Sep 25;150(3):1152-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23790741</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2017 Mar;135(3):239-249</Citation><ArticleIdList><ArticleId IdType="pubmed">27995622</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):749-755</Citation><ArticleIdList><ArticleId IdType="pubmed">28534186</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Adolesc Psychiatry Ment Health. 2017 Jul 12;11:34</Citation><ArticleIdList><ArticleId IdType="pubmed">28706563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):183-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17391360</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2016 Oct;26(10):1638-48</Citation><ArticleIdList><ArticleId IdType="pubmed">27511320</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2018 Aug;266:309-316</Citation><ArticleIdList><ArticleId IdType="pubmed">29598836</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacol Hung. 2016 Mar;18(1):57-67</Citation><ArticleIdList><ArticleId IdType="pubmed">27038871</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Res Ther. 2013 Jul;51(7):338-43</Citation><ArticleIdList><ArticleId IdType="pubmed">23639299</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2016 Apr;194:9-15</Citation><ArticleIdList><ArticleId IdType="pubmed">26800305</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2011 May;72(5):692-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20673560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 May;12(3):319-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20565439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2001;27(2):235-45</Citation><ArticleIdList><ArticleId IdType="pubmed">11354591</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Psychol. 2017 Oct 10;8:1750</Citation><ArticleIdList><ArticleId IdType="pubmed">29066991</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Psychiatr Care. 2014 Jan;50(1):44-50</Citation><ArticleIdList><ArticleId IdType="pubmed">24308864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Mar;16(2):159-71</Citation><ArticleIdList><ArticleId IdType="pubmed">24636366</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Qual Life Outcomes. 2005 Nov 15;3:72</Citation><ArticleIdList><ArticleId IdType="pubmed">16288650</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2009;78(5):285-97</Citation><ArticleIdList><ArticleId IdType="pubmed">19602917</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2017 Sep;45:190-197</Citation><ArticleIdList><ArticleId IdType="pubmed">28957786</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2010 Oct;16(5):298-307</Citation><ArticleIdList><ArticleId IdType="pubmed">19895584</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2012 Dec 1;72(11):943-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22770649</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Apr 30;186(2-3):254-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20647154</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Feb;161(2):262-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14754775</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Bipolar Disord. 2017 Dec;5(1):10</Citation><ArticleIdList><ArticleId IdType="pubmed">28188565</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1990 Dec;47(12):1106-11</Citation><ArticleIdList><ArticleId IdType="pubmed">2244795</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Rehabil J. 2017 Mar;40(1):53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">27100095</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Feb;209:147-154</Citation><ArticleIdList><ArticleId IdType="pubmed">27914248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):156-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19505727</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Feb;157(2):220-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10671390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2010 Nov 1;88(11):815-23</Citation><ArticleIdList><ArticleId IdType="pubmed">21076562</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2016 Jan;208(1):87-93</Citation><ArticleIdList><ArticleId IdType="pubmed">26541692</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Jan 15;171:13-21</Citation><ArticleIdList><ArticleId IdType="pubmed">25282145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 May;10(3):437-42</Citation><ArticleIdList><ArticleId IdType="pubmed">18402632</ArticleId></ArticleIdList></Reference><Reference><Citation>Disabil Rehabil. 2013;35(25):2138-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23586666</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Dec 1;223:10-16</Citation><ArticleIdList><ArticleId IdType="pubmed">28711743</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2014 Mar;29(3):134-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23276524</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 Dec;75(12):1347-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25099079</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 May;155(5):646-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9585716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Mar;17(2):128-38</Citation><ArticleIdList><ArticleId IdType="pubmed">25346391</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2014 Jun;75(6):e587-93</Citation><ArticleIdList><ArticleId IdType="pubmed">25004200</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2010 Dec;100(12):2366-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20966364</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2017 Apr;27(4):350-359</Citation><ArticleIdList><ArticleId IdType="pubmed">28126401</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2014 Sep 30;219(1):122-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24880581</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2013 Aug;170(8):852-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23511717</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Q. 2000 Winter;71(4):309-29</Citation><ArticleIdList><ArticleId IdType="pubmed">11025910</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2011 Mar;68(3):241-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21383262</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Ther. 2013 Jul;30(7):671-83</Citation><ArticleIdList><ArticleId IdType="pubmed">23839119</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Aug;70(8):1120-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19758523</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Sep;11(6):650-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19689507</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatry Neurosci. 2006 Mar;31(2):84-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16575423</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2002 Feb;63(2):120-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11874212</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2016 Oct;15(3):288-289</Citation><ArticleIdList><ArticleId IdType="pubmed">27717267</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2015 Aug 15;78(4):270-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25641635</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Feb;60(2):145-52</Citation><ArticleIdList><ArticleId IdType="pubmed">12578431</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Bipolar Disord. 2013 Oct 1;1(1):24</Citation><ArticleIdList><ArticleId IdType="pubmed">24660139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Sep;12(6):616-26</Citation><ArticleIdList><ArticleId IdType="pubmed">20868460</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2015 Feb;25(2):151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25661911</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2017;86(2):90-98</Citation><ArticleIdList><ArticleId IdType="pubmed">28183076</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Bipolar Disord. 2018 Sep 4;6(1):20</Citation><ArticleIdList><ArticleId IdType="pubmed">30178112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Jan 15;208:406-413</Citation><ArticleIdList><ArticleId IdType="pubmed">27810725</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2017 Nov/Dec;78(9):e1242-e1249</Citation><ArticleIdList><ArticleId IdType="pubmed">29045770</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2018 Aug;138(2):145-154</Citation><ArticleIdList><ArticleId IdType="pubmed">29726004</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2018 Mar 15;229:177-185</Citation><ArticleIdList><ArticleId IdType="pubmed">29316520</ArticleId></ArticleIdList></Reference><Reference><Citation>Prim Care Companion J Clin Psychiatry. 2010;12(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">21274359</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Jan 10;144(1-2):65-71</Citation><ArticleIdList><ArticleId IdType="pubmed">22862890</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2017 Dec;258:250-254</Citation><ArticleIdList><ArticleId IdType="pubmed">28844560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers. 2018 Oct;86(5):888-901</Citation><ArticleIdList><ArticleId IdType="pubmed">29171877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Psychiatry. 2016 Dec;3(12):1095-1096</Citation><ArticleIdList><ArticleId IdType="pubmed">28100424</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2017 Oct;27(10):959-969</Citation><ArticleIdList><ArticleId IdType="pubmed">28882405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2016 Mar;18(2):164-73</Citation><ArticleIdList><ArticleId IdType="pubmed">26946486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2017 Sep/Oct;78(8):e924-e932</Citation><ArticleIdList><ArticleId IdType="pubmed">28994517</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Apr;107(1-3):275-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17884176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Jun;17(4):424-37</Citation><ArticleIdList><ArticleId IdType="pubmed">25495748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp Community Psychiatry. 1988 Jun;39(6):652-7</Citation><ArticleIdList><ArticleId IdType="pubmed">3402925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Psiquiatr Salud Ment. 2015 Jul-Sep;8(3):117-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25959401</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2018 Mar 1;228:153-159</Citation><ArticleIdList><ArticleId IdType="pubmed">29248821</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Apr 01;212:128-137</Citation><ArticleIdList><ArticleId IdType="pubmed">28160685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Psychiatry. 2017 Mar;4(3):208-217</Citation><ArticleIdList><ArticleId IdType="pubmed">28185899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Sep;219:201-208</Citation><ArticleIdList><ArticleId IdType="pubmed">28570966</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2009 Jan 30;165(1-2):163-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19042030</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2016 May 23;16:157</Citation><ArticleIdList><ArticleId IdType="pubmed">27215976</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychologia. 2009 Aug;47(10):2015-28</Citation><ArticleIdList><ArticleId IdType="pubmed">19467352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):3-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17391344</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 12;10(6):e0127955</Citation><ArticleIdList><ArticleId IdType="pubmed">26070195</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2018 Nov;240:57-62</Citation><ArticleIdList><ArticleId IdType="pubmed">30053684</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2018 Sep 12;19(1):487</Citation><ArticleIdList><ArticleId IdType="pubmed">30208971</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30714166</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1467-6494</ISSN><JournalIssue CitedMedium="Internet"><Volume>88</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>Journal of personality</Title><ISOAbbreviation>J Pers</ISOAbbreviation></Journal><ArticleTitle>Identity in bipolar disorder: Self-worth and achievement.</ArticleTitle><Pagination><MedlinePgn>45-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jopy.12461</ELocationID><Abstract><AbstractText>This article considers self and self-concept in bipolar disorder. Bipolar disorder, defined on the basis of manic symptoms, is a highly debilitating psychopathology. It is heavily grounded in biology but symptom course is still very responsive to psychological and social forces in the lives of persons who have the disorder. This review assumes an overall view of the self that is typical of personality psychology: self as traits, self as goals and aspirations, and ongoing efforts to attain those goals. In this review, we will discuss two different facets of self and identity in bipolar disorder. First, we review a body of goal pursuit literature suggesting that persons with bipolar disorder endorse heightened ambitions for attaining goals and recognition from others. Second, we will review multiple findings which suggest that among persons with bipolar disorder, self-worth depends on measurable success in an extreme way. We will consider how the intersection of these two themes may lead to unique identity challenges for people with bipolar disorder, drawing from self-report, behavioral, and neuroscience findings to critically examine this viewpoint.</AbstractText><CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ironside</LastName><ForeName>Manon L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-7593-230X</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of California, Berkeley, Berkeley, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sheri L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of California, Berkeley, Berkeley, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carver</LastName><ForeName>Charles S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Miami, Coral Gables, Florida.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH076021</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH110477</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pers</MedlineTA><NlmUniqueID>2985194R</NlmUniqueID><ISSNLinking>0022-3506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004532" MajorTopicYN="Y">Ego</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012649" MajorTopicYN="Y">Self Concept</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">ambition</Keyword><Keyword MajorTopicYN="Y">behavioral activation system</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">contingent self-worth</Keyword><Keyword MajorTopicYN="Y">identity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>06</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30714166</ArticleId><ArticleId IdType="doi">10.1111/jopy.12461</ArticleId><ArticleId IdType="pmc">PMC6679801</ArticleId><ArticleId IdType="mid">NIHMS1015168</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Affect Disord. 2010 May;122(3):294-300</Citation><ArticleIdList><ArticleId IdType="pubmed">19773086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2007 May;116(2):313-28</Citation><ArticleIdList><ArticleId IdType="pubmed">17516764</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Apr 1;63(7):693-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17919457</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry. 2008 Summer;71(2):123-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18573034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Aug;8(4):362-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16879137</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2012 Aug;121(3):602-609</Citation><ArticleIdList><ArticleId IdType="pubmed">22103804</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Soc Psychol. 2002 Apr;82(4):610-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11999927</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Rev. 2010 Aug;30(6):721-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20579791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Mar 15;174:180-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25499686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2000 May;109(2):222-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10895560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Aug;8(4):382-99</Citation><ArticleIdList><ArticleId IdType="pubmed">16879139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Sep 25;150(3):948-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23759280</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Jun 1;178:160-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25837549</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Expect. 2009 Jun;12(2):120-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19538647</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 Nov;187:431-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16260818</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Rev. 2005 May;25(3):307-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Psychother. 2011 Sep-Oct;18(5):397-410</Citation><ArticleIdList><ArticleId IdType="pubmed">21887813</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2009 Aug;118(3):459-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19685944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognit Ther Res. 2013 Feb;37(1):139-149</Citation><ArticleIdList><ArticleId IdType="pubmed">23459574</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Sci. 2010 Jul;21(7):1021-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20519486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Aug;9(5):490-5</Citation><ArticleIdList><ArticleId IdType="pubmed">17680919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1986 Aug;95(3):214-22</Citation><ArticleIdList><ArticleId IdType="pubmed">3745642</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2000 Mar;30(2):467-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10824667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Psychopharmacol. 2010 Jan;25(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">20041478</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rev. 2001 Jul;108(3):593-623</Citation><ArticleIdList><ArticleId IdType="pubmed">11488379</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rev. 2009 Jan;116(1):252-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19159156</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Apr 25;146(3):407-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23021378</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Bull. 2005 Jan;131(1):76-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15631554</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Rev. 1995 Apr;102(2):246-68</Citation><ArticleIdList><ArticleId IdType="pubmed">7740090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognit Ther Res. 2009 Dec;33(6):552-569</Citation><ArticleIdList><ArticleId IdType="pubmed">20376291</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Jul;66(7):914-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16013908</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2009 Feb;194(2):146-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19182176</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2015 Jan;28(1):7-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25415499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 Feb;117(1):164-70</Citation><ArticleIdList><ArticleId IdType="pubmed">18266494</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2015 Jan 1;170:52-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25233239</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Rev. 2012 Feb;32(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">22088366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):183-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17391360</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Nov;157(11):1873-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11058490</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol. 2009 Sep;65(9):891-905</Citation><ArticleIdList><ArticleId IdType="pubmed">19455611</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Psychol Sci. 2016 May;4(3):451-463</Citation><ArticleIdList><ArticleId IdType="pubmed">27274949</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2011 Nov;134(1-3):102-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21641043</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2006 May 10;26(19):5160-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16687507</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2017 Feb;209:147-154</Citation><ArticleIdList><ArticleId IdType="pubmed">27914248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Soc Psychol. 1992 May;62(5):804-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1593420</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2013 Sep;43(9):1895-907</Citation><ArticleIdList><ArticleId IdType="pubmed">23194640</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2015 Feb;124(1):93-101</Citation><ArticleIdList><ArticleId IdType="pubmed">25688436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chronic Illn. 2011 Sep;7(3):209-24</Citation><ArticleIdList><ArticleId IdType="pubmed">21357643</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2003 May-Jun;37(3):187-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12650739</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Health Res. 2014 Jun 6;24(7):890-900</Citation><ArticleIdList><ArticleId IdType="pubmed">24970246</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2008 Aug;199(3):457-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18311558</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 May;117(2):268-277</Citation><ArticleIdList><ArticleId IdType="pubmed">18489203</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Psychol. 1989;40:457-92</Citation><ArticleIdList><ArticleId IdType="pubmed">2648983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Res Pers. 2008 Dec;42(6):1427-1438</Citation><ArticleIdList><ArticleId IdType="pubmed">20376289</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1980 Feb;137(2):198-202</Citation><ArticleIdList><ArticleId IdType="pubmed">7352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cognit Ther Res. 2006;30(3):377-395</Citation><ArticleIdList><ArticleId IdType="pubmed">20198117</ArticleId></ArticleIdList></Reference><Reference><Citation>J Behav Med. 1981 Mar;4(1):1-39</Citation><ArticleIdList><ArticleId IdType="pubmed">7288876</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2012 May;121(2):339-351</Citation><ArticleIdList><ArticleId IdType="pubmed">22004113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2007 Feb;116(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17324021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol. 2012 Jul;68(7):829-42</Citation><ArticleIdList><ArticleId IdType="pubmed">22623269</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 Feb;117(1):154-63</Citation><ArticleIdList><ArticleId IdType="pubmed">18266493</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Behav Neurosci. 2009 Sep 07;3:13</Citation><ArticleIdList><ArticleId IdType="pubmed">19826615</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2008 Nov;117(4):838-848</Citation><ArticleIdList><ArticleId IdType="pubmed">19025230</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychopathol Behav Assess. 2001 Sep 1;23(3):133-143</Citation><ArticleIdList><ArticleId IdType="pubmed">21765592</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2005 Jan;35(1):69-77</Citation><ArticleIdList><ArticleId IdType="pubmed">15842030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Dec;6(6):480-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15541063</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cogn Ther. 2009;2(2):176-187</Citation><ArticleIdList><ArticleId IdType="pubmed">20360995</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2014 Jan 30;215(1):61-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24182545</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2005 Nov;114(4):689-696</Citation><ArticleIdList><ArticleId IdType="pubmed">16351389</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurobiol. 2017 Apr;43:139-148</Citation><ArticleIdList><ArticleId IdType="pubmed">28390863</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 May;39(5):559-65</Citation><ArticleIdList><ArticleId IdType="pubmed">6124223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 2000 Nov;109(4):721-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11195996</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pers Soc Psychol. 1993 Dec;65(6):1190-204</Citation><ArticleIdList><ArticleId IdType="pubmed">8295118</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2002 Mar;105(3):164-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11939969</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Oct;66(10):1072-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19805697</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Clin Psychol. 2012;8:243-67</Citation><ArticleIdList><ArticleId IdType="pubmed">22077912</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Dec;151(3):1016-24</Citation><ArticleIdList><ArticleId IdType="pubmed">24064398</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2015 Nov;58:4-18</Citation><ArticleIdList><ArticleId IdType="pubmed">26297513</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2010 Jan;121(1):60-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19900840</ArticleId></ArticleIdList></Reference><Reference><Citation>Issues Ment Health Nurs. 2008 Nov;29(11):1217-36</Citation><ArticleIdList><ArticleId IdType="pubmed">18979326</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Apr;79(1-3):193-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15023494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2017 May;22(5):666-679</Citation><ArticleIdList><ArticleId IdType="pubmed">28289283</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Inq. 2018;29(3):139-144</Citation><ArticleIdList><ArticleId IdType="pubmed">31447528</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Cogn Sci. 2015 Sep;19(9):515-23</Citation><ArticleIdList><ArticleId IdType="pubmed">26231761</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25406047</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-1145</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of psychiatric practice</Title><ISOAbbreviation>J Psychiatr Pract</ISOAbbreviation></Journal><ArticleTitle>Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians.</ArticleTitle><Pagination><MedlinePgn>428-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/01.pra.0000456591.20622.9e</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients with adult attention-deficit/ hyperactivity disorder (ADHD) and bipolar disorder can present with similar symptoms, including increased energy, distractibility, disorganization, impulsivity, hyperactivity, and rapid speech. Determining whether the patient has either, or possibly both, of these syndromes can be a complex task. This review attempts to clarify where these disorders overlap, both symptomatically and epidemiologically, and where they diverge, to help clinicians increase the accuracy of their diagnoses. Changes to diagnostic criteria from the fourth to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (from DSM-IV-TR to DSM-5) are discussed, as is the evidence base for pharmacological treatments.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Studies and sources were identified using computerized searches.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adult ADHD and bipolar disorder have multiple overlapping symptoms, but there are differences in prevalence (ADHD affects 4.4% of adults in the United States versus 1.4% for bipolar disorder), onset of symptoms (usually before age 7 years in ADHD versus after age 12 years in bipolar disorder), disease course (chronic in ADHD versus cyclical in bipolar disorder), mood symptoms (absent in ADHD but always present in bipolar disorder), and psychotic symptoms (absent in ADHD but sometimes present in bipolar disorder). Approximately 20% of adult patients with ADHD also have bipolar disorder, while 10%-20% of patients with bipolar disorder have adult ADHD. Comorbidity of bipolar disorder and ADHD is associated with an earlier age of onset and a more chronic and disabling course of bipolar disorder, as well as more psychiatric comorbidity.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Distinguishing between adult ADHD and bipolar disorder requires careful attention to phenomenology and awareness of epidemiology, with a focus on childhood history, lifetime course of symptoms, and the possibility of comorbidity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brus</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>BRUS: Icahn School of Medicine at Mt. Sinai, New York, NY; SOLANTO: New York University School of Medicine, New York, NY; GOLDBERG: Icahn School of Medicine at Mt. Sinai and Silver Hill Hospital, New Canaan, CT.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solanto</LastName><ForeName>Mary V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Psychiatr Pract</MedlineTA><NlmUniqueID>100901141</NlmUniqueID><ISSNLinking>1527-4160</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="Y">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25406047</ArticleId><ArticleId IdType="doi">10.1097/01.pra.0000456591.20622.9e</ArticleId><ArticleId IdType="pii">00131746-201411000-00003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32040337</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1548-5951</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2020</Year><Month>05</Month><Day>07</Day></PubDate></JournalIssue><Title>Annual review of clinical psychology</Title><ISOAbbreviation>Annu Rev Clin Psychol</ISOAbbreviation></Journal><ArticleTitle>Creativity and Bipolar Disorder: A Shared Genetic Vulnerability.</ArticleTitle><Pagination><MedlinePgn>239-264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1146/annurev-clinpsy-050718-095449</ELocationID><Abstract><AbstractText>Bipolar disorder is a lifelong mood disorder characterized by extreme mood swings between mania and depression. Despite fitness costs associated with increased mortality and significant impairment, bipolar disorder has persisted in the population with a high heritability and a stable prevalence. Creativity and other positive traits have repeatedly been associated with the bipolar spectrum, particularly among unaffected first-degree relatives and those with milder expressions of bipolar traits. This suggests a model in which large doses of risk variants cause illness, but mild to moderate doses confer advantages, which serve to maintain bipolar disorder in the population. Bipolar disorder may thus be better conceptualized as a dimensional trait existing at the extreme of normal population variation in positive temperament, personality, and cognitive traits, aspects of which may reflect a shared vulnerability with creativity. Investigations of this shared vulnerability may provide insight into the genetic mechanisms underlying illness and suggest novel treatments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Tiffany A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California, San Diego, La Jolla, California 92093, USA; email: tgreenwood@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Rev Clin Psychol</MedlineTA><NlmUniqueID>101235325</NlmUniqueID><ISSNLinking>1548-5943</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003405" MajorTopicYN="Y">Creativity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">creativity</Keyword><Keyword MajorTopicYN="Y">evolution</Keyword><Keyword MajorTopicYN="Y">genetics</Keyword><Keyword MajorTopicYN="Y">psychosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32040337</ArticleId><ArticleId IdType="doi">10.1146/annurev-clinpsy-050718-095449</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30451546</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>01</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Biomarkers for bipolar disorder: current status and challenges ahead.</ArticleTitle><Pagination><MedlinePgn>67-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14737175.2019.1550361</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Bipolar disorder (BD) is a chronic psychiatric disorder marked by clinical and pathophysiological heterogeneity. There is a high expectation that personalized approaches can improve the management of patients with BD. For that, identification and validation of potential biomarkers are fundamental. Areas covered: This manuscript will critically review the current status of different biomarkers for BD, including peripheral, genetic, neuroimaging, and neurophysiological candidates, discussing the challenges to move the field forward. Expert commentary: There are no lab or complementary tests currently recommended for the diagnosis or management of patients with BD. Panels composed by multiple biomarkers will probably contribute to stratifying patients according to their clinical stage, therapeutic response, and prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Antonio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry &amp; Behavioral Sciences , McGovern Medical School, UT Health , Houston , TX , USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina , Universidade Federal de Minas Gerais (UFMG) , Belo Horizonte , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colpo</LastName><ForeName>Gabriela D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry &amp; Behavioral Sciences , McGovern Medical School, UT Health , Houston , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fries</LastName><ForeName>Gabriel R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry &amp; Behavioral Sciences , McGovern Medical School, UT Health , Houston , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Isabelle E</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry &amp; Behavioral Sciences , McGovern Medical School, UT Health , Houston , TX , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvaraj</LastName><ForeName>Sudhakar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>a Department of Psychiatry &amp; Behavioral Sciences , McGovern Medical School, UT Health , Houston , TX , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">biomarkers</Keyword><Keyword MajorTopicYN="Y">genetics</Keyword><Keyword MajorTopicYN="Y">inflammation markers</Keyword><Keyword MajorTopicYN="Y">neuroimaging</Keyword><Keyword MajorTopicYN="Y">neurophysiological markers</Keyword><Keyword MajorTopicYN="Y">oxidative stress markers</Keyword><Keyword MajorTopicYN="Y">personalized psychiatry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30451546</ArticleId><ArticleId IdType="doi">10.1080/14737175.2019.1550361</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21536161</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2011</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3147</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Geriatric bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>319-33, vii</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psc.2011.02.007</ELocationID><Abstract><AbstractText>Because the elderly are the fastest growing segment of the population, the number of older adults with bipolar disorder is increasing. Geriatric bipolar disorder is relatively rare, with an estimated lifetime prevalence of 0.5% to 1%, although approximately 4% to 17% of older patients in clinical psychiatric settings have bipolar disorder. Bipolar elders are disproportionately affected by medical burden. Given the complex nature of this disorder, comorbidity, and behavioral disturbances, various interventions may be indicated, including pharmacotherapies, electroconvulsive therapy, psychotherapies, and integrated care models. Additional research is needed to better understand the epidemiology, phenomenology, and treatment of geriatric bipolar disorder.</AbstractText><CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sajatovic</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106, USA. Martha.sajatovic@uhhospitals.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peijun</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="N">Electroconvulsive Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21536161</ArticleId><ArticleId IdType="pii">S0193-953X(11)00025-6</ArticleId><ArticleId IdType="doi">10.1016/j.psc.2011.02.007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20461491</PMID><DateCompleted><Year>2011</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-3524</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Neurotoxicity research</Title><ISOAbbreviation>Neurotox Res</ISOAbbreviation></Journal><ArticleTitle>Staging bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>279-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-010-9197-8</ELocationID><Abstract><AbstractText>The purpose of this study was to analyze the evidence supporting a staging model for bipolar disorder. The authors conducted an extensive Medline and Pubmed search of the published literature using a variety of search terms (staging, bipolar disorder, early intervention) to find relevant articles, which were reviewed in detail. Only recently specific proposals have been made to apply clinical staging to bipolar disorder. The staging model in bipolar disorder suggests a progression from prodromal (at-risk) to more severe and refractory presentations (Stage IV). A staging model implies a longitudinal appraisal of different aspects: clinical variables, such as number of episodes and subsyndromal symptoms, functional and cognitive impairment, comorbidity, biomarkers, and neuroanatomical changes. Staging models are based on the fact that response to treatment is generally better when it is introduced early in the course of the illness. It assumes that earlier stages have better prognosis and require simpler therapeutic regimens. Staging may assist in bipolar disorder treatment planning and prognosis, and emphasize the importance of early intervention. Further research is required in this exciting and novel area.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bipolar Disorders Program, Institute of Neuroscience, Hospital Clínic Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, Villarroel 170, 08036 Barcelona, Spain. evieta@clinic.ub.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinares</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotox Res</MedlineTA><NlmUniqueID>100929017</NlmUniqueID><ISSNLinking>1029-8428</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20461491</ArticleId><ArticleId IdType="doi">10.1007/s12640-010-9197-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Psychiatry Res. 2007 Sep 30;153(1):27-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17582509</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Jun;164(6):859-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17541042</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Psychiatry. 2008 Sep;30(3):243-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18833425</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1993 Apr;87(4):225-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8488741</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1999;249(5):227-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10591987</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2004 May;109(5):339-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15049770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Jun;9(4):324-38</Citation><ArticleIdList><ArticleId IdType="pubmed">17547579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Nov;9(7):671-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17988356</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Mar;158(3):420-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11229983</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2009 Jul;9(7):957-66</Citation><ArticleIdList><ArticleId IdType="pubmed">19589046</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 Jul;33(4):886-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17562693</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropsychiatr. 2010 Apr;22(2):50-3</Citation><ArticleIdList><ArticleId IdType="pubmed">25385029</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1355-61</Citation><ArticleIdList><ArticleId IdType="pubmed">18316149</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1986 Aug;149:191-201</Citation><ArticleIdList><ArticleId IdType="pubmed">3535979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):127-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19541368</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2008 Aug;2(3):136-46</Citation><ArticleIdList><ArticleId IdType="pubmed">19649153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17391354</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2007 Mar 19;415(1):87-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17234344</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Sep 1;60(5):432-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16581033</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2009 Apr;43(7):721-3</Citation><ArticleIdList><ArticleId IdType="pubmed">19081579</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatry Neurosci. 2009 Jul;34(4):263-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19568477</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2006 Aug;40(8):616-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16866756</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci. 2006 Jun 13;79(3):281-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16460767</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1366-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19666076</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2008;32(4):675-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18199480</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Aug;156(8):1264-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10450271</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Oct 15;62(8):894-900</Citation><ArticleIdList><ArticleId IdType="pubmed">17617385</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2009 Feb;12(1):137-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18845016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Feb;8(1):65-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16411982</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2008 Oct;7(3):148-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18836582</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Jun;123(1-3):81-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19853922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16542180</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2001 Feb;178:172-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11157432</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Aug;116(3):214-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19251324</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2006 Oct 23;407(2):146-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16959421</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2006 May 8;398(3):215-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16480819</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):156-60</Citation><ArticleIdList><ArticleId IdType="pubmed">19505727</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Jun;100(1-3):279-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17433450</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Nov;159(11):1841-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12411217</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Feb;5(1):53-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12656939</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1998 Jan;47(1-3):31-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9476741</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2009;42(4):209-18</Citation><ArticleIdList><ArticleId IdType="pubmed">19451753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Jan;67(1):95-101</Citation><ArticleIdList><ArticleId IdType="pubmed">16426094</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Apr;114(1-3):1-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18819715</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand Suppl. 2007;(434):17-26</Citation><ArticleIdList><ArticleId IdType="pubmed">17688459</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Apr 1;59(7):611-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16414030</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Apr;188:313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16582056</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2013 Jan;28(1):21-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22534552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1997 May 17;349(9063):1436-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9164317</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroreport. 2005 Apr 25;16(6):541-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15812303</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Jun;11(4):401-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19500093</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2009 Jan;194(1):18-24</Citation><ArticleIdList><ArticleId IdType="pubmed">19118320</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2009 May;12(4):447-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18771602</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2006 Mar;40(3):199-207</Citation><ArticleIdList><ArticleId IdType="pubmed">16476146</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2008 Aug;2(3):122-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19649152</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1992 Aug;149(8):999-1010</Citation><ArticleIdList><ArticleId IdType="pubmed">1353322</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258(5):300-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18297417</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">28647815</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Current psychiatry reports</Title><ISOAbbreviation>Curr Psychiatry Rep</ISOAbbreviation></Journal><ArticleTitle>Update on the Epidemiology, Diagnosis, and Treatment of Mania in Older-Age Bipolar Disorder.</ArticleTitle><Pagination><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11920-017-0804-8</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">The population over age 60 is growing more rapidly than the general population. Given the projected increase and need for data that can inform treatment, this review provides a brief description of newer publications focused on mania in older-age bipolar disorder (OABD), including epidemiology, diagnosis, and treatments.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Age cutoffs to define OABD range from 50 to 65 years. OABD clinical presentation and course of illness is highly variable, often characterized by mood episode recurrence, medical comorbidity, cognitive deficits, and impaired functioning. There is little pharmacotherapy data on mania in OABD. Lithium and valproate have been tested in a single randomized controlled trial and there is data of more limited quality with other compounds. Treating OABD is challenging due to medical complexity, comorbidity, diminished tolerance to treatment, and a limited evidence base. More data is needed to keep pace with clinical demand.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peijun</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University School of Medicine, Louis Stokes Veterans Administration Medical Center, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dols</LastName><ForeName>Annemiek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Old Age Psychiatry, GGZ inGeest, VU University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rej</LastName><ForeName>Soham</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jewish General Hospital/Lady Davis Institute, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sajatovic</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Psychiatry and of Neurology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, 10524 Euclid Avenue, Cleveland, OH, 44106, USA. Martha.sajatovic@uhhospitals.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Psychiatry Rep</MedlineTA><NlmUniqueID>100888960</NlmUniqueID><ISSNLinking>1523-3812</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Geriatric</Keyword><Keyword MajorTopicYN="N">Mania</Keyword><Keyword MajorTopicYN="N">Manic-depressive disorder</Keyword><Keyword MajorTopicYN="N">Mood stabilizers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28647815</ArticleId><ArticleId IdType="doi">10.1007/s11920-017-0804-8</ArticleId><ArticleId IdType="pii">10.1007/s11920-017-0804-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Psychiatry. 2017 Jan 1;174(1):70-76</Citation><ArticleIdList><ArticleId IdType="pubmed">27523498</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2017 Jan;78(1):129-137</Citation><ArticleIdList><ArticleId IdType="pubmed">27780336</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1998 May 15;43(10):705-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9606523</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2003 Oct;253(5):236-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14504992</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Feb;15(1):1-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23237061</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurol. 2010 Dec;23(6):628-32</Citation><ArticleIdList><ArticleId IdType="pubmed">20962637</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2000 Oct;2(5):440-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11122994</ArticleId></ArticleIdList></Reference><Reference><Citation>J Geriatr Psychiatry Neurol. 1995 Oct;8(4):234-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8561838</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2008 Dec;53(12):822-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19087480</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatry (London). 2013 Dec 1;3(6):621-633</Citation><ArticleIdList><ArticleId IdType="pubmed">24999372</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1993 Jul;150(7):1063-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8317577</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1988 Feb;145(2):172-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3341462</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 1997;33(1):113-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9133761</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Oct;70(10):1407-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19906344</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2008 Nov;16(11):922-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18978253</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1993 Feb;43(2):250-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8094895</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol. 2013 Apr;260(4):1155-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23314407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Feb;5(1):22-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12656934</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Oct;6(5):368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15383128</ArticleId></ArticleIdList></Reference><Reference><Citation>Maturitas. 2010 Jul;66(3):231-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20307944</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Aug;116(3):176-83</Citation><ArticleIdList><ArticleId IdType="pubmed">19087895</ArticleId></ArticleIdList></Reference><Reference><Citation>Funct Neurol. 2012 Jul-Sep;27(3):193-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23402681</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2010 Jul;25(7):732-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19823987</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Dec;64(12):1483-94</Citation><ArticleIdList><ArticleId IdType="pubmed">14728111</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Psychogeriatr. 2002 Sep;14(3):311-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12475092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2016 Mar;18(2):148-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26961121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Sep;15(6):633-44</Citation><ArticleIdList><ArticleId IdType="pubmed">23651122</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 2006 Nov;63(11):1627-31</Citation><ArticleIdList><ArticleId IdType="pubmed">17101833</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Sep;16(6):667-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24798095</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1999 Mar;60(3):181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10192594</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2014 Apr 1;75(7):565-73</Citation><ArticleIdList><ArticleId IdType="pubmed">24629669</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2008 Oct;42(13):1068-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18262204</ArticleId></ArticleIdList></Reference><Reference><Citation>J Alzheimers Dis. 2011;27(4):791-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 1993 Mar;38(2):137-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8467440</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1990 Nov 21;264(19):2511-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2232018</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Oct 24;9(10 ):e107829</Citation><ArticleIdList><ArticleId IdType="pubmed">25343370</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Sep;11(6):559-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Nov;162(11):2033-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16263839</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1996 Jun;57(6):238-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8666559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 May;9(3):301-4</Citation><ArticleIdList><ArticleId IdType="pubmed">17430306</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1995 Nov;56(11):514-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7592504</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Jun;73(6):803-10</Citation><ArticleIdList><ArticleId IdType="pubmed">22795205</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimers Dement. 2011 May;7(3):263-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2016 May 17;12:1203-13</Citation><ArticleIdList><ArticleId IdType="pubmed">27274256</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2009 Jul;197(7):471-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19597353</ArticleId></ArticleIdList></Reference><Reference><Citation>J Geriatr Psychiatry Neurol. 2003 Jun;16(2):117-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12807075</ArticleId></ArticleIdList></Reference><Reference><Citation>Vertex. 2015 Jul-Aug;26(122):265-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26672503</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1983 Feb;13(1):53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">6405416</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Oct;6(5):343-67</Citation><ArticleIdList><ArticleId IdType="pubmed">15383127</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):319-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16449489</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Pract. 2013 Nov;19(6):498-500</Citation><ArticleIdList><ArticleId IdType="pubmed">24241504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2014 Mar;16(2):113-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23919307</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Case Rep. 2011 Feb 02;2011:null</Citation><ArticleIdList><ArticleId IdType="pubmed">22714610</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Jul;66(7):785-95</Citation><ArticleIdList><ArticleId IdType="pubmed">19581570</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1991 Nov;52(11):472-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1744065</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1978 Nov;35(11):1333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">757997</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2006 Jun;21(6):582-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16783798</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):358-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22399793</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatry Neuropsychol Behav Neurol. 1999 Jan;12(1):35-51</Citation><ArticleIdList><ArticleId IdType="pubmed">10082332</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Apr;161(4):736-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15056521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 Nov;15(7):787-94</Citation><ArticleIdList><ArticleId IdType="pubmed">23992521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Feb;67(2):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16566616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Aug;3(4):181-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11552957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Nov;11(7):744-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19719787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Sep;10(6):662-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18837860</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2005 Apr;13(4):290-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15845754</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2017 Apr;47(6):1013-1029</Citation><ArticleIdList><ArticleId IdType="pubmed">27989245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Apr;61(4):304</Citation><ArticleIdList><ArticleId IdType="pubmed">10830157</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Feb 15;145(1):130-2</Citation><ArticleIdList><ArticleId IdType="pubmed">22877962</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Psychogeriatr. 2009 Aug;21(4):764-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19493381</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1970 Sep;127(3):345-51</Citation><ArticleIdList><ArticleId IdType="pubmed">5458599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Nov;17 (7):689-704</Citation><ArticleIdList><ArticleId IdType="pubmed">26384588</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1988 May-Jun;14(3):197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">2968383</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Feb;73(3):261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12547295</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 1998 Summer;6(3):257-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9659958</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2016 Aug;209(2):121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">27482038</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1983 Apr;142:391-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6405833</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Hum Neurosci. 2014 Nov 07;8:897</Citation><ArticleIdList><ArticleId IdType="pubmed">25426048</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2012 Mar;18(3):208-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22070456</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 2013 Nov;28(6):287-96</Citation><ArticleIdList><ArticleId IdType="pubmed">23873292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2010 May;81(5):547-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19965852</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1993 Jun;150(6):916-21</Citation><ArticleIdList><ArticleId IdType="pubmed">8494069</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 1999 Summer;7(3):188-202</Citation><ArticleIdList><ArticleId IdType="pubmed">10438689</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2008 Dec;23(12):1271-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18613269</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2014 Nov;22(11):1251-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23954039</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2009 Jun 30;168(1):67-77</Citation><ArticleIdList><ArticleId IdType="pubmed">19427705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Clin Psychiatry. 1998 Dec;10(4):165-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9988057</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2015 Sep;23(9):977-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25670662</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Jan;69(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18312036</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2015 Jul;30(7):710-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25335125</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Geriatr Psychiatry. 2006 Nov;21(11):1060-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16955445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2013 May;15(3):326-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23551834</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Geriatr Psychiatry. 2014 Nov;22(11):1066-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24495405</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1990 Nov;51(11):479-81</Citation><ArticleIdList><ArticleId IdType="pubmed">1977740</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain. 2011 Sep;134(Pt 9):2456-77</Citation><ArticleIdList><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Clin North Am. 2011 Jun;34(2):319-33, vii</Citation><ArticleIdList><ArticleId IdType="pubmed">21536161</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatry Neuropsychol Behav Neurol. 2000 Oct;13(4):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11186160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Dec;9(8):868-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18076536</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychiatr Dis Treat. 2016 Sep 07;12:2207-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27660450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11349478</PMID><DateCompleted><Year>2001</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-7125</ISSN><JournalIssue CitedMedium="Print"><Volume>85</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>May</Month></PubDate></JournalIssue><Title>The Medical clinics of North America</Title><ISOAbbreviation>Med Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>645-61, ix</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder (manic-depressive illness) is a common, recurrent, and severe psychiatric disorder that affects 1% to 3% of the US population. The illness is characterized by episodes of mania, depression, or mixed states (simultaneously occurring manic and depressive symptoms). Bipolar disorder frequently goes unrecognized and untreated for many years without clinical vigilance. New screening tools have been developed to assist physicians in making the diagnosis. Fortunately, several medications are now available to treat the acute mood episodes of bipolar disorder and to prevent further episodes with maintenance treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keck</LastName><ForeName>P E</ForeName><Initials>PE</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Psychiatry, Biological Psychiatry Program, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McElroy</LastName><ForeName>S L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Clin North Am</MedlineTA><NlmUniqueID>2985236R</NlmUniqueID><ISSNLinking>0025-7125</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="N">Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>79</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>5</Month><Day>15</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>6</Month><Day>2</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>5</Month><Day>15</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11349478</ArticleId><ArticleId IdType="pii">S0025-7125(05)70334-5</ArticleId><ArticleId IdType="doi">10.1016/s0025-7125(05)70334-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16097718</PMID><DateCompleted><Year>2005</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1088-0224</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3 Suppl</Issue><PubDate><Year>2005</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The American journal of managed care</Title><ISOAbbreviation>Am J Manag Care</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: disease burden.</ArticleTitle><Pagination><MedlinePgn>S80-4</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a chronic, severe, recurrent mood disorder. Traditional estimates of the prevalence of the disorder may underestimate the actual total disease burden. The condition can occur across a wide spectrum of ages, but the most common age of onset appears to be between the ages of 15 and 19. Bipolar disorder is often underdiagnosed or misdiagnosed, with profound negative clinical and economic consequences. Medical and psychiatric comorbidity is common in patients with bipolar disorder. Functional disability because of bipolar disorder is comparable with that of many chronic medical conditions. It has been estimated that the total annual societal cost of bipolar disorder may be as high as 45 billion dollars.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sajatovic</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Manag Care</MedlineTA><NlmUniqueID>9613960</NlmUniqueID><ISSNLinking>1088-0224</ISSNLinking></MedlineJournalInfo><CitationSubset>H</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="Y">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>47</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>9</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16097718</ArticleId><ArticleId IdType="pii">2889</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25351068</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-9018</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2014</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Nursing standard (Royal College of Nursing (Great Britain) : 1987)</Title><ISOAbbreviation>Nurs Stand</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7748/ns.29.9.19.s24</ELocationID><Abstract><AbstractText>Essential facts. Bipolar disorder is a potentially lifelong and disabling condition. Bipolar I, characterised by episodes of mania and depression, is estimated to affect 1 per cent of the adult population. Bipolar II, characterised by hypomania and depression, affects an estimated 0.4 per cent of adults. Episodes can vary in length and frequency.</AbstractText></Abstract><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nurs Stand</MedlineTA><NlmUniqueID>9012906</NlmUniqueID><ISSNLinking>0029-6570</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004509" MajorTopicYN="Y">Education, Nursing, Continuing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25351068</ArticleId><ArticleId IdType="doi">10.7748/ns.29.9.19.s24</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23645303</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0172-780X</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Neuro endocrinology letters</Title><ISOAbbreviation>Neuro Endocrinol Lett</ISOAbbreviation></Journal><ArticleTitle>Bipolar affective disorder and psychoeducation.</ArticleTitle><Pagination><MedlinePgn>83-96</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Bipolar affective disorder runs a natural course of frequent relapses and recurrences. Despite significant strides in the pharmacological treatment of bipolar disorder, most bipolar patients cannot be treated only by drugs. The limitations of using medication alone in symptomatic, relapse prevention, and satisfaction/quality of life terms have long prompted interest in wider forms of management. One of the promising way how to enhance remission seems to be combination of pharmacotherapy and psychoeducation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies were identified through PUBMED, Web of Science and Scopus databases as well as existing reviews. The search terms included "bipolar disorder", "psychoeducation", "psychotherapy", "psychosocial treatment", "family therapy", "individual therapy", "group therapy", and "psychoeducation". The search was performed by repeated use of the words in different combinations with no language or time limitations. This article is a review with conclusions concerned with psychoeducation in bipolar disorder.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Randomized controlled trials of cognitive behavioral therapy, interpersonal and social rhythm therapy, individual, group and family psychoeducation show that these approaches augment stabilizing effect of pharmacotherapy. Patients and their families should be educated about bipolar disorder, triggers, warning signs, mood relapse, suicidal ideation, and the effectiveness of early intervention to reduce complications. Psychosocial approaches are important therapeutic strategies for reducing relapse and rehospitalization in bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasko</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Hospital Olomouc, Olomouc, Czech Republic. prasko@fnol.cz</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ociskova</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kamaradova</LastName><ForeName>Dana</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Sedlackova</LastName><ForeName>Zuzana</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Cerna</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mainerova</LastName><ForeName>Barbora</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sandoval</LastName><ForeName>Aneta</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Neuro Endocrinol Lett</MedlineTA><NlmUniqueID>8008373</NlmUniqueID><ISSNLinking>0172-780X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005196" MajorTopicYN="N">Family Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="Y">Psychotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23645303</ArticleId><ArticleId IdType="pii">NEL340213R01</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14626095</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><JournalIssue CitedMedium="Print"><Issue>40</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Ryoikibetsu shokogun shirizu</Title><ISOAbbreviation>Ryoikibetsu Shokogun Shirizu</ISOAbbreviation></Journal><ArticleTitle>[Organic bipolar disorder].</ArticleTitle><Pagination><MedlinePgn>176-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Hideaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatry, Nippon Medical School.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Mahito</ForeName><Initials>M</Initials></Author></AuthorList><Language>jpn</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Ryoikibetsu Shokogun Shirizu</MedlineTA><NlmUniqueID>9501926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BMD2GNA4V</RegistryNumber><NameOfSubstance UI="D016651">Lithium Carbonate</NameOfSubstance></Chemical><Chemical><RegistryNumber>33CM23913M</RegistryNumber><NameOfSubstance UI="D002220">Carbamazepine</NameOfSubstance></Chemical><Chemical><RegistryNumber>614OI1Z5WI</RegistryNumber><NameOfSubstance UI="D014635">Valproic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002220" MajorTopicYN="N">Carbamazepine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016651" MajorTopicYN="N">Lithium Carbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014635" MajorTopicYN="N">Valproic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>15</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14626095</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27530107</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>08</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder? A meta-analytic review.</ArticleTitle><Pagination><MedlinePgn>389-403</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12419</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To identify clinical characteristics and adverse outcomes associated with an earlier age of onset of bipolar disorder.</AbstractText><AbstractText Label="METHODS">A comprehensive search yielded 15 empirical papers comparing clinical presentation and outcomes in individuals with bipolar disorder grouped according to age of onset (total N=7370). The following variables were examined to determine odds ratios (ORs) and 95% confidence intervals (CIs): presence of Axis I comorbidity, rapid cycling, psychotic symptoms, mixed episodes (DSM-IV), lifetime suicide attempts, lifetime alcohol and substance abuse, symptom severity, and treatment delay.</AbstractText><AbstractText Label="RESULTS">Early age of onset was found to be associated with longer delay to treatment (Hedges' g=0.39, P=.001), greater severity of depression (Hedges' g=0.42, P&lt;.001), and higher levels of comorbid anxiety (OR=2.34, P&lt;.001) and substance use (OR=1.80, P&lt;.001). Surprisingly, no association was found between early age of onset and clinical characteristics such as psychotic symptoms or mixed episodes as defined by DSM-IV.</AbstractText><AbstractText Label="CONCLUSIONS">Earlier age of onset of bipolar disorder is associated with factors that can negatively impact long-term outcomes such as increased comorbidity. However, no association was found between early onset and indicators of severity or treatment resistance such as psychotic symptoms. Clinical features found to have the strongest relationship with early age of onset were those potentially amenable to pharmacological and psychological treatment. Results highlight the importance of early identification and provide potential areas of focus for the development of early intervention in bipolar disorder.</AbstractText><CopyrightInformation>© 2016 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joslyn</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Psychology, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawes</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>School of Psychology, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunt</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Psychology, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Philip B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>School of Psychiatry, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001526" MajorTopicYN="N">Behavioral Symptoms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">age of onset</Keyword><Keyword MajorTopicYN="Y">bipolar disorder</Keyword><Keyword MajorTopicYN="Y">comorbidity</Keyword><Keyword MajorTopicYN="Y">meta-analysis</Keyword><Keyword MajorTopicYN="Y">outcomes</Keyword><Keyword MajorTopicYN="Y">prognosis</Keyword><Keyword MajorTopicYN="Y">severity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>06</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27530107</ArticleId><ArticleId IdType="doi">10.1111/bdi.12419</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20361175</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2010</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1433-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>5</Issue><PubDate><Year>2010</Year><Month>May</Month></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Bipolar affective disorder].</ArticleTitle><Pagination><MedlinePgn>523-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00115-009-2852-8</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Möller</LastName><ForeName>H-J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Psychiatrische Klinik der Ludwig-Maximilians-Universität, Nussbaumstrasse 7, 80336, München, Deutschland. hans-juergen.moeller@med.uni-muenchen.de</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D054711">Introductory Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Bipolare affektive Erkrankung.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20361175</ArticleId><ArticleId IdType="doi">10.1007/s00115-009-2852-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21190640</PMID><DateCompleted><Year>2011</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>12</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: new perspectives in health care and prevention.</ArticleTitle><Pagination><MedlinePgn>1689-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.10m06347yel</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">High rates of misdiagnosis, delayed diagnosis, and lack of recognition and treatment of comorbid conditions often lead patients with bipolar illness to have a chronic course with high disability, unemployment rates, and mortality. Despite the recognition that long-term outcome of bipolar disorder depends on systematic assessment of both interepisodic dysfunctional domains and comorbid psychiatric and medical conditions, treatment of bipolar disorder still focuses primarily on alleviation of acute symptoms and prevention of future recurrences. We propose here to review the evidence offering a modern view of bipolar disorder defined as a chronic and progressive multisystem disorder, taking into account characteristics of each patient as well as biosignatures in order to help design personalized treatments.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We conducted a systematic PubMed search of all English-language articles, published between 2000 and 2010, focusing on the English and French literature with bipolar disorder cross-referenced with the following search terms: emotional dysregulation, sleep and circadian rhythm disturbances, cognitive impairment, age at onset, comorbid medical and psychiatric conditions, psychosocial and medical interventions, outcome, remission, and personalized medicine. The search was conducted between July 2009 and July 2010. The literature on bipolar disorder was reviewed to provide supporting evidence that the assessment of various symptom domains that are dysfunctional between episodes should all be considered as core dimensions of the disorder.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Forty-one articles were identified through the PubMed search described above and selected on the basis of addressing any combination of the search terms in conjunction with bipolar disorder.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Current guidelines advocate the use of more or less similar treatment algorithms for all patients, ignoring the clinical, pathophysiological, and lifetime heterogeneity of bipolar disorder. Systematic assessment of interepisodic dimensions, along with comorbid medical and psychiatric risk factors, should be performed along the life cycle in order to plan specific and personalized pharmacologic, medical, and psychosocial interventions tailored to the needs of each patient and ready-to-test biosignatures to serve as risk factors or diagnostic or prognostic tools.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Medical and research findings, along with health economic data, support a more modern view of bipolar disorder as a chronic, progressive, multisystem disorder. This new comprehensive framework should guide the search to identify biomarkers and etiologic factors and should help design a new policy for health care, including prevention, diagnosis, treatment, and training.</AbstractText><CopyrightInformation>© Copyright 2010 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leboyer</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Hôpital Albert Chenevier, University Paris-Est, Assistance Publique-Hôpitaux de Paris, Creteil, France. Marion.leboyer@inserm.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kupfer</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH081003</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH081003</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Psychiatry. 2011 May;72(5):722-3</RefSource><PMID Version="1">21658352</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Psychiatry. 2011 May;72(5):724</RefSource><PMID Version="1">21658357</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="Y">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">HALMS567373</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21190640</ArticleId><ArticleId IdType="doi">10.4088/JCP.10m06347yel</ArticleId><ArticleId IdType="pmc">PMC3317891</ArticleId><ArticleId IdType="mid">HALMS567373</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Psychiatry. 2006 Jul;67(7):1034-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16889445</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2010 Mar;11(2):81-109</Citation><ArticleIdList><ArticleId IdType="pubmed">20148751</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2010 Mar 1;67(5):414-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19931855</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2007 Nov;12(11):1001-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17471288</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Jun;58(3):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">10802130</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2009 Feb;60(2):147-56</Citation><ArticleIdList><ArticleId IdType="pubmed">19176408</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 May;157(5):683-94</Citation><ArticleIdList><ArticleId IdType="pubmed">10784457</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2010 Mar;55(3):136-43</Citation><ArticleIdList><ArticleId IdType="pubmed">20370963</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2009 Jun;166(6):645-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19487400</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2009 Dec;11(6):494-502</Citation><ArticleIdList><ArticleId IdType="pubmed">19909673</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 May;64(5):543-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17485606</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuromolecular Med. 2009;11(4):328-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19649751</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Aug;61(8):549-55</Citation><ArticleIdList><ArticleId IdType="pubmed">10982196</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Dec;127(1-3):300-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20553823</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2002 Jun;59(6):530-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12044195</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Sep;62(9):996-1004</Citation><ArticleIdList><ArticleId IdType="pubmed">16143731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Sep;13(9):829, 833-57</Citation><ArticleIdList><ArticleId IdType="pubmed">18574483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13</Citation><ArticleIdList><ArticleId IdType="pubmed">17391354</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):257-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16449479</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Jan;64(1):53-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12590624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Med. 2005;37(3):196-205</Citation><ArticleIdList><ArticleId IdType="pubmed">16019718</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Jul;165(7):820-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18519522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Dec;10(8):867-76</Citation><ArticleIdList><ArticleId IdType="pubmed">19594502</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Aug;70(8):1078-90</Citation><ArticleIdList><ArticleId IdType="pubmed">19497250</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 May 25;293(20):2528-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15914754</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1989 Dec;46(12):1120-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2589926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Jun;11(4):391-400</Citation><ArticleIdList><ArticleId IdType="pubmed">19500092</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Aug;55(8):702-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9707380</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Nov;71(11):1518-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20584522</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2008 Jun;38(6):771-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17922938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2002 Dec;4(6):398-405</Citation><ArticleIdList><ArticleId IdType="pubmed">12519100</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Jun;80(2-3):145-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15207927</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroimage. 2010 Oct 15;53(1):58-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20595014</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pract Epidemiol Ment Health. 2009 Jan 23;5:3</Citation><ArticleIdList><ArticleId IdType="pubmed">19166608</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Apr;188:313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16582056</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2008 Nov;18(11):787-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18725178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Jun;11(4):401-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19500093</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Oct;67(10):1551-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17107246</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2009 Jul;70(7):1017-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19497247</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jan;162(1):50-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15625201</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2008 May 30;159(1-2):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18295902</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2000 Jun;57(6):572-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10839335</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Feb;66(2):128-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19188534</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17379666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 May;9(3):262-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17430301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann N Y Acad Sci. 2004 Dec;1032:1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15677391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Jun;7(3):281-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15898966</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2007 Jun;115(6):473-80</Citation><ArticleIdList><ArticleId IdType="pubmed">17498159</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Biol. 2007 Oct 23;17(20):R877-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17956744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Jun;11 Suppl 2:110-22</Citation><ArticleIdList><ArticleId IdType="pubmed">19538690</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Jan;160(1):112-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12505809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20085607</PMID><DateCompleted><Year>2010</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-7610</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of child psychology and psychiatry, and allied disciplines</Title><ISOAbbreviation>J Child Psychol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Pediatric bipolar disorder: evidence for prodromal states and early markers.</ArticleTitle><Pagination><MedlinePgn>459-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1469-7610.2010.02210.x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Childhood bipolar disorder remains a controversial but increasingly diagnosed disorder that is associated with significant impairment, chronic course and treatment resistance. Therefore, the search for prodromes or early markers of risk for later childhood bipolar disorder may be of great importance for prevention and/or early identification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature searches were conducted to identify reviews, case reports and empirical papers addressing the issue of prodromes of childhood bipolar disorder.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 54 articles were found that related to bipolar prodromes, risk factors for later childhood bipolar disorder, childhood risk for adult bipolar disorder, mania manifestations in early childhood, and neuropsychological and biological markers of childhood bipolar disorder. A review of articles suggest (a) childhood bipolar prodromes may be detectable prior to the onset of the disorder, (b) prodromal symptoms may display episodicity during childhood, (c) there is evidence of possible endophenotypic markers such as deficits in executive function, sustained attention, and emotion labeling, (d) there is a potential association with functional, structural, and biochemical alterations evident in brain structures involved in mood regulation, (e) a link between childhood bipolar disorder with early tempermental markers, such as emotional regulation and behavioral disinhibition and (f) there is some early but promising evidence of effective psychotherapeutic preventions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There has been very limited investigation of early prodromes of childhood bipolar disorder. Based on the promising findings of prodromes as well as high-risk states and possible endophenotypic markers, more controlled and targeted investigations into the early markers of bipolar disorder appear warranted and potentially fruitful. Until such longitudinal studies with appropriate controls are conducted, specific markers for bipolar prodromes will remain elusive, although evidence suggests they are manifest in at least some subgroups. The finding of promising psychotherapeutic prevention programs underscores the need to find specific and sensitive markers of bipolar prodromes in childhood.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luby</LastName><ForeName>Joan L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Washington University School of Medicine, St. Louis, MO 63110, USA. lubyj@psychiatry.wustl.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navsaria</LastName><ForeName>Neha</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH064769</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH 64769-01</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Child Psychol Psychiatry</MedlineTA><NlmUniqueID>0375361</NlmUniqueID><ISSNLinking>0021-9630</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="Y">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>97</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20085607</ArticleId><ArticleId IdType="pii">JCPP2210</ArticleId><ArticleId IdType="doi">10.1111/j.1469-7610.2010.02210.x</ArticleId><ArticleId IdType="pmc">PMC3184298</ArticleId><ArticleId IdType="mid">NIHMS250270</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Psychiatry. 2007 May;68(5):789-95</Citation><ArticleIdList><ArticleId IdType="pubmed">17503991</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Spectr. 2006 Apr;11(4):298-311</Citation><ArticleIdList><ArticleId IdType="pubmed">16641835</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Jan;158(1):125-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11136645</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16449480</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2008 Oct;65(10):1125-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18838629</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Oct;63(10):1139-48</Citation><ArticleIdList><ArticleId IdType="pubmed">17015816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Dec;9(8):828-38</Citation><ArticleIdList><ArticleId IdType="pubmed">18076532</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1994 Aug;31(4):281-94</Citation><ArticleIdList><ArticleId IdType="pubmed">7989643</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 May;33(3):703-14</Citation><ArticleIdList><ArticleId IdType="pubmed">17478437</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2004 Jan;29(1):99-106</Citation><ArticleIdList><ArticleId IdType="pubmed">14575732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychol. 2003 Jan;39(1):164-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12518817</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Feb;121(1-2):127-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19541368</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):409-17</Citation><ArticleIdList><ArticleId IdType="pubmed">15843762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Aug;3(4):202-10</Citation><ArticleIdList><ArticleId IdType="pubmed">11552959</ArticleId></ArticleIdList></Reference><Reference><Citation>Monogr Soc Res Child Dev. 1994;59(2-3):25-52</Citation><ArticleIdList><ArticleId IdType="pubmed">7984164</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2003;29(4):717-28</Citation><ArticleIdList><ArticleId IdType="pubmed">14989409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2008 May;47(5):532-539</Citation><ArticleIdList><ArticleId IdType="pubmed">18356765</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Stress. 2007 Aug;20(4):631-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17721975</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jul;62(7):734-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15997014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ment Retard Dev Disabil Res Rev. 2007;13(1):16-25</Citation><ArticleIdList><ArticleId IdType="pubmed">17326115</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Oct;82 Suppl 1:S25-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15571787</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):73-108</Citation><ArticleIdList><ArticleId IdType="pubmed">16321726</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 Sep;64(9):1032-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17768268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):1070-1079</Citation><ArticleIdList><ArticleId IdType="pubmed">17667485</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2000 Oct;39(10):1245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11026178</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2001 Jul;31(5):915-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11459389</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Sep;162(9):1644-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16135623</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2009 Jul;166(7):795-804</Citation><ArticleIdList><ArticleId IdType="pubmed">19448190</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2009 Aug;66(8):897-905</Citation><ArticleIdList><ArticleId IdType="pubmed">19652129</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Oct;162(10):1904-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16199837</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Jan;164(1):52-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17202544</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1978 Nov;133:429-35</Citation><ArticleIdList><ArticleId IdType="pubmed">728692</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2003 Fall;13(3):267-71</Citation><ArticleIdList><ArticleId IdType="pubmed">14642014</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1984 Feb;141(2):236-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6691484</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Oct 28;302(16):1765-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19861668</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Oct;77(1):11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14550931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2007 Apr;17(2):237-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17489719</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2002 Apr 1;51(7):563-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11950458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Oct;6(5):426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15383136</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychoneuroendocrinology. 2006 Nov;31(10):1164-80</Citation><ArticleIdList><ArticleId IdType="pubmed">17055665</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2003 Winter;13(4):463-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14977459</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Mar;85(1-2):181-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15780688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1994 Feb;103(1):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">8040472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1104-11</Citation><ArticleIdList><ArticleId IdType="pubmed">16239857</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2005 Nov;39(6):611-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16009376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):395-422</Citation><ArticleIdList><ArticleId IdType="pubmed">16492265</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2005 Oct 1;58(7):583-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16197929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychopathol. 2006 Fall;18(4):971-88</Citation><ArticleIdList><ArticleId IdType="pubmed">17064425</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Mar;165(3):385-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18245180</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2000 Apr;39(4):453-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10761347</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 May;61(5):459-67</Citation><ArticleIdList><ArticleId IdType="pubmed">15123490</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Adolesc Psychiatr Clin N Am. 2009 Apr;18(2):391-403, ix</Citation><ArticleIdList><ArticleId IdType="pubmed">19264269</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1993 Jan;32(1):34-42</Citation><ArticleIdList><ArticleId IdType="pubmed">8428882</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Jun 1;53(11):985-99</Citation><ArticleIdList><ArticleId IdType="pubmed">12788244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Aug;7(4):344-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16026487</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2001 May;31(4):695-704</Citation><ArticleIdList><ArticleId IdType="pubmed">11352371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Dec;9(8):799-809</Citation><ArticleIdList><ArticleId IdType="pubmed">18076529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Jun;6(3):171-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15117396</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2003 Winter;13(4):489-94</Citation><ArticleIdList><ArticleId IdType="pubmed">14977461</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Feb;63(2):175-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16461861</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Dev. 1984 Feb;55(1):112-22</Citation><ArticleIdList><ArticleId IdType="pubmed">6705614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychopathol. 2006 Spring;18(2):573-89</Citation><ArticleIdList><ArticleId IdType="pubmed">16600068</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2003;29(4):633-51</Citation><ArticleIdList><ArticleId IdType="pubmed">14989404</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2000 Sep;30(5):1025-36</Citation><ArticleIdList><ArticleId IdType="pubmed">12027040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1994 May;33(4):461-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8005898</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2003 Winter;13(4):495-505</Citation><ArticleIdList><ArticleId IdType="pubmed">14977462</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Jun 1;53(11):1043-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12788249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2004 Jun;43(6):708-17</Citation><ArticleIdList><ArticleId IdType="pubmed">15167087</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8900-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16735472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2003 Jul;42(7):786-96</Citation><ArticleIdList><ArticleId IdType="pubmed">12819438</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychopathol. 2008 Summer;20(3):881-97</Citation><ArticleIdList><ArticleId IdType="pubmed">18606036</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2004 Jan 1;121(3):207-17</Citation><ArticleIdList><ArticleId IdType="pubmed">14675740</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):103-11</Citation><ArticleIdList><ArticleId IdType="pubmed">1537760</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Psychopathol. 2006 Fall;18(4):1247-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17064437</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):871-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11501685</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Apr;160(4):636-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12668349</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Adolesc Psychopharmacol. 2002 Spring;12(1):3-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12014593</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Psychol Psychiatry. 2007 Sep;48(9):852-62</Citation><ArticleIdList><ArticleId IdType="pubmed">17714370</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2007 Apr;164(4):582-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17403971</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2007 Jul;52(7):409-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17688004</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2005 May-Jun;13(3):125-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16020026</ArticleId></ArticleIdList></Reference><Reference><Citation>Child Adolesc Psychiatr Clin N Am. 2006 Oct;15(4):899-917, viii-ix</Citation><ArticleIdList><ArticleId IdType="pubmed">16952767</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Psychol Psychiatry. 1996 Jul;37(5):543-50</Citation><ArticleIdList><ArticleId IdType="pubmed">8807434</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 1999 Mar 1;45(5):639-46</Citation><ArticleIdList><ArticleId IdType="pubmed">10088052</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Child Adolesc Psychiatry. 2001 Apr;40(4):450-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11314571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26039851</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-6899</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3 Behavioral Neurology and Neuropsychiatry</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Continuum (Minneapolis, Minn.)</Title><ISOAbbreviation>Continuum (Minneap Minn)</ISOAbbreviation></Journal><ArticleTitle>Mania.</ArticleTitle><Pagination><MedlinePgn>737-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/01.CON.0000466663.28026.6f</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Primary mania and hypomania in full or subsyndromal forms are the defining features of bipolar disorder and are common in neurologic patients, as are manic syndromes precipitated by medications used to treat neurologic disorders. This article addresses the diagnosis, pathophysiology, treatment, and course of bipolar disorder after a manic episode as well as mania as a manifestation of neurologic disease.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Mania can be a primary psychiatric disorder but can also be a symptom of a neurologic disorder, especially right-sided cerebrovascular disease. Treatments (such as corticosteroids and dopaminergic agents) for neurologic illnesses regularly induce mania. The neurobiology of primary mania and bipolar disorder involves alterations in intracellular signaling, changes in gene expression, neural network interactions, and apoptosis. Except when induced by time-limited treatment with a provoking agent, mania tends to be highly recurrent and to alternate or be exhibited alongside depression. Symptoms of mania become more complex and treatment refractory with time, although effective treatment improves the long-term outcome.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Behavioral manifestations of mania may be more obvious than affective symptoms, especially in patients with aprosodia. Atypical antipsychotic drugs are often first-line acute treatments, but the evidence supporting their long-term prophylactic efficacy is questionable. In addition to being an established mood stabilizer, lithium has putative neuroprotective properties, although a side effect can be impaired memory.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubovsky</LastName><ForeName>Steven L</ForeName><Initials>SL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Continuum (Minneap Minn)</MedlineTA><NlmUniqueID>9509333</NlmUniqueID><ISSNLinking>1080-2371</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009446" MajorTopicYN="N">Neurobiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26039851</ArticleId><ArticleId IdType="doi">10.1212/01.CON.0000466663.28026.6f</ArticleId><ArticleId IdType="pii">00132979-201506000-00016</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11281071</PMID><DateCompleted><Year>2001</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0279-3695</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of psychosocial nursing and mental health services</Title><ISOAbbreviation>J Psychosoc Nurs Ment Health Serv</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder in children.</ArticleTitle><Pagination><MedlinePgn>12-23</MedlinePgn></Pagination><Abstract><AbstractText>This article presents an overview of bipolar disorder (BPD) in children, a condition that only recently has been recognized as a legitimate diagnosis. Bipolar disorder in children is underrecognized for many reasons including lack of awareness, diagnostic confusion, and the different clinical picture in children. Available data strongly suggest that prepubertal childhood BPD is a non-episodic, chronic, rapid cycling, mixed manic state. It may be comorbid with attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) or it may demonstrate features of ADHD and CD, further complicating recognition and subsequent treatment. Treatment issues are discussed, and some reasons for the urgency of early recognition and treatment are explained.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>W K</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Indiana University School of Nursing, Indianapolis, Indiana, USA. wkmohr@iupui.edu</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Psychosoc Nurs Ment Health Serv</MedlineTA><NlmUniqueID>8200911</NlmUniqueID><ISSNLinking>0279-3695</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002653" MajorTopicYN="N">Child Behavior Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002665" MajorTopicYN="N">Child Psychiatry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011568" MajorTopicYN="N">Psychiatric Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002666" MajorTopicYN="N">Psychology, Child</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>54</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>4</Month><Day>3</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>7</Month><Day>13</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>4</Month><Day>3</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11281071</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22891492</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-629X</ISSN><JournalIssue CitedMedium="Print"><Volume>67</Volume><Issue>5-6</Issue><PubDate><MedlineDate>2012 May-Jun</MedlineDate></PubDate></JournalIssue><Title>Revue medicale de Liege</Title><ISOAbbreviation>Rev Med Liege</ISOAbbreviation></Journal><ArticleTitle>[Bipolar disorder: a multifactorial disease].</ArticleTitle><Pagination><MedlinePgn>366-73</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a multifactorial disease with a strong genetic component. However, environmental factors also play a role in the onset of the disease and in manic and depressive recurrence. The onset of the disorder is the consequence of a complex interaction between genetic and environmental factors. This gene-environment interaction is well illustrated by the influence of childhood trauma on the clinical expression of the disease in terms of age of onset, comorbidity and suicide. The complexity and heterogeneity of bipolar disorder require the identification of homogenous sub-groups with the use of biomarkers that could help reduce the etiological heterogeneity and better target the therapeutical options.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pitchot</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Service de Psychiatrie et de Psychologie médicale, CHU de Liège, Belgique. wpitchot@chu.ulg.ac.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scantamburlo</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Ansseau</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Souery</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Le trouble bipolaire: une affection bien complexe.</VernacularTitle></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Rev Med Liege</MedlineTA><NlmUniqueID>0404317</NlmUniqueID><ISSNLinking>0370-629X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004777" MajorTopicYN="N">Environment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059647" MajorTopicYN="N">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22891492</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17459551</PMID><DateCompleted><Year>2007</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0278-5846</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2007</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Progress in neuro-psychopharmacology &amp; biological psychiatry</Title><ISOAbbreviation>Prog Neuropsychopharmacol Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: how far are we from a rigorous definition and effective management?</ArticleTitle><Pagination><MedlinePgn>975-96</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a pathological disturbance of mood, characterized by waxing and waning manic, depressive and, sometimes distinctly mixed states. A diagnosis of bipolar disorder can only be made with certainty when the manic syndrome declares itself. Most individuals who are diagnosed with this disorder will experience both poles of the illness recurrently, but depressive episodes are the commonest cause of morbidity and, indeed, of death by suicide. Twin, adoption and epidemiological studies suggest a strongly genetic aetiology. It is a genetically and phenotypically complex disorder. Thus, the genes contributing are likely to be numerous and of small effect. Individuals with bipolar disorder also display deficits on a range of neuropsychological tasks in both the acute and euthymic phases of illness and correlations between number of affective episodes experienced and task performance are commonly reported. Current self-report and observer-rated scales are optimized for unipolar depression and hence limited in their ability to accurately assess bipolar depression. The development of a specific depression rating scale will improve the assessment of bipolar depression in both research and clinical settings. It will improve the development of better treatments and interventions. Guidelines support the use of antidepressants for bipolar depression. With regard to the adverse effects of antidepressants for bipolar depression, double-blind, placebo-controlled data suggest that antidepressant monotherapy or the addition of a tricyclic antidepressant may worsen the course of bipolar disorder. Importantly, adjunctive psychotherapies add significantly (both statistically and clinically) to the efficacy of pharmacological treatment regimens. The successful management of bipolar disorder clearly demands improved recognition of bipolar disorder and effective long-term treatment for bipolar depression as well as mania.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emilien</LastName><ForeName>Gérard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wyeth Research, Clinical Neuroscience Programs, Coeur Défense - Tour A - La Défense 4, 92931 Paris La Défense Cedex, France. emilig@wyeth.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Septien</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Brisard</LastName><ForeName>Claudine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Corruble</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bourin</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Prog Neuropsychopharmacol Biol Psychiatry</MedlineTA><NlmUniqueID>8211617</NlmUniqueID><ISSNLinking>0278-5846</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="N">Terminology as Topic</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>225</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>03</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>8</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17459551</ArticleId><ArticleId IdType="pii">S0278-5846(07)00100-5</ArticleId><ArticleId IdType="doi">10.1016/j.pnpbp.2007.03.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23782499</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Stage managing bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>471-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12099</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Clinical staging is widespread in medicine - it informs prognosis, clinical course, and treatment, and assists individualized care. Staging places an individual on a probabilistic continuum of increasing potential disease severity, ranging from clinically at-risk or latency stage through first threshold episode of illness or recurrence, and, finally, to late or end-stage disease. The aim of the present paper was to examine and update the evidence regarding staging in bipolar disorder, and how this might inform targeted and individualized intervention approaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We provide a narrative review of the relevant information.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In bipolar disorder, the validity of staging is informed by a range of findings that accompany illness progression, including neuroimaging data suggesting incremental volume loss, cognitive changes, and a declining likelihood of response to pharmacological and psychosocial treatments. Staging informs the adoption of a number of approaches, including the active promotion of both indicated prevention for at-risk individuals and early intervention strategies for newly diagnosed individuals, and the tailored implementation of treatments according to the stage of illness.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The nature of bipolar disorder implies the presence of an active process of neuroprogression that is considered to be at least partly mediated by inflammation, oxidative stress, apoptosis, and changes in neurogenesis. It further supports the concept of neuroprotection, in that a diversity of agents have putative effects against these molecular targets. Clinically, staging suggests that the at-risk state or first episode is a period that requires particularly active and broad-based treatment, consistent with the hope that the temporal trajectory of the illness can be altered. Prompt treatment may be potentially neuroprotective and attenuate the neurostructural and neurocognitive changes that emerge with chronicity. Staging highlights the need for interventions at a service delivery level and implementing treatments at the earliest stage of illness possible.</AbstractText><CopyrightInformation>© 2013 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Deakin University, Geelong; Department of Psychiatry, University of Melbourne, Melbourne, Vic., Australia; Orygen Youth Health, Melbourne, Vic., Australia; Florey Institute for Neuroscience and Mental Health, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Lesley</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Dodd</LastName><ForeName>Seetal</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cotton</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Macneil</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Daglas</LastName><ForeName>Rothanthi</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Conus</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Bechdolf</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Moylan</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Malhi</LastName><ForeName>Gin S</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="Y">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">clinical staging</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">early intervention</Keyword><Keyword MajorTopicYN="N">mania</Keyword><Keyword MajorTopicYN="N">neuroprogression</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23782499</ArticleId><ArticleId IdType="doi">10.1111/bdi.12099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bipolar Disord. 2010 Dec;12(8):758-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21176023</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2012 Jan;12(1):5-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22243040</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2007;31(6):858-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17555817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2013 May;18(5):595-606</Citation><ArticleIdList><ArticleId IdType="pubmed">22525486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):103-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16542180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2010 Aug;12(5):557-67</Citation><ArticleIdList><ArticleId IdType="pubmed">20712758</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1999;249(5):227-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10591987</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2012 Nov;46(11):1058-67</Citation><ArticleIdList><ArticleId IdType="pubmed">23015748</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Jun;123(1-3):81-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19853922</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2010 Aug 16;193(4 Suppl):S36-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20712560</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2009 Jul;9(7):957-66</Citation><ArticleIdList><ArticleId IdType="pubmed">19589046</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2008;77(3):133-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18277059</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Psychiatry Clin Pract. 2004;8(2):91-100</Citation><ArticleIdList><ArticleId IdType="pubmed">24926841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2009 Aug;11(5):474-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19624386</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2009 Feb;113(1-2):1-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18684514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Jun;13(4):396-405</Citation><ArticleIdList><ArticleId IdType="pubmed">21843279</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2006 Aug;40(8):616-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16866756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Aug-Sep;13(5-6):556-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22017224</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Apr;188:313-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16582056</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Nov;159(11):1841-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12411217</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2008;32(4):675-92</Citation><ArticleIdList><ArticleId IdType="pubmed">18199480</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pediatr Adolesc Med. 2004 May;158(5):478-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15123482</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1992 Aug;149(8):999-1010</Citation><ArticleIdList><ArticleId IdType="pubmed">1353322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Psychopharmacol. 2002 Jun;17(4):175-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12404684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Feb;13(1):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">21320256</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Jun;100(1-3):279-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17433450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2010 Dec;127(1-3):316-20</Citation><ArticleIdList><ArticleId IdType="pubmed">20619465</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2007 Sep;10(9):1089-93</Citation><ArticleIdList><ArticleId IdType="pubmed">17726474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Feb;8(1):65-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16411982</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Aug;156(8):1264-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10450271</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Apr;3(2):79-87</Citation><ArticleIdList><ArticleId IdType="pubmed">11333067</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2012 Nov;6(4):380-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22225628</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Interv Psychiatry. 2011 May;5(2):100-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21535422</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2007 Nov;103(1-3):181-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17324469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2012 Feb;136(3):1000-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21802741</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatry Neurosci. 2009 Jul;34(4):263-71</Citation><ArticleIdList><ArticleId IdType="pubmed">19568477</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Pharmacol Sci. 2008 Jul;29(7):346-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18538422</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Pharm Des. 2012;18(4):358-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22239567</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2011 Jan;35(3):804-17</Citation><ArticleIdList><ArticleId IdType="pubmed">20934453</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2009 May;12(4):447-58</Citation><ArticleIdList><ArticleId IdType="pubmed">18771602</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2007 Dec;116(6):467-72</Citation><ArticleIdList><ArticleId IdType="pubmed">17997725</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1993 Apr;87(4):225-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8488741</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2012 Nov;201(5):339-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23118032</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1986 Aug;149:191-201</Citation><ArticleIdList><ArticleId IdType="pubmed">3535979</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2010 Aug;55(8):486-97</Citation><ArticleIdList><ArticleId IdType="pubmed">20723276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Nov;9(7):671-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17988356</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1989 Nov 30;321(22):1489-93</Citation><ArticleIdList><ArticleId IdType="pubmed">2811970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23237061</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2013</Year><Month>01</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.</ArticleTitle><Pagination><MedlinePgn>1-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12025</ELocationID><Abstract><AbstractText>The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first-line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first-line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first-line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second-line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not-recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long-acting injection, and adjunctive ziprasidone continue to be first-line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third-line options.</AbstractText><CopyrightInformation>© 2012 John Wiley and Sons A/S.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yatham</LastName><ForeName>Lakshmi N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. yatham@interchange.ubc.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Sidney H</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Sagar V</ForeName><Initials>SV</Initials></Author><Author ValidYN="Y"><LastName>Schaffer</LastName><ForeName>Ayal</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Alda</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>O'Donovan</LastName><ForeName>Claire</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Macqueen</LastName><ForeName>Glenda</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Roger S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Verinder</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ravindran</LastName><ForeName>Arun</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>L Trevor</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Milev</LastName><ForeName>Roumen</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bond</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Benicio N</ForeName><Initials>BN</Initials></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Benjamin I</ForeName><Initials>BI</Initials></Author><Author ValidYN="Y"><LastName>Lafer</LastName><ForeName>Beny</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Birmaher</LastName><ForeName>Boris</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Kyooseob</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nolen</LastName><ForeName>Willem A</ForeName><Initials>WA</Initials></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014151">Anti-Anxiety Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014151" MajorTopicYN="N">Anti-Anxiety Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="N">Guidelines as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23237061</ArticleId><ArticleId IdType="doi">10.1111/bdi.12025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19358880</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7544</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>1</Issue><PubDate><Year>2009</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Neuroscience</Title><ISOAbbreviation>Neuroscience</ISOAbbreviation></Journal><ArticleTitle>The genetics of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>331-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroscience.2009.03.080</ELocationID><Abstract><AbstractText>Bipolar disorder is a mood disorder characterized by impairing episodes of mania and depression. Twin studies have established that bipolar disorder is among the most heritable of medical disorders and efforts to identify specific susceptibility genes have intensified over the past two decades. The search for genes influencing bipolar disorder has been complicated by a paucity of animal models, limited understanding of pathogenesis, and the genetic and phenotypic complexity of the syndrome. Linkage studies have implicated several chromosomal regions as harboring relevant genes, but results have been inconsistent. It is now widely accepted that the genetic liability to bipolar disorder reflects the action of many genes of individually small effect, a scenario for which linkage studies are poorly suited. Thus, association studies, which are more powerful for the detection of modest effect loci, have become the focus of gene-finding research. A large number of candidate genes, including biological candidates derived from hypotheses about the pathogenesis of the disorder and positional candidates derived from linkage and cytogenetic studies, have been evaluated. Several of these genes have been associated with the disorder in independent studies (including BDNF, DAOA, DISC1, GRIK4, SLC6A4, and TPH2), but none has been established. The clinical heterogeneity of bipolar disorder and its phenotypic and genetic overlap with other disorders (especially schizophrenia, schizoaffective disorder, and major depressive disorder) have raised questions about the optimal phenotype definition for genetic studies. Nevertheless, genomewide association analysis, which has successfully identified susceptibility genes for a variety of complex disorders, has begun to implicate specific genes for bipolar disorder (DGKH, CACNA1C, ANK3). The polygenicity of the disorder means that very large samples will be needed to detect the modest effect loci that likely contribute to bipolar disorder. Detailed genetic dissection of the disorder may provide novel targets (both pharmacologic and psychosocial) for intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnett</LastName><ForeName>J H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Center for Human Genetic Research, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smoller</LastName><ForeName>J W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH079799</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH079799-02</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroscience</MedlineTA><NlmUniqueID>7605074</NlmUniqueID><ISSNLinking>0306-4522</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>140</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>12</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>03</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>4</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>4</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19358880</ArticleId><ArticleId IdType="pii">S0306-4522(09)00576-4</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2009.03.080</ArticleId><ArticleId IdType="pmc">PMC3637882</ArticleId><ArticleId IdType="mid">NIHMS108143</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curr Psychiatry Rep. 2001 Aug;3(4):332-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11470041</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):35-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12898572</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2007 May;64(5):543-52</Citation><ArticleIdList><ArticleId IdType="pubmed">17485606</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 May;60(5):497-502</Citation><ArticleIdList><ArticleId IdType="pubmed">12742871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1990 Jul 7;336(8706):13-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1973210</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):110-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15578606</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Oct;161(10):1814-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15465978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7(4):405-11</Citation><ArticleIdList><ArticleId IdType="pubmed">11986984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2009 Sep;14(9):865-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18317464</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Genet. 2004 Sep;20(9):439-44</Citation><ArticleIdList><ArticleId IdType="pubmed">15313553</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2008 Sep 1;64(5):419-27</Citation><ArticleIdList><ArticleId IdType="pubmed">18466881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16987893</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2005 Dec;30(12):2216-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15956996</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetics. 2005 Oct;171(2):813-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16020784</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2005 Dec;183(3):378-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16240163</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2008 Mar;82(3):696-711</Citation><ArticleIdList><ArticleId IdType="pubmed">18319075</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Apr;63(4):366-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16585465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2008 Nov;10(7):816-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19032713</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2003 Jul;73(1):49-62</Citation><ArticleIdList><ArticleId IdType="pubmed">12802785</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):155-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19025758</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2005 Aug;2(8):e124</Citation><ArticleIdList><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2006 Mar;5(2):150-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16507006</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2004 Feb;184:110-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14754822</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Chronobiol. 1983;8(3):129-47</Citation><ArticleIdList><ArticleId IdType="pubmed">6862696</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2008 Jul;165(7):820-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18519522</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 Aug;155(8):1016-22</Citation><ArticleIdList><ArticleId IdType="pubmed">9699687</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1997 Sep;27(5):1079-89</Citation><ArticleIdList><ArticleId IdType="pubmed">9300513</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 May;40(5):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18372903</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2007 May;114(2):222-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17395264</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2002 Aug 2;297(5582):851-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12161658</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2007 Oct 15;16(20):2517-28</Citation><ArticleIdList><ArticleId IdType="pubmed">17673452</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1998 Jul 10;81(4):308-12</Citation><ArticleIdList><ArticleId IdType="pubmed">9674976</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Feb;13(2):197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">17486107</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2005 Aug 5;137B(1):36-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15952199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2009 Apr;14(4):376-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19114987</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):90-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12497621</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2007 Jun;190:515-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17541112</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Hum Genet. 2006 Jun;14(6):660-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16721402</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Sep;163(9):1561-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16946181</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Funct. 2005 Oct 18;1:19</Citation><ArticleIdList><ArticleId IdType="pubmed">16232322</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2008 Jun;38(6):771-85</Citation><ArticleIdList><ArticleId IdType="pubmed">17922938</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jul 18;301(5631):386-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12869766</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 May;186:364-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15863738</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2002 Apr;159(4):539-45</Citation><ArticleIdList><ArticleId IdType="pubmed">11925290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Jun;13(6):558-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18317468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2002 Jun;70(1):91-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12113924</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2000 Apr 7;42(2):83-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10742646</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2005 Oct;77(4):582-95</Citation><ArticleIdList><ArticleId IdType="pubmed">16175504</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2008 Sep;65(9):1034-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18762589</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2006 Jun;84(2-3):214-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16549338</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1976 Sep;54(3):167-73</Citation><ArticleIdList><ArticleId IdType="pubmed">970193</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2008 Apr 25;320(5875):539-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18369103</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1990 Nov 21;264(19):2511-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2232018</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Dev Brain Res. 1996 Mar 29;92(1):91-100</Citation><ArticleIdList><ArticleId IdType="pubmed">8861727</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2008 Jul;65(7):785-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18606951</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2008 Jul;34(4):791-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18502736</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Genet. 1995 May;25(3):217-32</Citation><ArticleIdList><ArticleId IdType="pubmed">7598665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Jul;40(7):880-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18511947</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1997 Mar;27(2):411-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9089833</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Oct;163(10):1754-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17012686</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1993 Nov;50(11):871-83</Citation><ArticleIdList><ArticleId IdType="pubmed">8215813</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 1994 Dec;49(4):975-83</Citation><ArticleIdList><ArticleId IdType="pubmed">7886116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2007 May;8(5):355-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17453016</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1981 Jan;38(1):58-61</Citation><ArticleIdList><ArticleId IdType="pubmed">7458569</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):48-58</Citation><ArticleIdList><ArticleId IdType="pubmed">14601036</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1996 Sep 13;273(5281):1516-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8801636</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1993 Apr;87(4):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8488750</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):259-65</Citation><ArticleIdList><ArticleId IdType="pubmed">17357145</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jun;62(6):593-602</Citation><ArticleIdList><ArticleId IdType="pubmed">15939837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 May;13(5):466-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18421293</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Jun 1;53(11):970-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12788242</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17553960</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Jul 15;60(2):93-105</Citation><ArticleIdList><ArticleId IdType="pubmed">16406007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 Oct;39(10):1157-67</Citation><ArticleIdList><ArticleId IdType="pubmed">7125846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2002 Oct;63(10):942-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12416605</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 1981 Dec;5(3):277-85</Citation><ArticleIdList><ArticleId IdType="pubmed">6948310</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 1996 Sep 20;67(5):473-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8886164</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Genet. 2008 Jul;9(7):527-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18560438</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Nov;81(5):974-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17924339</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2004 Nov;75(5):862-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15386212</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1047-55</Citation><ArticleIdList><ArticleId IdType="pubmed">18228528</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2002 Apr;32(3):503-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11989995</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Feb 14;358(7):667-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18184952</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Genet. 2008 Jun;18(3):110-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18496207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2003 Nov 15;123B(1):23-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14582141</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Genet. 2005 Mar;42(3):193-204</Citation><ArticleIdList><ArticleId IdType="pubmed">15744031</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2008 Jan 5;147B(1):18-26</Citation><ArticleIdList><ArticleId IdType="pubmed">17525972</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2007 Mar;91(1-3):51-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17270400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2009 Sep;14(9):874-84</Citation><ArticleIdList><ArticleId IdType="pubmed">18317462</ArticleId></ArticleIdList></Reference><Reference><Citation>Novartis Found Symp. 2008;289:60-72; discussion 72-3, 87-93</Citation><ArticleIdList><ArticleId IdType="pubmed">18497095</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Mar;162(3):609-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15741482</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jun;62(6):642-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15939841</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 May 15;61(10):1121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17346679</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2008 Jul;34(4):760-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18502737</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Jul;163(7):1138-46</Citation><ArticleIdList><ArticleId IdType="pubmed">16816216</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1976 Aug;133(8):905-8</Citation><ArticleIdList><ArticleId IdType="pubmed">942002</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Mar;85(1-2):135-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15780684</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Oct;63(10):1130-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17015815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Dec;60(12):1209-15</Citation><ArticleIdList><ArticleId IdType="pubmed">14662553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Aug;81(2):123-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15306137</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Sep 15;48(6):531-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11018225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2002 Feb 2;359(9304):426-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11844533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Sep;40(9):1053-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18677311</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Apr;160(4):636-45</Citation><ArticleIdList><ArticleId IdType="pubmed">12668349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 Sep;11(9):847-57</Citation><ArticleIdList><ArticleId IdType="pubmed">16819533</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Mar;188:199-201</Citation><ArticleIdList><ArticleId IdType="pubmed">16507957</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2007 Apr;80(4):605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17357068</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 2001 Dec 8;105(8):765-73</Citation><ArticleIdList><ArticleId IdType="pubmed">11803528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Bull. 2007 Jul;33(4):905-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17551090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 May;39(5):559-65</Citation><ArticleIdList><ArticleId IdType="pubmed">6124223</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Hum Genet. 2005 Dec;77(6):918-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16380905</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Psychiatry Rep. 2007 Dec;9(6):504-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18221632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2007 Jan;12(1):94-104</Citation><ArticleIdList><ArticleId IdType="pubmed">16940976</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Oct;63(10):1103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17015812</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14940-5</Citation><ArticleIdList><ArticleId IdType="pubmed">18824690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2000 May 22;9(9):1415-23</Citation><ArticleIdList><ArticleId IdType="pubmed">10814723</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2001 Jun 15;49(12):1062-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11430848</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17379666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 Oct;11(10):903-13</Citation><ArticleIdList><ArticleId IdType="pubmed">16801953</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Oct;95(1-3):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16793142</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1989 Oct;46(10):867-72</Citation><ArticleIdList><ArticleId IdType="pubmed">2802925</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1987 May;44(5):461-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3579497</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1992 Sep;49(9):703-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1514875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenet Genomics. 2007 Aug;17(8):605-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2007 Apr 20;316(5823):445-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17363630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Aug;8(4):322-37</Citation><ArticleIdList><ArticleId IdType="pubmed">16879133</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1977 Jun;34(6):715-7</Citation><ArticleIdList><ArticleId IdType="pubmed">869667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Mol Genet. 2006 Mar 1;15(5):743-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16434481</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2009 Aug;39(8):1277-87</Citation><ArticleIdList><ArticleId IdType="pubmed">19250581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat Res. 2005 Jun 3;573(1-2):54-69</Citation><ArticleIdList><ArticleId IdType="pubmed">15829237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Sep;40(9):1056-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18711365</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jul;162(7):1266-72</Citation><ArticleIdList><ArticleId IdType="pubmed">15994708</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23530885</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1753-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Expert opinion on medical diagnostics</Title><ISOAbbreviation>Expert Opin Med Diagn</ISOAbbreviation></Journal><ArticleTitle>Novel biomarkers for bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>147-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1517/17530059.2013.734807</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Bipolar disorder is diagnosed on the basis of patient and/or family reports and behavioral observation. Traditionally regarded as an affective disorder involving behavioral changes, bipolar disorder has been reconceptualized as a multisystem disease associated with mood, cognitive, metabolic, autonomic and sleep/wake dysfunctions. Accordingly, recent studies have focused on the identification of biomarkers related to the pathophysiological mechanisms underlying the development, clinical presentation and course of bipolar disorder.</AbstractText><AbstractText Label="AREAS COVERED" NlmCategory="METHODS">This article provides an overview of the available literature regarding circulating peripheral and neuroimaging biomarkers in bipolar disorder. Neurotrophic factors, immune parameters, oxidative stress parameters, hormones and neuroimaging findings were taken into consideration.</AbstractText><AbstractText Label="EXPERT OPINION" NlmCategory="CONCLUSIONS">Biomarkers research in bipolar disorder is a new field with an expanding knowledge. Current evidence suggests that a single biomarker will not be able to cover the biological and clinical complexity of bipolar disorder. Alternatively, a composite of biomarkers, including neurotrophic factors, cytokines and oxidative stress molecules, may be promising to identify altered mood states and neuroprogression in bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Antonio Lucio</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Departamento de Clínica Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil. altexr@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Izabela Guimarães</ForeName><Initials>IG</Initials></Author><Author ValidYN="Y"><LastName>Machado-Vieira</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Lucas Bortolotto</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Wieck</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Moisés E</ForeName><Initials>ME</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Med Diagn</MedlineTA><NlmUniqueID>101392201</NlmUniqueID><ISSNLinking>1753-0059</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23530885</ArticleId><ArticleId IdType="doi">10.1517/17530059.2013.734807</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21658341</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2011</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder self-assessment.</ArticleTitle><Pagination><MedlinePgn>e16</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.9017we1c</ELocationID><Abstract><AbstractText>Bipolar disorder is a complex condition that is difficult to diagnose and treat, and many patients with this illness are not receiving adequate care, particularly in the early stages of the disorder when effective treatment is most critical. Self-Assessment CME is an educational activity in which clinicians answer a series of multiple-choice questions to ascertain their current knowledge and practice in treating CNS disorders. After completing the self-assessment, clinicians have the opportunity to review correct answers, see how their colleagues responded, and receive recommendations for further reading. This Self-Assessment CME activity focuses on recognizing and bridging gaps in knowledge pertaining to bipolar disorder recognition and treatment.</AbstractText><CopyrightInformation>© Copyright 2011 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>King</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Parkwood Behavioral Health System, Olive Branch, Mississippi, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D054710">Interactive Tutorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21658341</ArticleId><ArticleId IdType="doi">10.4088/JCP.9017we1c</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23253393</PMID><DateCompleted><Year>2013</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Is there a clinical prodrome of bipolar disorder? A review of the evidence.</ArticleTitle><Pagination><MedlinePgn>89-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1586/ern.12.149</ELocationID><Abstract><AbstractText>Bipolar disorder is a prevalent, chronic and heterogeneous psychiatric disorder. There is increasing evidence that early recognition and treatment can improve long-term outcomes and prevent disability. Early intervention services for schizophrenia are well-funded and developed throughout the UK with close attention paid to the prodromal or early warning signs of schizophrenia, whereas there are currently no clear guidelines on the clinical, biological and neuropsychological markers of early bipolar disorder. This article reviews the growing literature on the bipolar prodrome and the differentiation between the syndromes of unipolar and bipolar depression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute of Health and Wellbeing, University of Glasgow, Mental Health and Wellbeing, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23253393</ArticleId><ArticleId IdType="doi">10.1586/ern.12.149</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18088203</PMID><DateCompleted><Year>2008</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2009</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-8360</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Expert review of neurotherapeutics</Title><ISOAbbreviation>Expert Rev Neurother</ISOAbbreviation></Journal><ArticleTitle>Neurobiology of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>93-110</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is one of the most severely debilitating of all medical illnesses. It can lead to significant suffering for patients and their families, limit functioning and workplace productivity, and with its risks of increased morbidity and mortality, it is increasingly recognized as a major public health problem. For a large number of patients, outcomes are poor. Patients with bipolar disorder generally experience high rates of relapse, a chronic recurrent course, lingering residual symptoms, functional impairment, psychosocial disability and diminished well-being. Despite this, little is known about the specific pathophysiology of bipolar disorder. A better understanding of the neurobiological underpinnings of this condition, informed by preclinical and clinical research, will be essential for the future development of specific targeted therapies that are more effective, achieve their effects more quickly and are better tolerated than currently available treatments. An abundance of research has implicated specific neuroendocrine, neurotransmitter and intracellular signaling systems in the pathophysiology and treatment of this illness. More recently, genetic association studies have identified numerous genes that confer vulnerability to the disorder, many of which are known to function in the signaling pathways previously identified as relevant to the etiology of the illness. In this article, we will review current knowledge regarding the neurotransmitter systems, signaling networks, neuroendocrine systems and genetics of bipolar disorder; all of these allow insight into the mechanism of illness and thus offer potential novel directions for the development of novel therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Newberg</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>National Institute of Mental Health, 10 Center Drive, MSC 1282, Building 10-CRC, Room 7-5545, Bethesda, MD 20892-1282, USA. newberga@mail.nih.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catapano</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Zarate</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Manji</LastName><ForeName>Husseini K</ForeName><Initials>HK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Neurother</MedlineTA><NlmUniqueID>101129944</NlmUniqueID><ISSNLinking>1473-7175</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009446" MajorTopicYN="Y">Neurobiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009490" MajorTopicYN="N">Neurosecretory Systems</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>144</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>2</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18088203</ArticleId><ArticleId IdType="doi">10.1586/14737175.8.1.93</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22201897</PMID><DateCompleted><Year>2012</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1945-0508</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2012</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Frontiers in bioscience (Elite edition)</Title><ISOAbbreviation>Front Biosci (Elite Ed)</ISOAbbreviation></Journal><ArticleTitle>Neuroimaging biomarkers in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>593-606</MedlinePgn></Pagination><Abstract><AbstractText>There is an urgent need to identify objective biomarkers for the assessment of bipolar disorder, to improve diagnosis and prognostic evaluation. Neuroimaging is a particularly promising approach. We review here the structural and functional neuroimaging studies carried out on bipolar disorder. These studies have led to the development of neurobiological models of bipolar disorder assuming cortical-limbic dysregulation. Dorsal brain structures are thought to decrease in volume and activity in bipolar disorder, reducing inhibition of the ventral-limbic network and enhancing emotional responses. These models also assume abnormal prefrontal-subcortical limbic connectivity. This abnormal connectivity has been identified by both diffusion tensor imaging studies (anatomical connectivity) and functional MRI (functional connectivity). However, studies are currently limited by the heterogeneity of the patients included. Future research should include studies to validate biomarkers for the assessment of bipolar disorder and studies of large and well characterized samples of patients with bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Houenou</LastName><ForeName>Josselin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>AP-HP, University Paris-East, Department of Psychiatry, Henri Mondor-Albert Chenevier Hospitals, Creteil, F-94010, France. josselin.houenou@inserm.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Albis</LastName><ForeName>Marc-Antoine</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Vederine</LastName><ForeName>Francois-Eric</ForeName><Initials>FE</Initials></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Chantal</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Leboyer</LastName><ForeName>Marion</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wessa</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Front Biosci (Elite Ed)</MedlineTA><NlmUniqueID>101485240</NlmUniqueID><ISSNLinking>1945-0494</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22201897</ArticleId><ArticleId IdType="pii">402</ArticleId><ArticleId IdType="doi">10.2741/402</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24636153</PMID><DateCompleted><Year>2015</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention.</ArticleTitle><Pagination><MedlinePgn>455-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12133</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Bipolar disorder is a multifaceted illness and there is often a substantial delay between the first onset of symptoms and diagnosis. Early detection has the potential to curtail illness progression and disorder-associated burden but it requires a clear understanding of the initial bipolar prodrome. This article summarizes the phenomenology of bipolar disorder with an emphasis on the initial prodrome, the evolution of the illness, and the implications for prevention and early intervention.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature review was undertaken using Medline, Web of Science, and a hand search of relevant literature using keywords (e.g., phenomenology, initial or early symptoms, risk factors, and predictors/prediction). Findings from the literature were reviewed and synthesized and have been put into a clinical context.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Bipolar disorder is a recurrent, persistent, and disabling illness that typically develops in adolescence or early adulthood. The literature search yielded 28 articles, in which mood lability, nonspecific, non-mood symptoms, and cyclothymic temperament were the most cited prodromal features.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A small number of key prospective studies have provided evidence in support of an initial bipolar prodrome; however, methodological differences across studies have prohibited its clear delineation. It is, therefore, not currently possible to anticipate those who will develop bipolar disorder solely on the basis of early phenomenology. Accurate characterization of the bipolar disorder prodrome through high-quality, prospective research studies with adequate control groups will ultimately facilitate prompt and accurate diagnosis.</AbstractText><CopyrightInformation>© 2013 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malhi</LastName><ForeName>Gin S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia; Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bargh</LastName><ForeName>Danielle M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Coulston</LastName><ForeName>Carissa M</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Pritha</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018479" MajorTopicYN="Y">Early Intervention, Educational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">early intervention</Keyword><Keyword MajorTopicYN="N">mania</Keyword><Keyword MajorTopicYN="N">phenomenology</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">prodrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24636153</ArticleId><ArticleId IdType="doi">10.1111/bdi.12133</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12720477</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0160-6689</ISSN><JournalIssue CitedMedium="Print"><Volume>64 Suppl 6</Volume><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder and schizophrenia: distinct illnesses or a continuum?</ArticleTitle><Pagination><MedlinePgn>23-7; discussion 28</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder continues to present complex diagnostic and therapeutic challenges. Originally considered 2 separate diseases (mania and depression), bipolar disorder is now recognized to be a single disorder characterized by different subtypes and degrees of severity. Despite the availability of official guidelines, such as the DSM-IV and ICD-10, diagnosis is still problematic. Traditionally, bipolar disorder has been considered a clinical entity distinct from schizophrenia, although that assumption is being increasingly challenged. Proponents of a bipolar continuum theory support the concept of an expanded psychiatric continuum ranging from unipolar to bipolar disorders all the way to schizophrenia. This notion is supported by various independent findings. Both bipolar disorder and schizophrenia demonstrate a high degree of genetic transmissibility. Some data reported in family and twin studies suggest hereditary overlap between the 2 disorders. Gene mapping for both diseases is in its early stages, but certain susceptibility markers appear to be located on the same chromosomes. Bipolar disorder and schizophrenia also demonstrate some similarities in neurotransmitter dysfunction. As further indirect evidence of a possible association, many newer atypical antipsychotic agents approved for the treatment of schizophrenia are also proving useful for bipolar disorder. Ongoing research should aid in the understanding of bipolar disorder and foster the development of more effective treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Möller</LastName><ForeName>Hans-Jürgen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Psychiatric Department of the University of Munich, Munich, Germany. hans-juergen.moeller@psy.med.uni-muenchen.de</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="N">Schizophrenic Psychology</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>43</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12720477</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15898850</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1059-8405</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of school nursing : the official publication of the National Association of School Nurses</Title><ISOAbbreviation>J Sch Nurs</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder in school-age children.</ArticleTitle><Pagination><MedlinePgn>152-7</MedlinePgn></Pagination><Abstract><AbstractText>This article examines the individual components of bipolar disorder in children and the behaviors that can escalate as a result of misdiagnosis and treatment. The brain/behavior relationship in bipolar disorders can be affected by genetics, developmental failure, or environmental influences, which can cause an onset of dramatic mood swings and dysfunctional behavior. School is often the site where mental health disorders are observed when comparing behaviors with other children. Assessing the emotional, academic, and health needs of a student with a bipolar disorder is a critical step in designing effective interventions and school accommodations. Without appropriate medical, psychological, pharmaceutical, and academic interventions, a child is at risk for uncontrolled mania, depression, substance abuse, or suicide. The school nurse is part of the multidisciplinary team and plays a key role in facilitating case management to potentially reverse this possible negative trajectory. Successful case management provides children with bipolar disorder the opportunity to reach their academic potential.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>Patricia M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Nova Southeastern University, Ft. Lauderdale, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Mary Rae</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Sch Nurs</MedlineTA><NlmUniqueID>9206498</NlmUniqueID><ISSNLinking>1059-8405</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002652" MajorTopicYN="N">Child Behavior</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002669" MajorTopicYN="Y">Child Welfare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009730" MajorTopicYN="N">Nursing Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002666" MajorTopicYN="N">Psychology, Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012572" MajorTopicYN="N">School Health Services</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012573" MajorTopicYN="N">School Nursing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>26</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15898850</ArticleId><ArticleId IdType="doi">10.1177/10598405050210030501</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26896814</PMID><DateCompleted><Year>2016</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>195</Volume><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Can neuroimaging disentangle bipolar disorder?</ArticleTitle><Pagination><MedlinePgn>199-214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2016.01.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(15)30753-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bipolar disorder heterogeneity is large, leading to difficulties in identifying neuropathophysiological and etiological mechanisms and hindering the formation of clinically homogeneous patient groups in clinical trials. Identifying markers of clinically more homogeneous groups would help disentangle BD heterogeneity. Neuroimaging may aid in identifying such groups by highlighting specific biomarkers of BD subtypes or clinical dimensions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic literature search of the neuroimaging literature assessing biomarkers of relevant BD phenotypes (type-I vs. II, presence vs. absence of psychotic features, suicidal behavior and impulsivity, rapid cycling, good vs. poor medication response, age at onset, cognitive performance and circadian abnormalities).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Consistent biomarkers were associated with suicidal behavior, i.e. frontal/anterior alterations (prefrontal and cingulate grey matter, prefrontal white matter) in patients with a history of suicide attempts; and with cognitive performance, i.e. involvement of frontal and temporal regions, superior and inferior longitudinal fasciculus, right thalamic radiation, and corpus callosum in executive dysfunctions. For the other dimensions and sub-types studied, no consistent biomarkers were identified.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Studies were heterogeneous both in methodology and outcome.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Though theoretically promising, neuroimaging has not yet proven capable of disentangling subtypes and dimensions of bipolar disorder, due to high between-study heterogeneity. We issue recommendations for future studies.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hozer</LastName><ForeName>Franz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurospin, UNIACT, Psychiatry Team, I2BM, CEA Saclay, F-91191 Gif-Sur-Yvette, France; INSERM U955, IMRB, Université Paris Est, Equipe 15 "Psychiatrie Translationnelle", Créteil F-94000, France; Fondation Fondamental, Créteil F-94010, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houenou</LastName><ForeName>Josselin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neurospin, UNIACT, Psychiatry Team, I2BM, CEA Saclay, F-91191 Gif-Sur-Yvette, France; INSERM U955, IMRB, Université Paris Est, Equipe 15 "Psychiatrie Translationnelle", Créteil F-94000, France; Fondation Fondamental, Créteil F-94010, France; AP-HP, Hôpitaux Universitaires Mondor, DHU PePsy, Pôle de Psychiatrie, Créteil F-94000, France. Electronic address: josselin.houenou@inserm.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Dimension</Keyword><Keyword MajorTopicYN="N">Heterogeneity</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Sub-types</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>01</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26896814</ArticleId><ArticleId IdType="pii">S0165-0327(15)30753-9</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2016.01.039</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19498214</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2009</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0009-9228</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2009</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical pediatrics</Title><ISOAbbreviation>Clin Pediatr (Phila)</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>693-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0009922808316663</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abell</LastName><ForeName>Sue</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ey</LastName><ForeName>John L</ForeName><Initials>JL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Pediatr (Phila)</MedlineTA><NlmUniqueID>0372606</NlmUniqueID><ISSNLinking>0009-9228</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>6</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19498214</ArticleId><ArticleId IdType="pii">48/6/693</ArticleId><ArticleId IdType="doi">10.1177/0009922808316663</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21475373</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1213-8118</ISSN><JournalIssue CitedMedium="Internet"><Volume>155</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia</Title><ISOAbbreviation>Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>19-26</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Provide an overview of how bipolar disorder affects cognitive function in patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE and PsycInfo data bases were searched for articles indexed by the combinations of MESH term or key word "bipolar disorder" with the following terms: "cognition", "memory", "neuropsychology", "neuropsychological tests", "lithium", "anticonvulsants", "antipsychotics", and "schizophrenia". Constraints limiting time period of publications or their language were not applied. Reference lists of publications identified by these procedures were hand-searched for additional relevant citations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There is evidence of stable and lasting cognitive impairment in all phases of bipolar disorder, including the remission phase, particularly in the following domains: sustained attention, memory and executive functions. But research on the cognitive functions has yielded inconsistent results over recent years. There is a growing need for clarification regarding the magnitude, clinical relevance and confounding variables of cognitive impairment in bipolar patients. The impact of bipolar illness on cognition can be influenced by age of onset, pharmacological treatments, individual response, familial risk factors, and clinical features. In addition to the mood state, cognitive performance in bipolar patients is influenced by seasonality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Previous optimistic assumptions about the prognosis of bipolar disorder were based on the success of the control of mood symptoms by pharmacotherapy. However, it is now clear that the "remitted" euthymic bipolar patients have distinct impairments of executive function, verbal memory, psychomotor speed, and sustained attention. Mood stabilizers and atypical antipsychotics may reduce cognitive deficits in certain domains and may have a positive effect on quality of life and social functioning.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Latalova</LastName><ForeName>Klara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic. klaralat@centrum.cz</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasko</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Diveky</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Velartova</LastName><ForeName>Hana</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Czech Republic</Country><MedlineTA>Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub</MedlineTA><NlmUniqueID>101140142</NlmUniqueID><ISSNLinking>1213-8118</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21475373</ArticleId><ArticleId IdType="doi">10.5507/bp.155.2011.003</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3288976</PMID><DateCompleted><Year>1988</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0193-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>1988</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Late-onset bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>117-31</MedlinePgn></Pagination><Abstract><AbstractText>Mania in old age is not as rare as it was once thought to be. It may constitute up to 5 per cent of admissions in the psychogeriatric department. The clinical picture, for the most part, seems to correspond with mania in younger patients, although some patients may have atypical presentations. Secondary mania should be excluded first, before a firm diagnosis of primary affective disorder is made. The prognosis and treatment of late onset mania do not seem to differ appreciably from those in younger patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yassa</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>McGill University, Montreal, Québec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>N P</ForeName><Initials>NP</Initials></Author><Author ValidYN="Y"><LastName>Iskandar</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005162" MajorTopicYN="N">Factitious Disorders</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>92</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1988</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1988</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1988</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3288976</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30638572</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>393</Volume><Issue>10167</Issue><PubDate><Year>2019</Year><Month>01</Month><Day>12</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Picturing health: living with bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>119-126</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(18)33254-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(18)33254-9</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zellweger</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D019477">Portrait</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30638572</ArticleId><ArticleId IdType="pii">S0140-6736(18)33254-9</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(18)33254-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16321726</PMID><DateCompleted><Year>2006</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1056-4993</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2006</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Child and adolescent psychiatric clinics of North America</Title><ISOAbbreviation>Child Adolesc Psychiatr Clin N Am</ISOAbbreviation></Journal><ArticleTitle>Pediatric bipolar disorder: emerging diagnostic and treatment approaches.</ArticleTitle><Pagination><MedlinePgn>73-108</MedlinePgn></Pagination><Abstract><AbstractText>Children and adolescents who have bipolar disorder often are encountered in clinical settings and frequently require treatment with mood stabilizers and atypical antipsychotics. New screening and diagnostic tools are available to aid in the diagnosis of bipolar disorder in children and adolescents. Additional data supporting the use of mood stabilizers and atypical antipsychotics in this population also are emerging. Combinations of existing psychotropics remain the most effective treatment of pediatric bipolar disorder at this point. This article reviews the phenomenology and clinical characteristics of pediatric bipolar disorder and current approaches to pharmacotherapy. It is becoming apparent that bipolar disorder is often a chronic disorder in children and adolescents, much like diabetes, and is best managed with a combination of medications and psychosocial therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kowatch</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Pediatrics, University of Cincinnati Medical Center &amp; Cincinnati Children's Hospital Medical Center, MSB 7261, PO Box 670559, Cincinnati, OH 45267-0559, USA. robert.kowatch@uc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DelBello</LastName><ForeName>Melissa P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Child Adolesc Psychiatr Clin N Am</MedlineTA><NlmUniqueID>9313451</NlmUniqueID><ISSNLinking>1056-4993</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>100</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16321726</ArticleId><ArticleId IdType="pii">S1056-4993(05)00078-7</ArticleId><ArticleId IdType="doi">10.1016/j.chc.2005.08.013</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21237352</PMID><DateCompleted><Year>2011</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2011</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0013-7006</ISSN><JournalIssue CitedMedium="Internet"><Volume>36 Suppl 6</Volume><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>L'Encephale</Title><ISOAbbreviation>Encephale</ISOAbbreviation></Journal><ArticleTitle>[Bipolar disorder: Continuity from child to adult?].</ArticleTitle><Pagination><MedlinePgn>S173-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0013-7006(10)70053-1</ELocationID><Abstract><AbstractText>Early onset (pediatric) bipolar disorders are still an issue of much controversy due to several clinical particularities of the thymic episodes at this age. To date, there is indeed no consensus regarding the prevalence of bipolar disorders before puberty. Diagnosis criteria in children and young adolescents remain thus elusive. The purpose of this review is to provide an overview of this issue. The idea of continuity, from childhood to adulthood, in bipolar disorders also raises important questions regarding predictive factors of bipolar disorders in adults. Studies on the childhood of bipolar adults, as well as studies on the children of bipolar parents will be reviewed, in an attempt to identify the psychopathological substrates of bipolar disorders.</AbstractText><CopyrightInformation>Copyright Â© 2010 L'Encéphale. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Da Fonseca</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service de Pédopsychiatrie, bd Sainte Marguerite 13009 Marseille, France. ddafonseca@ap-hm.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bat</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Rouviere</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Campredon</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Bastard-Rosset</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Viellard</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Deruelle</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Azorin</LastName><ForeName>J-M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Fakra</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Adida</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Troubles bipolaires : continuité enfant-adulte ?</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Encephale</MedlineTA><NlmUniqueID>7505643</NlmUniqueID><ISSNLinking>0013-7006</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011599" MajorTopicYN="N">Psychopathology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21237352</ArticleId><ArticleId IdType="pii">S0013-7006(10)70053-1</ArticleId><ArticleId IdType="doi">10.1016/S0013-7006(10)70053-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25723771</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2015</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-3522</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Fortschritte der Neurologie-Psychiatrie</Title><ISOAbbreviation>Fortschr Neurol Psychiatr</ISOAbbreviation></Journal><ArticleTitle>[Differential diagnosis of bipolar disorder: historical and clinical implications and perspectives].</ArticleTitle><Pagination><MedlinePgn>74-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0034-1398934</ELocationID><Abstract><AbstractText>In DSM-5, bipolar disorder (BS) is no longer conceptualised as a pure mood disorder together with unipolar depression, but as a bridge between schizophrenia and depressive disorders. This nosological classification is founded on the historical context of the 19th century. In addition to unipolar depression and schizophrenia, schizoaffective disorder, borderline personality disorder and attention-deficit hyperactivity disorder (ADHD) overlap with BS symptomatology. Overlap also exists with somatic diseases such as multiple sclerosis, Cushing's syndrome and syphilis as well as iatrogenic affective syndromes. </AbstractText><CopyrightInformation>© Georg Thieme Verlag KG Stuttgart · New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>F M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät der Universität Leipzig.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinberg</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät der Universität Leipzig, Archiv für Leipziger Psychiatriegeschichte.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himmerich</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik für Psychiatrie und Psychotherapie, Medizinische Fakultät der Universität Leipzig.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Differenzialdiagnostik der Bipolaren Störung: historische und klinische Implikationen und Perspektiven.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Fortschr Neurol Psychiatr</MedlineTA><NlmUniqueID>8103137</NlmUniqueID><ISSNLinking>0720-4299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25723771</ArticleId><ArticleId IdType="doi">10.1055/s-0034-1398934</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11239105</PMID><DateCompleted><Year>2001</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1075-2730</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2001</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Psychiatric services (Washington, D.C.)</Title><ISOAbbreviation>Psychiatr Serv</ISOAbbreviation></Journal><ArticleTitle>Bipolar II disorder: symptoms, course, and response to treatment.</ArticleTitle><Pagination><MedlinePgn>358-61</MedlinePgn></Pagination><Abstract><AbstractText>The authors provide an overview of the diagnosis, course, and treatment of bipolar II disorder, a distinct subtype that is often misdiagnosed as unipolar depression or bipolar I disorder. They discuss research suggesting that underdiagnosis of bipolar II disorder reflects a failure to identify subthreshold expression of mania (hypomania). The course of bipolar II disorder is different from that of bipolar I disorder or unipolar depression, with distinct differences in rates of recovery, clinical features, and number of episodes. The risk of suicide appears to be particularly elevated. High rates of comorbid disorders have been reported, including substance abuse or dependence, anxiety disorders, and personality disorders. Few definitive studies exist on which to base conclusions about the differential efficacy of various treatment strategies in bipolar II disorder and bipolar I disorder. Preliminary studies suggest that the newer anticonvulsants may be of benefit for patients with bipolar II disorder, while other data suggest that there may be a greater role for antidepressant medications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>MacQueen</LastName><ForeName>G M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>McMaster University, McMaster University Medical Center, Hamilton, Ontario, Canada. macqueng@mcmaster.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>L T</ForeName><Initials>LT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Serv</MedlineTA><NlmUniqueID>9502838</NlmUniqueID><ISSNLinking>1075-2730</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017831" MajorTopicYN="N">Diagnosis, Dual (Psychiatry)</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010554" MajorTopicYN="N">Personality Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>55</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>3</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>5</Month><Day>18</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>3</Month><Day>10</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11239105</ArticleId><ArticleId IdType="doi">10.1176/appi.ps.52.3.358</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24254199</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-1645</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2013</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current psychiatry reports</Title><ISOAbbreviation>Curr Psychiatry Rep</ISOAbbreviation></Journal><ArticleTitle>Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.</ArticleTitle><Pagination><MedlinePgn>422</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11920-013-0422-z</ELocationID><Abstract><AbstractText>It is clinically important to recognize both bipolar disorder and borderline personality disorder (BPD) in patients seeking treatment for depression, and it is important to distinguish between the two. The most studied question on the relationship between BPD and bipolar disorder is their diagnostic concordance. Across studies approximately 10 % of patients with BPD had bipolar I disorder and another 10 % had bipolar II disorder. Likewise, approximately 20 % of bipolar II patients were diagnosed with BPD, though only 10 % of bipolar I patients were diagnosed with BPD. While the comorbidity rates are substantial, each disorder is, nonetheless, diagnosed in the absence of the other in the vast majority of cases (80-90 %). In studies examining personality disorders broadly, other personality disorders were more commonly diagnosed in bipolar patients than was BPD. Likewise, the converse is also true: other axis I disorders such as major depression, substance abuse, and post-traumatic stress disorder are more commonly diagnosed in patients with BPD than is bipolar disorder. Studies comparing patients with BPD and bipolar disorder find significant differences on a range of variables. These findings challenge the notion that BPD is part of the bipolar spectrum. While a substantial literature has documented problems with the under-recognition and under-diagnosis of bipolar disorder, more recent studies have found evidence of bipolar disorder over-diagnosis and that BPD is a significant contributor to over-diagnosis. Re-conceptualizing the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, diagnostic criteria for bipolar disorder as a type of test, rather than the final word on diagnosis, shifts the diagnostician from thinking solely whether a patient does or does not have a disorder to considering the risks of false-positive and false-negative diagnoses, and the ease by which each type of diagnostic error can be corrected by longitudinal observation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI, USA, mzimmerman@lifespan.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Theresa A</ForeName><Initials>TA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Psychiatry Rep</MedlineTA><NlmUniqueID>100888960</NlmUniqueID><ISSNLinking>1523-3812</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001883" MajorTopicYN="N">Borderline Personality Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24254199</ArticleId><ArticleId IdType="doi">10.1007/s11920-013-0422-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Clin Psychiatry. 2005 Nov;66(11):1432-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16420081</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Oct;64(10):1201-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14658969</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 1999 May;187(5):313-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10348089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Jun;69(6):935-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18466044</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1994 Aug;31(4):281-94</Citation><ArticleIdList><ArticleId IdType="pubmed">7989643</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Dec;67(1-3):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11869772</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1998 Mar-Apr;39(2):72-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9515191</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pract Epidemiol Ment Health. 2006 Mar 08;2:2</Citation><ArticleIdList><ArticleId IdType="pubmed">16524481</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005;66 Suppl 1:13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15693747</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 1993 Jun;3(2):103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8364346</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2008 Nov;69(11):1751-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18945397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2013 Sep;74(9):880-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24107761</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2010 Sep-Oct;51(5):486-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20728005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2001 Oct;3(5):253-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11903208</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2004 Jun;38(6):433-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15209835</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2002 Mar;47(2):125-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11926074</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Psychopharmacol. 2004 Jul;19(5):355-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15252830</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Psychoanal Assoc. 1986;34(4):863-93</Citation><ArticleIdList><ArticleId IdType="pubmed">3819306</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Jan;71(1):26-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19646366</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2004 Dec;110(6):401-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15521823</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2000 Mar-Apr;41(2):106-10</Citation><ArticleIdList><ArticleId IdType="pubmed">10741888</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 1999;10(4):175-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10690579</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2004 May-Jun;12(3):140-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15371068</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">12507741</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2008 Jul;109(1-2):83-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18082895</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2008 Jun 30;159(3):300-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18445508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Apr;79(1-3):297-303</Citation><ArticleIdList><ArticleId IdType="pubmed">15023511</ArticleId></ArticleIdList></Reference><Reference><Citation>World Psychiatry. 2011 Feb;10(1):45-51</Citation><ArticleIdList><ArticleId IdType="pubmed">21379356</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Board Fam Pract. 2005 Jul-Aug;18(4):233-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15994469</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1983 Jan;40(1):23-30</Citation><ArticleIdList><ArticleId IdType="pubmed">6849616</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Jun;65(1):3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11426507</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1999 Jul-Aug;40(4):245-52</Citation><ArticleIdList><ArticleId IdType="pubmed">10428182</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Jan;160(1):178-80</Citation><ArticleIdList><ArticleId IdType="pubmed">12505821</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2003 Jan-Feb;44(1):28-34</Citation><ArticleIdList><ArticleId IdType="pubmed">12524633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Apr;7(2):192-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15762861</ArticleId></ArticleIdList></Reference><Reference><Citation>J Nerv Ment Dis. 2006 Dec;194(12):967-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17164638</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 Feb 23;293(8):956-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15728166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Dec;5(6):456-63</Citation><ArticleIdList><ArticleId IdType="pubmed">14636371</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2001 Nov-Dec;35(6):307-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11684137</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 1988 Jun;33(5):336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">3409151</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2000 Sep-Oct;41(5):339-43</Citation><ArticleIdList><ArticleId IdType="pubmed">11011829</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2004 Aug;49(8):551-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15453104</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Nov;157(11):1873-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11058490</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1999 Nov;60(11):752-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10584763</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1996 Dec;153(12):1598-606</Citation><ArticleIdList><ArticleId IdType="pubmed">8942457</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2011 Jun 30;188(1):40-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21131058</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2005 Dec;56(12):1529-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16339614</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1998 Sep;50(2-3):163-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9858076</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2002 Mar;47(2):195-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11926084</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Feb;64(2):161-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12633125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2001;62 Suppl 14:5-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11469675</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2004 May-Jun;12(3):133-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15371067</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2007 Sep;116(3):189-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17655560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2012 Mar;14(2):127-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22420588</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2007 Mar-Apr;48(2):145-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17292705</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jun;92(2-3):141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16529822</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1988 Oct;78(4):485-92</Citation><ArticleIdList><ArticleId IdType="pubmed">3227970</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2004;65 Suppl 15:5-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15554789</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Oct;61(10):804-8; quiz 809</Citation><ArticleIdList><ArticleId IdType="pubmed">11078046</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Oct;88(2):217-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16125784</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Serv. 2001 Jan;52(1):51-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11141528</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1988 Jul;153:44-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3224249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Feb;61(2):134-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10732661</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Board Fam Pract. 2005 Jul-Aug;18(4):271-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15994473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2010 Sep;71(9):1212-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20361913</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2012 Apr;73(4):437-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22579144</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr J Univ Ott. 1990 Mar;15(1):22-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2326383</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2011 Aug;68(8):791-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21810644</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychol. 2007 Jan;63(1):73-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17115430</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr J Univ Ott. 1982 Sep;7(3):190-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6758006</ArticleId></ArticleIdList></Reference><Reference><Citation>Harv Rev Psychiatry. 2011 Sep-Oct;19(5):219-28</Citation><ArticleIdList><ArticleId IdType="pubmed">21916824</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1990 Nov-Dec;31(6):499-510</Citation><ArticleIdList><ArticleId IdType="pubmed">2265534</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2007 Oct;68(10):1533-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17960968</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1985 Feb;46(2):41-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3968045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Mar;66(3):339-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15766300</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1997 Mar-Apr;38(2):102-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9056129</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 1998 Apr;32(2):276-80</Citation><ArticleIdList><ArticleId IdType="pubmed">9588307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Sep;9(6):646-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17845280</ArticleId></ArticleIdList></Reference><Reference><Citation>Depress Anxiety. 2004;19(4):199-208</Citation><ArticleIdList><ArticleId IdType="pubmed">15274168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Apr;5(2):115-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12680901</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Nov 1;82(3):373-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15555688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1995 Aug 18;34(4):269-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8550952</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 Dec;155(12):1733-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9842784</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005;66 Suppl 5:11-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16038597</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Jul;163(7):1173-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16816221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Dec;5(6):436-42</Citation><ArticleIdList><ArticleId IdType="pubmed">14636367</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 1998 Mar-Apr;39(2):63-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9515190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Abnorm Psychol. 1989 May;98(2):117-26</Citation><ArticleIdList><ArticleId IdType="pubmed">2708652</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Feb;152(2):232-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7840357</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22652924</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2012</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2617-2402</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>The Israel journal of psychiatry and related sciences</Title><ISOAbbreviation>Isr J Psychiatry Relat Sci</ISOAbbreviation></Journal><ArticleTitle>Editorial: Pediatric bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>2</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belmaker</LastName><ForeName>R H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Assistant Director, Beersheva Mental Health Center, Israel   Hoffer-Vickar Professor of Psychiatry, Ben-Gurion University of the Negev, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbelle</LastName><ForeName>Shoshana</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D054711">Introductory Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Israel</Country><MedlineTA>Isr J Psychiatry Relat Sci</MedlineTA><NlmUniqueID>8108287</NlmUniqueID><ISSNLinking>0333-7308</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22652924</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10439204</PMID><DateCompleted><Year>1999</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1040-8703</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>1999</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Current opinion in pediatrics</Title><ISOAbbreviation>Curr Opin Pediatr</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder in children and adolescents.</ArticleTitle><Pagination><MedlinePgn>317-22</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is an affective or mood disorder that affects children and adolescents as well as adults. Originally thought to be rare in childhood, this disorder is now diagnosed even in the prepubertal age group. With pediatricians providing health care for the majority of children and adolescents, these physicians will see the children early in their presentation with affective disorder. This review focuses on the early recognition of children with bipolar disorder or children who are at increased risk of developing mania. Early recognition can lead to early treatment and reduce both short- and long-term morbidity and mortality. This review covers the definition, epidemiology, presentation and differential diagnosis, comorbid diagnoses, precipitants, risk factors, treatment, and outcome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Robb</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Children's National Medical Center, Washington, DC 20010-2970, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Pediatr</MedlineTA><NlmUniqueID>9000850</NlmUniqueID><ISSNLinking>1040-8703</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010372" MajorTopicYN="N">Pediatrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000297" MajorTopicYN="Y">Psychology, Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002666" MajorTopicYN="Y">Psychology, Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>44</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10439204</ArticleId><ArticleId IdType="doi">10.1097/00008480-199908000-00009</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2672748</PMID><DateCompleted><Year>1989</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-838X</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>3</Issue><PubDate><Year>1989</Year><Month>Sep</Month></PubDate></JournalIssue><Title>American family physician</Title><ISOAbbreviation>Am Fam Physician</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>156-66</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar illness is a serious heritable mood disorder characterized by recurrent episodes of depression and mania. The mean age of onset is under 25 years of age, but the period of risk extends from prepuberty to senescence. Fifteen percent of persons with the disorder commit suicide. Bipolar disorder carries an increased risk of cardiovascular disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dilsaver</LastName><ForeName>S C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Ohio State University College of Medicine, Columbus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Fam Physician</MedlineTA><NlmUniqueID>1272646</NlmUniqueID><ISSNLinking>0002-838X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>59</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1989</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1989</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">2672748</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10550861</PMID><DateCompleted><Year>1999</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0193-953X</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>1999</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Psychiatric clinics of North America</Title><ISOAbbreviation>Psychiatr Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Bipolar II disorder and suicidal behavior.</ArticleTitle><Pagination><MedlinePgn>667-73, ix-x</MedlinePgn></Pagination><Abstract><AbstractText>Despite the fact that the nosologic position of bipolar II disorder continues to be debated, several lines of research indicate that it is a distinct nosologic category that should be separated from both bipolar I and unipolar major depression. This review of the authors' and others' work demonstrates that the lifetime risk of suicide attempts is highest in bipolar II and lowest in unipolar patients, whereas risk is intermediate in bipolar I patients. Moreover, two reports show that bipolar II patients are over represented among suicide victims. Clinicians must take great care in not missing this diagnosis, which, when untreated, has ominous prognostic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rihmer</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Institute for Psychiatry and Neurology, Budapest.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pestality</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Psychiatr Clin North Am</MedlineTA><NlmUniqueID>7708110</NlmUniqueID><ISSNLinking>0193-953X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>33</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>11</Month><Day>7</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>11</Month><Day>7</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10550861</ArticleId><ArticleId IdType="pii">S0193-953X(05)70101-5</ArticleId><ArticleId IdType="doi">10.1016/s0193-953x(05)70101-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19809006</PMID><DateCompleted><Year>2010</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2009</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1542-6270</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2009</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Annals of pharmacotherapy</Title><ISOAbbreviation>Ann Pharmacother</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder patient care opportunities: let's answer the call.</ArticleTitle><Pagination><MedlinePgn>1890-2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1345/aph.1M432</ELocationID><Abstract><AbstractText>Bipolar disorder is a brain illness with complexities in its composition and treatment. Results from the National Comorbidity Survey Replication study estimate the lifetime prevalence of bipolar spectrum illnesses to be 4.5%. These patients were also reported to have their illnesses frequently treated suboptimally and to be at risk of suffering extensive disability. Pharmacists are in a key position to deliver important pharmacy care services to patients who have bipolar disorder and receive treatments in need of close monitoring. Described here are the results of this study and opportunities for pharmacists to support this important patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caley</LastName><ForeName>Charles F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>School of Pharmacy, University of Connecticut, Storrs, CT, USA. c.caley@uconn.edu</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Pharmacother</MedlineTA><NlmUniqueID>9203131</NlmUniqueID><ISSNLinking>1060-0280</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005791" MajorTopicYN="N">Patient Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>9</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19809006</ArticleId><ArticleId IdType="pii">aph.1M432</ArticleId><ArticleId IdType="doi">10.1345/aph.1M432</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23542544</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1769-7115</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of physiology, Paris</Title><ISOAbbreviation>J Physiol Paris</ISOAbbreviation></Journal><ArticleTitle>Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset.</ArticleTitle><Pagination><MedlinePgn>278-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jphysparis.2013.03.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0928-4257(13)00008-9</ELocationID><Abstract><AbstractText>Bipolar disorder is a multifactorial psychiatric disorder with developmental and progressive neurophysiological alterations. This disorder is typically characterized by cyclical and recurrent episodes of mania and depression but is heterogeneous in its clinical presentation and outcome. Although the DSM-IV-TR criteria identify several features that are of phenomenological relevance, these are of less utility for defining homogeneous subgroups, for analyses of correlations with biomarkers or for directing focused medication strategies. We provide a comprehensive review of existing evidence regarding to age at onset in bipolar disorder. Eight admixture studies demonstrate three homogeneous subgroups of patients with bipolar disorder identified according to age at onset (early, intermediate and late age at onset), with two cutoff points, at 21 and 34 years. It is suggested that the early-onset subgroup has specific clinical features and outcomes different from those of the other subgroups. Early-onset subgroup may be considered a more suitable clinical phenotype for the identification of susceptibility genes with recent data demonstrating associations with genetic variants specifically in this subgroup. The use of age at onset as a specifier may also facilitate the identification of other biological markers for use in brain imaging, circadian, inflammatory and cognitive research. A key challenge is posed by the use of age at onset in treatment decision algorithms, although further research is required to increase the evidence-base. We discuss three potential benefits of specifying age at onset, namely: focused medication strategies, the targeted prevention of specific comorbid conditions and decreasing the duration of untreated illness. We argue that age at onset should be included as a specifier for bipolar disorders.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Geoffroy</LastName><ForeName>Pierre Alexis</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Inserm U955, Créteil 94000, France. pierre.a.geoffroy@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etain</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Chantal</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Jamain</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Leboyer</LastName><ForeName>Marion</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bellivier</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>J Physiol Paris</MedlineTA><NlmUniqueID>9309351</NlmUniqueID><ISSNLinking>0928-4257</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Admixture</Keyword><Keyword MajorTopicYN="N">Age at onset</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Early-onset bipolar disorder</Keyword><Keyword MajorTopicYN="N">Genetic</Keyword><Keyword MajorTopicYN="N">Phenotype</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23542544</ArticleId><ArticleId IdType="pii">S0928-4257(13)00008-9</ArticleId><ArticleId IdType="doi">10.1016/j.jphysparis.2013.03.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15154068</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-7557</ISSN><JournalIssue CitedMedium="Print"><Volume>80</Volume><Issue>2 Suppl</Issue><PubDate><Year>2004</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Jornal de pediatria</Title><ISOAbbreviation>J Pediatr (Rio J)</ISOAbbreviation></Journal><ArticleTitle>[Bipolar disorder and depression in childhood and adolescence].</ArticleTitle><Pagination><MedlinePgn>S11-20</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To provide a historical review of childhood depression and bipolar disorder, covering concepts, diagnostic categories, epidemiology, genetic and neurobiological aspects as well as predisposing factors and treatment modalities.</AbstractText><AbstractText Label="SOURCES OF DATA" NlmCategory="METHODS">Extensive review of the literature on child depression and bipolar disorder.</AbstractText><AbstractText Label="SUMMARY OF THE FINDINGS" NlmCategory="RESULTS">Child depression and bipolar disorder are associated with genetic factors, mood, adverse life events, divorce, academic problems, physical and sexual abuse, and neurobiological factors. Treatment usually includes medication and psychotherapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These are important childhood disorders whose diagnosis is often difficult. The identification and treatment of depression and bipolar disorder reduces the suffering of affected children and adolescents. The pediatrician can intervene by orienting the family in mild cases, but must be alert to cases requiring more aggressive treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>Dênio</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Universidade de Brasília, DF. dlima@br.inter.net</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Depressão e doença bipolar na infância e adolescência.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Pediatr (Rio J)</MedlineTA><NlmUniqueID>2985188R</NlmUniqueID><ISSNLinking>0021-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="Y">Depressive Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>65</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15154068</ArticleId><ArticleId IdType="doi">10.2223/1164</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20193644</PMID><DateCompleted><Year>2010</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2010</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>2</Issue><PubDate><Year>2010</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Course and impact of bipolar disorder in young patients.</ArticleTitle><Pagination><MedlinePgn>e05</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.8125tx7c</ELocationID><Abstract><AbstractText>The presentation of bipolar disorder in children and adolescents may vary from its presentation in adults. Rage, irritability, and long episodes are common manifestations of mania in young people with bipolar disorder. Frequent comorbid disorders in young patients include ADHD and anxiety disorders. Prodromal and subsyndromal states of bipolar disorder, such as bipolar disorder NOS, present opportunities for early intervention and prevention. Early recognition and intervention are crucial, because untreated pediatric bipolar disorder becomes chronic, has a high incidence of relapse, and has a poor prognosis.</AbstractText><CopyrightInformation>Copyright 2010 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Kiki D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences and the Bipolar Disorders Program, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007508" MajorTopicYN="N">Irritable Mood</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011889" MajorTopicYN="N">Rage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>0</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20193644</ArticleId><ArticleId IdType="doi">10.4088/JCP.8125tx7c</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9300191</PMID><DateCompleted><Year>1997</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1040-8703</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>1997</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Current opinion in pediatrics</Title><ISOAbbreviation>Curr Opin Pediatr</ISOAbbreviation></Journal><ArticleTitle>Juvenile onset bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>346-53</MedlinePgn></Pagination><Abstract><AbstractText>This article reviews juvenile onset bipolar disorder with regard to history, diagnosis, comorbidity, differential diagnosis, prevalence, etiology, treatment, and outcome. Specifically, it deals with past and current diagnostic criteria for juvenile onset bipolar disorder, the controversy around its comorbidity with attention deficit hyperactivity disorder (ADHD), and how to differentiate it from ADHD, conduct disorder, drug and alcohol abuse, and schizophrenia, Genetic and neuroimaging studies investigating the possible etiology of this condition are also described. Treatment, both pharmacological (eg, lithium, neuroleptics, anticonvulsants, benzodiazepines, antidepressants) and psychosocial (eg, psychoeducation of child and family, school intervention, family, group and/or individual therapy) are outlined. Finally, long-term outcome and factors which may influence outcome are addressed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hechtman</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Montreal Children's Hospital, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Pediatr</MedlineTA><NlmUniqueID>9000850</NlmUniqueID><ISSNLinking>1040-8703</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000296" MajorTopicYN="N">Adolescent Psychiatry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002665" MajorTopicYN="N">Child Psychiatry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>84</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>9</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9300191</ArticleId><ArticleId IdType="doi">10.1097/00008480-199708000-00008</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31246151</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-4673</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Issues in mental health nursing</Title><ISOAbbreviation>Issues Ment Health Nurs</ISOAbbreviation></Journal><ArticleTitle>Identifying the Complexity of Diagnosing Bipolar Disorder: A Focused Ethnography.</ArticleTitle><Pagination><MedlinePgn>812-818</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/01612840.2019.1615584</ELocationID><Abstract><AbstractText><b>Purpose:</b> To identify and describe the complexity of diagnosing bipolar disorder, including the diagnostic process and patient experiences of being newly diagnosed with bipolar disorder. <b>Design:</b> A mixed-methods focused ethnography was conducted, grounded in a post-positivist foundation. <b>Methods:</b> Medical records (<i>n</i> = 100) of patients whose diagnosis had been switched to bipolar disorder were examined. Six weeks post-hospitalization, ten outpatients with the diagnosis of bipolar disorder underwent an in-depth interview. <b>Findings:</b> Four diagnostic processes were identified during the retrospective record review. Two patterns and five themes were identified from the interviews. The first pattern, living with undiagnosed bipolar disorder, demonstrated common experiences of distinguishing impulsive moods and behavior, suffering life challenges, and seeking relief. The second pattern, acclimating to a new diagnosis of bipolar disorder, demonstrated participants' ways of understanding the diagnosis and reconciling the diagnosis. Patterns in the interviews corroborated data from the record review. <b>Conclusions:</b> The rendering of an appropriate diagnosis is key. Many participants' lives were significantly improved when diagnosis was made, and treatment recommendations for bipolar disorder (BPD) were initiated. These findings offer clinicians and researchers new ways to think about the complexity of the diagnosis of BPD including contrasting decision-making outcomes along a screening, diagnosis, and treatment continuum, as well as using the diagnostic event to instigate meaningful life change in the patient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stiles</LastName><ForeName>Brandie M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Jonas Veterans Healthcare Scholar, Centerpointe Hospital , St. Louis , MO , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fish</LastName><ForeName>Anne F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>University of Missouri-St. Louis , St. Louis , MO , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandermause</LastName><ForeName>Roxanne</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0560-5450</Identifier><AffiliationInfo><Affiliation>University of Missouri-St. Louis , St. Louis , MO , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Azfar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centerpointe Hospital , St. Louis , MO , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Issues Ment Health Nurs</MedlineTA><NlmUniqueID>7907126</NlmUniqueID><ISSNLinking>0161-2840</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000884" MajorTopicYN="N">Anthropology, Cultural</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009733" MajorTopicYN="Y">Nursing Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31246151</ArticleId><ArticleId IdType="doi">10.1080/01612840.2019.1615584</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15310256</PMID><DateCompleted><Year>2004</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-729X</ISSN><JournalIssue CitedMedium="Print"><Volume>181</Volume><Issue>4</Issue><PubDate><Year>2004</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>The Medical journal of Australia</Title><ISOAbbreviation>Med J Aust</ISOAbbreviation></Journal><ArticleTitle>Major advances in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>207-10</MedlinePgn></Pagination><Abstract><AbstractText>There have been major advances in clinical understanding and treatment of bipolar disorder over the past decade. Randomised controlled trials of pharmacological treatments and psychological interventions have shown that there are effective short-term and long-term treatments for the disorder. Despite advances in treatment, diagnosis is often delayed or mistaken, and many people who could benefit are not using the treatments available. Functional and symptomatic recovery from episodes of bipolar disorder is frequently less complete than previously considered, and disability is often profound. Although manic episodes are the distinguishing feature of bipolar disorder, it appears that depression is the predominant mood disturbance and that much of the functional impairment associated with bipolar disorder results from this. Comorbidity with anxiety disorders or substance misuse is common. Advances in genetics, brain imaging and basic pharmacology are starting to provide understanding of the complex causative processes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Philip B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>School of Psychiatry, University of New South Wales, Prince of Wales Hospital, Randwick, NSW 2031, Australia. phil.mitchell@unsw.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malhi</LastName><ForeName>Gin S</ForeName><Initials>GS</Initials></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Jillian R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Med J Aust</MedlineTA><NlmUniqueID>0400714</NlmUniqueID><ISSNLinking>0025-729X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014227">Triazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>N7U69T4SZR</RegistryNumber><NameOfSubstance UI="D000077152">Olanzapine</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3H27498KS</RegistryNumber><NameOfSubstance UI="D000077213">Lamotrigine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077213" MajorTopicYN="N">Lamotrigine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077152" MajorTopicYN="N">Olanzapine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017367" MajorTopicYN="N">Serotonin Uptake Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014227" MajorTopicYN="N">Triazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>44</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>10</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15310256</ArticleId><ArticleId IdType="pii">mit10278_fm</ArticleId><ArticleId IdType="doi">10.5694/j.1326-5377.2004.tb06238.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17513092</PMID><DateCompleted><Year>2008</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2007</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0924-977X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>11</Issue><PubDate><Year>2007</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</Title><ISOAbbreviation>Eur Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Current issues in bipolar disorder: a critical review.</ArticleTitle><Pagination><MedlinePgn>687-95</MedlinePgn></Pagination><Abstract><AbstractText>Although awareness on bipolar disorder has increased during the last decade, this condition remains characterized by a disabling burden, in terms of morbidity and functional impairment. This paper aims to review some critical issues in the current knowledge on Bipolar disorder. Although large European epidemiological studies are lacking, Bipolar disorder is characterized by a set of severe features, including an early age of onset, a chronic outcome and an important suicidal risk. A majority of bipolar patients also experience a comorbid Axis I condition, including substance abuse, anxiety disorder and attention-deficit hyperactivity disorder. This situation presents a therapeutic challenge, since antidepressants or methylphenidate may be associated with the risk of inducing mania. Recently, a large number of studies have provided evidence for the efficacy of new compounds in the treatment of both mania and bipolar depression, but also in long-term relapse prevention. Recent research has also allowed for the redefinition of the concept of mood stabilizer and for improving existing guidelines on the clinical management of Bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oswald</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University Clinics of Brussels, Erasme Hospital, Brussels, Belgium. poswald@ulb.ac.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souery</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Kasper</LastName><ForeName>Siegfried</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lecrubier</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Montgomery</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wyckaert</LastName><ForeName>Sabien</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zohar</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mendlewicz</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Neuropsychopharmacol</MedlineTA><NlmUniqueID>9111390</NlmUniqueID><ISSNLinking>0924-977X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>93</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>09</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>02</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>03</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>5</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>2</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>5</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17513092</ArticleId><ArticleId IdType="pii">S0924-977X(07)00083-1</ArticleId><ArticleId IdType="doi">10.1016/j.euroneuro.2007.03.006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17099564</PMID><DateCompleted><Year>2007</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0013-7006</ISSN><JournalIssue CitedMedium="Print"><Volume>32 Pt 2</Volume><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>L'Encephale</Title><ISOAbbreviation>Encephale</ISOAbbreviation></Journal><ArticleTitle>[Evolution of bipolar disorder].</ArticleTitle><Pagination><MedlinePgn>S506-10</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellivier</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Département Universitaire de Psychiatrie Adulte (Professeur M. Leboyer), CHU Henri Mondor, Albert Chenevier, 94010 Créteil cedex.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Evolution du trouble bipolaire.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Encephale</MedlineTA><NlmUniqueID>7505643</NlmUniqueID><ISSNLinking>0013-7006</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BMD2GNA4V</RegistryNumber><NameOfSubstance UI="D016651">Lithium Carbonate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016651" MajorTopicYN="N">Lithium Carbonate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>77</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17099564</ArticleId><ArticleId IdType="pii">S0013-7006(06)76194-2</ArticleId><ArticleId IdType="doi">10.1016/s0013-7006(06)76194-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22286568</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1809-452X</ISSN><JournalIssue CitedMedium="Internet"><Volume>33 Suppl 2</Volume><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)</Title><ISOAbbreviation>Braz J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Early intervention for bipolar disorder: current imperatives, future directions.</ArticleTitle><Pagination><MedlinePgn>s197-212</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1516-44462011000600006</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of this article is to discuss the rationale/background for early intervention in bipolar disorder.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Narrative review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There are often significant delays before the diagnosis of bipolar disorder is made and effective management initiated. Growing evidence from both preclinical and clinical literature points to a clear need for improved early identification and early intervention in bipolar disorder. Increasing efforts are being applied to the identification of those at high risk of onset of bipolar disorder. It is hoped that identification of an early prodrome of illness will allow preventative measures to be taken.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a clear rationale for improved early identification and early intervention in bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King’s College London, UK. matthew.j.taylor@kcl.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bressan</LastName><ForeName>Rodrigo Affonseca</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Pan Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Brietzke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Psychiatry</MedlineTA><NlmUniqueID>100895975</NlmUniqueID><ISSNLinking>1516-4446</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061345" MajorTopicYN="Y">Early Medical Intervention</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013405" MajorTopicYN="N">Suicide</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22286568</ArticleId><ArticleId IdType="pii">S1516-44462011000600006</ArticleId><ArticleId IdType="doi">10.1590/s1516-44462011000600006</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21135922</PMID><DateCompleted><Year>2011</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2010</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-7294</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>12</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of family practice</Title><ISOAbbreviation>J Fam Pract</ISOAbbreviation></Journal><ArticleTitle>When to suspect bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>682-8</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disease is often misdiagnosed, sometimes repeatedly. The screening tool and tips you'll find here will help you identify patients without delay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loganathan</LastName><ForeName>Muruga</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allegheny General Hospital, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohano</LastName><ForeName>Kavita</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>R Jeanie</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yonglin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>El-Mallakh</LastName><ForeName>Rif S</ForeName><Initials>RS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Fam Pract</MedlineTA><NlmUniqueID>7502590</NlmUniqueID><ISSNLinking>0094-3509</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21135922</ArticleId><ArticleId IdType="pii">jfp_5912b</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">27004564</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-5618</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Bipolar disorders</Title><ISOAbbreviation>Bipolar Disord</ISOAbbreviation></Journal><ArticleTitle>The Lithium Battery: assessing the neurocognitive profile of lithium in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>102-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bdi.12375</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the present study was to characterize the neurocognitive effects of lithium in bipolar disorder to inform clinical and research approaches for further investigation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Key words pertaining to neurocognition in bipolar disorder and lithium treatment were used to search recognized databases to identify relevant literature. The authors also retrieved gray literature (e.g., book chapters) known to them and examined pertinent articles from bibliographies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A limited number of studies have examined the effects of lithium on neurocognition in bipolar disorder and, although in some domains a consistent picture emerges, in many domains the findings are mixed. Lithium administration appears to reshape key components of neurocognition - in particular, psychomotor speed, verbal memory, and verbal fluency. Notably, it has a sophisticated neurocognitive profile, such that while lithium impairs neurocognition across some domains, it seemingly preserves others - possibly those vulnerable to the effects of bipolar disorder. Furthermore, its effects are likely to be direct and indirect (via mood, for example) and cumulative with duration of treatment. Disentangling the components of neurocognition modulated by lithium in the context of a fluctuating and complex illness such as bipolar disorder is a significant challenge but one that therefore demands a stratified and systematic approach, such as that provided by the Lithium Battery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In order to delineate the effects of lithium therapy on neurocognition in bipolar disorder within both research and clinical practice, a greater understanding and measurement of the relatively stable neurocognitive components is needed to examine those that indeed change with lithium treatment. In order to achieve this, we propose a Lithium Battery-Clinical and a Lithium Battery-Research that can be applied to these respective settings.</AbstractText><CopyrightInformation>© 2016 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malhi</LastName><ForeName>Gin S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAulay</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gershon</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emeritus Professor of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mind and Brain Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gessler</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritz</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Pritha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Outhred</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-2534-3635</Identifier><AffiliationInfo><Affiliation>Academic Department of Psychiatry, Kolling Institute, Northern Sydney Local Health District, St. Leonards, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School Northern, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CADE Clinic, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Bipolar Disord</MedlineTA><NlmUniqueID>100883596</NlmUniqueID><ISSNLinking>1398-5647</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054539" MajorTopicYN="N">Medication Therapy Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011597" MajorTopicYN="N">Psychomotor Performance</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">assessment</Keyword><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">lithium</Keyword><Keyword MajorTopicYN="N">neurocognition</Keyword><Keyword MajorTopicYN="N">psychomotor speed</Keyword><Keyword MajorTopicYN="N">verbal fluency</Keyword><Keyword MajorTopicYN="N">verbal memory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>01</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27004564</ArticleId><ArticleId IdType="doi">10.1111/bdi.12375</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15142614</PMID><DateCompleted><Year>2004</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0924-977X</ISSN><JournalIssue CitedMedium="Print"><Volume>14 Suppl 2</Volume><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</Title><ISOAbbreviation>Eur Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>The phenotypic spectra of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>S94-9</MedlinePgn></Pagination><Abstract><AbstractText>Many findings that seem to be inconsistent in bipolar disorder research could be explained by heterogeneity of the illness and by imprecise diagnostic boundaries. This review of published data finds support for the existence of three main subtypes of bipolar disorder: (1) classical, (2) psychosis spectrum and (3) 'characterological'. These differ with respect to clinical presentation and course of illness, family history and possibly long-term treatment response. For instance, in a series of genetic studies, lithium responders showed an episodic course of illness with a family history of mostly bipolar disorder. In contrast, responders to lamotrigine monotherapy had a rapid-cycling clinical course and frequent comorbid conditions, especially in the anxiety-panic disorder spectrum. Their relatives had elevated rates of anxiety and major depression, but not bipolar disorder. In summary, recognising the clinical and familial subtypes of bipolar disorder might lead to more targeted treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alda</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Dalhousie University, 5909 Jubilee Road, Halifax, Nova Scotia, Canada B3H 2E2. malda@Dal.ca</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Neuropsychopharmacol</MedlineTA><NlmUniqueID>9111390</NlmUniqueID><ISSNLinking>0924-977X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018740" MajorTopicYN="Y">Genetic Heterogeneity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>47</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>02</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2004</Year><Month>03</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>03</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>5</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>8</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>5</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15142614</ArticleId><ArticleId IdType="doi">10.1016/j.euroneuro.2004.03.006</ArticleId><ArticleId IdType="pii">S0924977X04000525</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17696573</PMID><DateCompleted><Year>2007</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1172-7047</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2007</Year></PubDate></JournalIssue><Title>CNS drugs</Title><ISOAbbreviation>CNS Drugs</ISOAbbreviation></Journal><ArticleTitle>Bipolar II disorder : epidemiology, diagnosis and management.</ArticleTitle><Pagination><MedlinePgn>727-40</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar II disorder (BP-II) is defined, by DSM-IV, as recurrent episodes of depression and hypomania. Hypomania, according to DSM-IV, requires elevated (euphoric) and/or irritable mood, plus at least three of the following symptoms (four if mood is only irritable): grandiosity, decreased need for sleep, increased talking, racing thoughts, distractibility, overactivity (an increase in goal-directed activity), psychomotor agitation and excessive involvement in risky activities. This observable change in functioning should not be severe enough to cause marked impairment of social or occupational functioning, or to require hospitalisation. The distinction between BP-II and bipolar I disorder (BP-I) is not clearcut. The symptoms of mania (defining BP-I) and hypomania (defining BP-II) are the same, apart from the presence of psychosis in mania, and the distinction is based on the presence of marked impairment associated with mania, i.e. mania is more severe and may require hospitalisation. This is an unclear boundary that can lead to misclassification; however, the fact that hypomania often increases functioning makes the distinction between mania and hypomania clearer. BP-II depression can be syndromal and subsyndromal, and it is the prominent feature of BP-II. It is often a mixed depression, i.e. it has concurrent, usually subsyndromal, hypomanic symptoms. It is the depression that usually leads the patient to seek treatment.DSM-IV bipolar disorders (BP-I, BP-II, cyclothymic disorder and bipolar disorder not otherwise classified, which includes very rapid cycling and recurrent hypomania) are now considered to be part of the 'bipolar spectrum'. This is not included in DSM-IV, but is thought to also include antidepressant/substance-associated hypomania, cyclothymic temperament (a trait of highly unstable mood, thinking and behaviour), unipolar mixed depression and highly recurrent unipolar depression.BP-II is underdiagnosed in clinical practice, and its pharmacological treatment is understudied. Underdiagnosis is demonstrated by recent epidemiological studies. While, in DSM-IV, BP-II is reported to have a lifetime community prevalence of 0.5%, epidemiological studies have instead found that it has a lifetime community prevalence (including the bipolar spectrum) of around 5%. In depressed outpatients, one in two may have BP-II. The recent increased diagnosing of BP-II in research settings is related to several factors, including the introduction of the use of semi-structured interviews by trained research clinicians, a relaxation of diagnostic criteria such that the minimum duration of hypomania is now less than the 4 days stipulated by DSM-IV, and a probing for a history of hypomania focused more on overactivity (increased goal-directed activity) than on mood change (although this is still required for a diagnosis of hypomania). Guidelines on the treatment of BP-II are mainly consensus based and tend to follow those for the treatment of BP-I, because there have been few controlled studies of the treatment of BP-II. The current, limited evidence supports the following lines of treatment for BP-II. Hypomania is likely to respond to the same agents useful for mania, i.e. mood-stabilising agents such as lithium and valproate, and the second-generation antipsychotics (i.e. olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole). Hypomania should be treated even if associated with overfunctioning, because a depression often soon follows hypomania (the hypomania-depression cycle). For the treatment of acute BP-II depression, two controlled studies of quetiapine have not found clearcut positive effects. Naturalistic studies, although open to several biases, have found antidepressants in acute BP-II depression to be as effective as in unipolar depression; however, one recent large controlled study (mainly in patients with BP-I) has found antidepressants to be no more effective than placebo. Results from naturalistic studies and clinical observations on mixed depression, while in need of replication in controlled studies, indicate that antidepressants may worsen the concurrent intradepression hypomanic symptoms. The only preventive treatment for both depression and hypomania that is supported by several, albeit older, controlled studies is lithium. Lamotrigine has shown some efficacy in delaying depression recurrences, but there have also been several negative unpublished studies of the drug in this indication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Benazzi</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hecker Psychiatry Research Center, a University of California at San Diego (USA) Collaborating Center at Forli, Italy. FrancoBenazzi@FBenazzi.it</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>CNS Drugs</MedlineTA><NlmUniqueID>9431220</NlmUniqueID><ISSNLinking>1172-7047</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>177</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>8</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>10</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>8</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17696573</ArticleId><ArticleId IdType="pii">2193</ArticleId><ArticleId IdType="doi">10.2165/00023210-200721090-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Gen Psychiatry. 1997 Apr;54(4):329-36</Citation><ArticleIdList><ArticleId IdType="pubmed">9107149</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 Sep;39(9):1065-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6810839</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 Nov;39(11):1344-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6814397</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Apr;91(2-3):133-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16458364</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1983 Sep;140(9):1127-33</Citation><ArticleIdList><ArticleId IdType="pubmed">6351641</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):187-96</Citation><ArticleIdList><ArticleId IdType="pubmed">15708416</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Jun;62(6):593-602</Citation><ArticleIdList><ArticleId IdType="pubmed">15939837</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 1998 Oct;18(5):414-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9790160</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Jul 1;56(1):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15219473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):65-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12507739</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Jun;92(2-3):205-14</Citation><ArticleIdList><ArticleId IdType="pubmed">16516304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Oct;6(5):440-1</Citation><ArticleIdList><ArticleId IdType="pubmed">15383139</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1976 Jan;33(1):117-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1108832</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Dec;62(12):1322-30</Citation><ArticleIdList><ArticleId IdType="pubmed">16330720</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Aug;67(8):1246-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16965203</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2005 Sep-Oct;38(5):268-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16179813</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1998 Jan;55(1):27-32</Citation><ArticleIdList><ArticleId IdType="pubmed">9435757</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Dec;96(3):233-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16427137</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2007;76(1):40-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17170562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Dec;96(3):183-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16427131</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):210-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16449473</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1998 May;155(5):638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">9585715</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Dec;96(3):259-69</Citation><ArticleIdList><ArticleId IdType="pubmed">16997383</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):232-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16449476</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):68-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16019119</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1998 Sep;50(2-3):153-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9858075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1997 Apr;43(2):163-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9165385</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1992 Dec;149(12):1633-44</Citation><ArticleIdList><ArticleId IdType="pubmed">1359799</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Sep;61(9):630-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11030482</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):167-78</Citation><ArticleIdList><ArticleId IdType="pubmed">15708414</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Mar;63(3):246-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16520428</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Oct;8(5 Pt 2):596-617</Citation><ArticleIdList><ArticleId IdType="pubmed">17042833</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 1993 Apr;87(4):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">8488750</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1991 Sep;48(9):807-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Nov;162(11):2152-61</Citation><ArticleIdList><ArticleId IdType="pubmed">16263857</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2004 Jul 15;127(3):247-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15296824</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1279-85</Citation><ArticleIdList><ArticleId IdType="pubmed">15588754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):123-31</Citation><ArticleIdList><ArticleId IdType="pubmed">12507745</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):133-46</Citation><ArticleIdList><ArticleId IdType="pubmed">12507746</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Mar;60(3):261-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12622659</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1982 Jun;139(6):747-52</Citation><ArticleIdList><ArticleId IdType="pubmed">6805339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Mar 17;369(9565):935-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17368155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2004 Aug;6(4):305-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15225148</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2004 Mar;65(3):432-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15096085</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1043-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16682104</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):97-103</Citation><ArticleIdList><ArticleId IdType="pubmed">16978754</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Jul;66(7):914-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16013908</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1988 Feb;145(2):179-84</Citation><ArticleIdList><ArticleId IdType="pubmed">3341463</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Apr;64(4):403-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12716240</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2005;74(1):61-2</Citation><ArticleIdList><ArticleId IdType="pubmed">15627859</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Dec;67(1-3):123-32</Citation><ArticleIdList><ArticleId IdType="pubmed">11869759</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2000 Nov;61(11):841-50</Citation><ArticleIdList><ArticleId IdType="pubmed">11105737</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):49-57</Citation><ArticleIdList><ArticleId IdType="pubmed">12507737</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Nov;163(11):1905-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17074942</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Oct;63(10):1130-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17015815</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 May;92(1):45-54</Citation><ArticleIdList><ArticleId IdType="pubmed">16488021</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2005 Jun;66(6):693-704</Citation><ArticleIdList><ArticleId IdType="pubmed">15960561</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):87-98</Citation><ArticleIdList><ArticleId IdType="pubmed">12507741</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2007 Mar;22(2):99-103</Citation><ArticleIdList><ArticleId IdType="pubmed">17129709</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2004 Dec;110(6):401-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15521823</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2003 Oct;4(4):166-71</Citation><ArticleIdList><ArticleId IdType="pubmed">14608587</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):259-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15708424</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 May;67(5):712-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16841620</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2004 Nov-Dec;45(6):441-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15526254</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopathology. 2007;40(1):54-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17065838</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Jul;161(7):1264-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15229060</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2006 Jan;51(1):9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16491979</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1999 Feb;60(2):79-88</Citation><ArticleIdList><ArticleId IdType="pubmed">10084633</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1982 Oct;39(10):1157-67</Citation><ArticleIdList><ArticleId IdType="pubmed">7125846</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Dec;67(1-3):213-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11869771</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Jul;67(7):1025-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16889444</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):33-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12507735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Aug;94(1-3):111-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16701902</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2007;76(2):70-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17230047</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Oct;88(2):217-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16125784</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Oct;63(10):1139-48</Citation><ArticleIdList><ArticleId IdType="pubmed">17015816</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006;67 Suppl 11:18-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17029492</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Mar;67(3):355-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16649820</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):113-22</Citation><ArticleIdList><ArticleId IdType="pubmed">12507744</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Biol Psychiatry. 2007;8(2):105-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17455103</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1995 Feb;52(2):114-23</Citation><ArticleIdList><ArticleId IdType="pubmed">7848047</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1991 Jul;148(7):910-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2053632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 1998 Dec;18(6):435-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9864074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 1997 Oct;46(1):73-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9387089</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2003 Jun;6(2):127-37</Citation><ArticleIdList><ArticleId IdType="pubmed">12890306</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2003 Jul;108(1):4-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12807371</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2001 Aug;158(8):1265-70</Citation><ArticleIdList><ArticleId IdType="pubmed">11481161</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2004 Mar-Apr;45(2):77-82</Citation><ArticleIdList><ArticleId IdType="pubmed">14999656</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2005 Nov-Dec;46(6):399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">16275206</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Psychiatry. 2002 Mar;47(2):125-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11926074</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2006 Feb;63(2):175-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16461861</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Aug;189:124-31</Citation><ArticleIdList><ArticleId IdType="pubmed">16880481</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2006 Oct;189:346-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17012658</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Psychiatry. 2006 Jun;21(4):274-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16675205</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):149-57</Citation><ArticleIdList><ArticleId IdType="pubmed">15708412</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Neurol Sci. 1984;234(1):13-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6333343</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2004 Nov;110(5):374-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15458561</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2004 Sep;161(9):1537-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15337640</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2006 May;36(5):619-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16438739</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):225-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15708420</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2003 Jan-Feb;44(1):21-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12524632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):19-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12507734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Oct;7(5):441-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16176437</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2003 Jul;28(7):1374-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12784116</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2005 Oct;59(5):570-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16194260</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2006 Jan;67(1):48-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16426088</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2007 Jan;68(1):102-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17284137</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1994 Jan;51(1):8-19</Citation><ArticleIdList><ArticleId IdType="pubmed">8279933</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1970 Jan;126(7):983-7</Citation><ArticleIdList><ArticleId IdType="pubmed">5409569</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Mar;156(3):426-30</Citation><ArticleIdList><ArticleId IdType="pubmed">10080559</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2002 Jun;59(6):530-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12044195</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2005 Jul;162(7):1351-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15994719</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 1999 Sep;14(5):283-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10529071</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):159-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15708413</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2005 Jul;187:87-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15994577</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1105-11</Citation><ArticleIdList><ArticleId IdType="pubmed">12452532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2000 Sep;2(3 Pt 2):281-93</Citation><ArticleIdList><ArticleId IdType="pubmed">11249806</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):199-205</Citation><ArticleIdList><ArticleId IdType="pubmed">12507752</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1988 Feb;18(1):141-53</Citation><ArticleIdList><ArticleId IdType="pubmed">3363034</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2002 Aug;59(8):736-40</Citation><ArticleIdList><ArticleId IdType="pubmed">12150650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2003 Dec;5(6):421-33</Citation><ArticleIdList><ArticleId IdType="pubmed">14636365</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychopharmacol. 2006 Dec;26(6):600-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17110817</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Mar;85(1-2):3-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15780671</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):7-18</Citation><ArticleIdList><ArticleId IdType="pubmed">12507733</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Jan;160(1):4-12</Citation><ArticleIdList><ArticleId IdType="pubmed">12505793</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2003 Sep;64(9):1013-24</Citation><ArticleIdList><ArticleId IdType="pubmed">14628976</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Apr;60(4):392-400</Citation><ArticleIdList><ArticleId IdType="pubmed">12695317</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2007 Mar;190:189-91</Citation><ArticleIdList><ArticleId IdType="pubmed">17329735</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychother Psychosom. 2007;76(2):65-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17230046</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 2004 May;34(4):597-611</Citation><ArticleIdList><ArticleId IdType="pubmed">15099415</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2002 Apr;68(2-3):203-13</Citation><ArticleIdList><ArticleId IdType="pubmed">12063148</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Apr 26;356(17):1711-22</Citation><ArticleIdList><ArticleId IdType="pubmed">17392295</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):141-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15708411</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Mar;152(3):385-90</Citation><ArticleIdList><ArticleId IdType="pubmed">7864264</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2004 May-Jun;45(3):168-74</Citation><ArticleIdList><ArticleId IdType="pubmed">15124146</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Feb;163(2):313-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16449487</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2006 Sep;163(9):1644; author reply 1644-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16946197</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Jul;160(7):1263-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12832240</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2004 Feb;78(2):149-52</Citation><ArticleIdList><ArticleId IdType="pubmed">14706725</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 2004 May;65(5):627-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15163248</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2003 Sep;60(9):914-20</Citation><ArticleIdList><ArticleId IdType="pubmed">12963673</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Sep;59(3):225-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10854639</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2003 Jan;73(1-2):39-47</Citation><ArticleIdList><ArticleId IdType="pubmed">12507736</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Psychiatry. 2005 Aug;39(8):726-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16050927</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16078087</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neuropharmacol. 1990;13 Suppl 1:S66-70</Citation><ArticleIdList><ArticleId IdType="pubmed">2116228</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1978 May;135(5):570-2</Citation><ArticleIdList><ArticleId IdType="pubmed">347953</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2003 Apr;107(4):268-74</Citation><ArticleIdList><ArticleId IdType="pubmed">12662249</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Dec;96(3):189-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16427136</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2006 Dec;96(3):197-205</Citation><ArticleIdList><ArticleId IdType="pubmed">16824616</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Clin Psychopharmacol. 2007 Mar;22(2):93-100</Citation><ArticleIdList><ArticleId IdType="pubmed">17293709</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2001 Dec;67(1-3):105-14</Citation><ArticleIdList><ArticleId IdType="pubmed">11869757</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2005 Oct;62(10):1089-96</Citation><ArticleIdList><ArticleId IdType="pubmed">16203954</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2000 Nov;157(11):1873-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11058490</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2005 May-Jun;46(3):159-66</Citation><ArticleIdList><ArticleId IdType="pubmed">16021584</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2003 Sep;27(6):985-91</Citation><ArticleIdList><ArticleId IdType="pubmed">14499315</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 Dec;160(12):2134-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14638583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Oct;7(5):456-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16176439</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1984 Nov;41(11):1096-104</Citation><ArticleIdList><ArticleId IdType="pubmed">6437366</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmakopsychiatr Neuropsychopharmakol. 1976 May;9(3):100-7</Citation><ArticleIdList><ArticleId IdType="pubmed">981326</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Feb;84(2-3):133-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15708410</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2005 Apr;85(3):245-58</Citation><ArticleIdList><ArticleId IdType="pubmed">15780694</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatr Clin North Am. 2002 Dec;25(4):699-712, v</Citation><ArticleIdList><ArticleId IdType="pubmed">12462856</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25860561</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2238-0019</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><MedlineDate>2015 Jan-Mar</MedlineDate></PubDate></JournalIssue><Title>Trends in psychiatry and psychotherapy</Title><ISOAbbreviation>Trends Psychiatry Psychother</ISOAbbreviation></Journal><ArticleTitle>Biomarkers and staging of bipolar disorder: a systematic review.</ArticleTitle><Pagination><MedlinePgn>3-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/2237-6089-2014-0002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2237-60892015000100003</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">A growing body of evidence suggests that bipolar disorder (BD) is a progressive disease according to clinical, biochemical and neuroimaging findings. This study reviewed the literature on the relationship between specific biomarkers and BD stages.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive literature search of MEDLINE and PubMed was conducted to identify studies in English and Portuguese using the keywords biomarker, neurotrophic factors, inflammation, oxidative stress, neuroprogression and staging models cross-referenced with bipolar disorder.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Morphometric studies of patients with BD found neuroanatomic abnormalities, such as ventricular enlargement, grey matter loss in the hippocampus and cerebellum, volume decreases in the prefrontal cortex and variations in the size of the amygdala. Other studies demonstrated that serum concentrations of neurotrophic factors, inflammatory mediators and oxidative stress may be used as BD biomarkers.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The analysis of neurobiological changes associated with BD progression and activity may confirm the existence of BD biomarkers, which may be then included in staging models that will lead to improvements in treatment algorithms and more effective, individually tailored treatment regimens. Biomarkers may also be used to define early interventions to control disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roda</LastName><ForeName>Ângela</ForeName><Initials>Â</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chendo</LastName><ForeName>Inês</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina de Lisboa, University Clinic, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunz</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Trends Psychiatry Psychother</MedlineTA><NlmUniqueID>101610695</NlmUniqueID><ISSNLinking>2237-6089</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>02</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25860561</ArticleId><ArticleId IdType="pii">S2237-60892015000100003</ArticleId><ArticleId IdType="doi">10.1590/2237-6089-2014-0002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20141702</PMID><DateCompleted><Year>2010</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2010</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>12</Issue><PubDate><Year>2009</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Diagnosis and treatment of bipolar disorder in young patients.</ArticleTitle><Pagination><MedlinePgn>e45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.8125cc10c</ELocationID><Abstract><AbstractText>Untreated early-onset bipolar disorder is associated with higher rates of rapid cycling, more comorbidity, and more severe mania and depression than adult-onset bipolar disorder. Correctly diagnosing bipolar disorder early in its course can prevent exposing a young patient to treatments that may exacerbate or advance the progression of the disorder. Appropriate pharmacologic and psychosocial interventions are necessary in the acute treatment of pediatric bipolar disorder.</AbstractText><CopyrightInformation>Copyright 2009 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Findling</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>0</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20141702</ArticleId><ArticleId IdType="doi">10.4088/JCP.8125cc10c</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25753128</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-5949</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Month>May</Month></PubDate></JournalIssue><Title>CNS neuroscience &amp; therapeutics</Title><ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation></Journal><ArticleTitle>Glial pathology in bipolar disorder: potential therapeutic implications.</ArticleTitle><Pagination><MedlinePgn>393-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cns.12390</ELocationID><Abstract><AbstractText>Bipolar disorder (BD) is a chronic and severe mental disorder with recurrent episodes of mania and depression. In addition to neuronal alterations, accumulating evidences have revealed the importance of glial system in pathophysiology and phenotype of the illness. Postmortem studies have repeatedly demonstrated the alterations in glial cells and its functions in patients with BD. The activated microglia and inflammatory cytokines are proposed to be the potential biomarkers that may help to predict disease exacerbation in BD. On the other hand, anti-BD drugs have been shown to produce profound effects on glial activity, which not only contributes to the therapeutic efficacy, but may also provide a potential target for the drug development of BD. We will focus on the recent development of glial abnormalities and potential therapeutic benefits targeted to glial modulation in BD.</AbstractText><CopyrightInformation>© 2015 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiao-Hua</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory for Translational Research for Neuropsycho-Diseases, Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China; Department of Pharmacology, College of Pharmacy, Hebei North University, Zhangjiakou, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Xue-Chu</ForeName><Initials>XC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>CNS Neurosci Ther</MedlineTA><NlmUniqueID>101473265</NlmUniqueID><ISSNLinking>1755-5930</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibipolar drugs</Keyword><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">Glial cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>01</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>02</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25753128</ArticleId><ArticleId IdType="doi">10.1111/cns.12390</ArticleId><ArticleId IdType="pmc">PMC6495495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell. 1999 Jun 11;97(6):703-16</Citation><ArticleIdList><ArticleId IdType="pubmed">10380923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2000 Mar;5(2):142-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10822341</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biochem Cell Biol. 2001 Jul;33(7):637-68</Citation><ArticleIdList><ArticleId IdType="pubmed">11390274</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 2001 Jul 15;55(5):597-610</Citation><ArticleIdList><ArticleId IdType="pubmed">11576756</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 2002 Jun;12(3):269-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12007679</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsc Res Tech. 2003 Apr 15;60(6):614-32</Citation><ArticleIdList><ArticleId IdType="pubmed">12645009</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Sep 6;362(9386):798-805</Citation><ArticleIdList><ArticleId IdType="pubmed">13678875</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2004 Feb;58(1):82-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14678462</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Apr 1;67(2-3):269-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14984887</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 Jul 29;351(5):476-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15282355</ArticleId></ArticleIdList></Reference><Reference><Citation>Life Sci. 2004 Dec 31;76(7):805-11</Citation><ArticleIdList><ArticleId IdType="pubmed">15581912</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 2005;133(2):453-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15885920</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Res. 2006;55(3):325-38</Citation><ArticleIdList><ArticleId IdType="pubmed">16083303</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Oct;7(5):393-403</Citation><ArticleIdList><ArticleId IdType="pubmed">16176432</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2006 Oct;9(5):613-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16259646</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2006 May 8;398(3):215-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16480819</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Sep 1;60(5):491-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16712803</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jan 15;61(2):142-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16893527</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2007 Sep;41(6):523-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16956621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2006 Dec;11(12):1116-25</Citation><ArticleIdList><ArticleId IdType="pubmed">16969367</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2007 Feb 2;353(1):127-32</Citation><ArticleIdList><ArticleId IdType="pubmed">17173861</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2007 Aug;10(4):547-55</Citation><ArticleIdList><ArticleId IdType="pubmed">17291372</ArticleId></ArticleIdList></Reference><Reference><Citation>Drug News Perspect. 2006 Dec;19(10):597-602</Citation><ArticleIdList><ArticleId IdType="pubmed">17299601</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 May 8;104(19):8131-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17483467</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2007 Jun;6(3):219-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17511618</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1094-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17525977</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2007 Oct;194(3):333-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17594078</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 2007 Sep;55(12):1263-71</Citation><ArticleIdList><ArticleId IdType="pubmed">17659525</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2007 Sep 28;361(3):605-10</Citation><ArticleIdList><ArticleId IdType="pubmed">17669366</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2008 Oct;33(11):2551-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18235426</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2008 Oct;200(2):187-95</Citation><ArticleIdList><ArticleId IdType="pubmed">18506424</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1761-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18789369</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2009 Jan;56(1):90-113</Citation><ArticleIdList><ArticleId IdType="pubmed">18793656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2010 Apr;15(4):384-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19488045</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron Glia Biol. 2008 Aug;4(3):235-47</Citation><ArticleIdList><ArticleId IdType="pubmed">19497143</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2009 Sep;57(4):375-85</Citation><ArticleIdList><ArticleId IdType="pubmed">19596362</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2009 Winter;15(4):333-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19889130</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Int. 2010 Nov;57(4):451-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20156504</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2010 May 14;475(2):95-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20350583</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Psychiatr Scand. 2010 Dec;122(6):507-15</Citation><ArticleIdList><ArticleId IdType="pubmed">20712826</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2011 Dec;17(6):699-704</Citation><ArticleIdList><ArticleId IdType="pubmed">20961400</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatry Neurosci. 2011 Mar;36(2):114-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21138659</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Neurobiol. 2011 Apr;21(2):353-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21277196</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2011 Aug;25(6):1206-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21443944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Biochem Behav. 2012 Feb;100(4):712-25</Citation><ArticleIdList><ArticleId IdType="pubmed">21463649</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2011 Dec;45(12):1608-16</Citation><ArticleIdList><ArticleId IdType="pubmed">21889167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2011 Aug-Sep;13(5-6):486-99</Citation><ArticleIdList><ArticleId IdType="pubmed">22017218</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2012 Mar;18(3):214-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22070572</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):111-20</Citation><ArticleIdList><ArticleId IdType="pubmed">22343008</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2012 Mar;18(3):193</Citation><ArticleIdList><ArticleId IdType="pubmed">22449106</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 2013 Jan;61(1):62-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22740320</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2013 Jan 10;144(1-2):16-27</Citation><ArticleIdList><ArticleId IdType="pubmed">22749156</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2012 Nov;37(11):2524-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22965852</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Psychiatry. 2013 Jan;26(1):19-26</Citation><ArticleIdList><ArticleId IdType="pubmed">23196997</ArticleId></ArticleIdList></Reference><Reference><Citation>Glia. 2013 May;61(5):694-709</Citation><ArticleIdList><ArticleId IdType="pubmed">23378038</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2013 Apr;38(4):834-41</Citation><ArticleIdList><ArticleId IdType="pubmed">23397284</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Drug Targets. 2013 Oct;14(11):1237-48</Citation><ArticleIdList><ArticleId IdType="pubmed">23701298</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 2013 Nov;47(11):1694-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23896207</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurol Disord Drug Targets. 2013 Sep;12(6):799-806</Citation><ArticleIdList><ArticleId IdType="pubmed">24047522</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2014 Jan;20(1):10-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24188794</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2014 May;20(5):391-402</Citation><ArticleIdList><ArticleId IdType="pubmed">24422972</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Psychiatry. 2014 Jan 21;4:e350</Citation><ArticleIdList><ArticleId IdType="pubmed">24448212</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Biobehav Rev. 2014 May;42:132-47</Citation><ArticleIdList><ArticleId IdType="pubmed">24603026</ArticleId></ArticleIdList></Reference><Reference><Citation>CNS Neurosci Ther. 2014 Aug;20(8):754-62</Citation><ArticleIdList><ArticleId IdType="pubmed">24628733</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Behav Immun. 2014 Aug;40:131-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24632338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2015 Feb;17(1):39-49</Citation><ArticleIdList><ArticleId IdType="pubmed">25039314</ArticleId></ArticleIdList></Reference><Reference><Citation>Mov Disord. 2015 Apr;30(4):494-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25100667</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurocytol. 1986 Aug;15(4):511-24</Citation><ArticleIdList><ArticleId IdType="pubmed">3018177</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 1995;37(4):417-29</Citation><ArticleIdList><ArticleId IdType="pubmed">7620916</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Bull. 1996;40(3):167-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8736577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1998 Sep 1;18(17):6822-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9712653</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9789081</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1998;248(6):301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9928909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12957719</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0924-977X</ISSN><JournalIssue CitedMedium="Print"><Volume>13 Suppl 2</Volume><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</Title><ISOAbbreviation>Eur Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Diagnostic issues in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>S43-50</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a highly recurrent and chronic psychiatric condition that shortens life expectancy, causes functional impairment and disruption to social, work and family life. Several forms of bipolar disorder are recognised, including both bipolar I and bipolar II disorder. Bipolar I is characterised by recurrent episodes of depression and mania whereas bipolar II disorder is characterised by recurrent depression and hypomania, a milder form of mania. There has been debate concerning the definition of hypomania since at least the 1970s. The main areas of argument focus on the minimum duration of hypomania, its stem criteria and the number of symptoms required for diagnosis. Arriving at the correct definition of hypomania is a key diagnostic issue. There is increasing evidence for the existence of a broad spectrum of bipolar disorders, and data demonstrating the clinical validity of modifying some of the criteria for hypomania are reviewed here.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angst</LastName><ForeName>Jules</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zurich University Psychiatric Hospital, Lenggstrasse 31 CH-8029, Zürich, Switzerland. jangst@bli.unizh.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamma</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Benazzi</LastName><ForeName>Franco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ajdacic</LastName><ForeName>Vladeta</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Eich</LastName><ForeName>Dominique</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Rössler</LastName><ForeName>Wulf</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Neuropsychopharmacol</MedlineTA><NlmUniqueID>9111390</NlmUniqueID><ISSNLinking>0924-977X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="Y">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>25</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12957719</ArticleId><ArticleId IdType="pii">S0924977X03000774</ArticleId><ArticleId IdType="doi">10.1016/s0924-977x(03)00077-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12020569</PMID><DateCompleted><Year>2002</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0140-6736</ISSN><JournalIssue CitedMedium="Print"><Volume>359</Volume><Issue>9318</Issue><PubDate><Year>2002</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1702</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shiwach</LastName><ForeName>Raj</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2002 Jan 19;359(9302):241-7</RefSource><PMID Version="1">11812578</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009656" MajorTopicYN="N" Type="Geographic">North America</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>22</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>6</Month><Day>20</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>22</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12020569</ArticleId><ArticleId IdType="pii">S0140-6736(02)08586-0</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(02)08586-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16963579</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0895-0172</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Season>Summer</Season></PubDate></JournalIssue><Title>The Journal of neuropsychiatry and clinical neurosciences</Title><ISOAbbreviation>J Neuropsychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: imaging state versus trait.</ArticleTitle><Pagination><MedlinePgn>296-301</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Jacqueline N W</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Veterans Affairs Mid Atlantic Mental Illness Research Education, and Clinical Center, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurley</LastName><ForeName>Robin A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Taber</LastName><ForeName>Katherine H</ForeName><Initials>KH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neuropsychiatry Clin Neurosci</MedlineTA><NlmUniqueID>8911344</NlmUniqueID><ISSNLinking>0895-0172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008032" MajorTopicYN="N">Limbic System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>40</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>9</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>10</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>9</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16963579</ArticleId><ArticleId IdType="pii">18/3/296</ArticleId><ArticleId IdType="doi">10.1176/jnp.2006.18.3.296</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29950190</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>05</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Clinical course predicts long-term outcomes in bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1109-1117</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291718001678</ELocationID><Abstract><AbstractText Label="BACKGROUND">The long-term outcomes of bipolar disorder range from lasting remission to chronic course or frequent recurrences requiring admissions. The distinction between bipolar I and II disorders has limited utility in outcome prediction. It is unclear to what extent the clinical course of bipolar disorder predicts long-term outcomes.</AbstractText><AbstractText Label="METHODS">A representative sample of 191 individuals diagnosed with bipolar I or II disorder was recruited and followed for up to 5 years using a life-chart method. We previously described the clinical course over the first 18 months with dimensional course characteristics and latent classes. Now we test if these course characteristics predict long-term outcomes, including time ill (time with any mood symptoms) and hospital admissions over a second non-overlapping follow-up period in 111 individuals with available data from both 18 months and 5 years follow-ups.</AbstractText><AbstractText Label="RESULTS">Dimensional course characteristics from the first 18 months prospectively predicted outcomes over the following 3.5 years. The proportion of time depressed, the severity of depressive symptoms and the proportion of time manic predicted more time ill. The proportion of time manic, the severity of manic symptoms and depression-to-mania switching predicted a greater likelihood of hospital admissions. All predictions remained significant after controlling for age, sex and bipolar I v. II disorder.</AbstractText><AbstractText Label="CONCLUSIONS">Differential associations with long-term outcomes suggest that course characteristics may facilitate care planning with greater predictive validity than established types of bipolar disorders. A clinical course dominated by depressive symptoms predicts a greater proportion of time ill. A clinical course characterized by manic episodes predicts hospital admissions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uher</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry,Dalhousie University,Halifax,Nova Scotia,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pallaskorpi</LastName><ForeName>Sanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mental Health Unit,National Institute of Health and Welfare,Helsinki,Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suominen</LastName><ForeName>Kirsi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Helsinki City Department of Social Services and Healthcare,Mental Health and Substance Abuse Services,Helsinki,Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantere</LastName><ForeName>Outi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Psychiatry,McGill University,Montréal, QC,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlova</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry,Dalhousie University,Halifax,Nova Scotia,Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isometsä</LastName><ForeName>Erkki</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry,University of Helsinki and Helsinki University Central Hospital,Helsinki,Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="N">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078331" MajorTopicYN="N">Correlation of Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="N">Patient Admission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bipolar disorder</Keyword><Keyword MajorTopicYN="Y">clinical course</Keyword><Keyword MajorTopicYN="Y">hospital admissions</Keyword><Keyword MajorTopicYN="Y">long-term follow-up</Keyword><Keyword MajorTopicYN="Y">outcome prediction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29950190</ArticleId><ArticleId IdType="pii">S0033291718001678</ArticleId><ArticleId IdType="doi">10.1017/S0033291718001678</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16907698</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2006</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1041-2972</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2006</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of the American Academy of Nurse Practitioners</Title><ISOAbbreviation>J Am Acad Nurse Pract</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: etiology, diagnosis, and management.</ArticleTitle><Pagination><MedlinePgn>368-73</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To review the epidemiology and disease characteristics of the bipolar disorder (BD) spectrum, render an accurate and timely diagnosis, and review treatment options through provider and patient collaboration.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Comprehensive review of current scientific literature derived from electronic databases and professional medical references.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">BD is a multifactorial disease that can interfere with cognition and behavior, causing a severe impact on patients and families. The variable course and often delayed diagnosis of this disorder can cause frustration for the patient and the healthcare provider. Because most undiagnosed patients with BD seek treatment within the primary care setting, it is imperative that clinicians become expert in the recognition of and intervention for this condition.</AbstractText><AbstractText Label="IMPLICATIONS FOR PRACTICE" NlmCategory="CONCLUSIONS">The primary care provider is in a key position to render early diagnosis and treatment of BD. This disease should always be considered as part of the differential diagnosis for depression or anxiety. Nurse practitioners can be effective providers by using good nursing practices of communication, education, and advocacy for the patient and family. Knowledge of current diagnostic criteria and management is imperative for successful treatment of patients with BD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pulmonary and Critical Care Consultants of Austin, LLP, Texas, USA. raykimmer@sbcglobal.net</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Nurse Pract</MedlineTA><NlmUniqueID>8916634</NlmUniqueID><ISSNLinking>1041-2972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009722" MajorTopicYN="N">Nurse Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>24</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>10</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16907698</ArticleId><ArticleId IdType="pii">JAAN148</ArticleId><ArticleId IdType="doi">10.1111/j.1745-7599.2006.00148.x</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19418649</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-1527</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>5</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>Optometry (St. Louis, Mo.)</Title><ISOAbbreviation>Optometry</ISOAbbreviation></Journal><ArticleTitle>Bipolar affective disorder.</ArticleTitle><Pagination><MedlinePgn>217-8</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Byron Y</ForeName><Initials>BY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Optometry</MedlineTA><NlmUniqueID>100912421</NlmUniqueID><ISSNLinking>1558-1527</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19418649</ArticleId><ArticleId IdType="doi">10.1016/j.optm.2009.03.005</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31917906</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>12</Month><Day>31</Day></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.4088/JCP.OT18053BR1C</ELocationID><ELocationID EIdType="pii" ValidYN="Y">OT18053BR1C</ELocationID><Abstract><AbstractText>Too many patients receive incorrect treatment for bipolar disorder; prescribing seems to differ more by clinician than by patient characteristics. New treatment guidelines are available for the management of acute manic episodes and can help clinicians make treatment decisions tailored to their patients' individual symptom clusters and illness characteristics, leading to greater chances of lasting remission. However, many clinicians lack familiarity with these symptom targeting best practices. Therefore, clinicians need education on how to manage bipolar I disorder symptoms with evidence-based treatment options. In addition, as new treatment targets are identified, clinicians need education on psychopharmacologic and pharmacokinetic advances.</AbstractText><CopyrightInformation>© Copyright 2019 Physicians Postgraduate Press, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suppes</LastName><ForeName>Trisha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, and the US Department of Veterans Affairs Palo Alto Health Care System, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31917906</ArticleId><ArticleId IdType="doi">10.4088/JCP.OT18053BR1C</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19339764</PMID><DateCompleted><Year>2009</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder: from genes to behavior pathways.</ArticleTitle><Pagination><MedlinePgn>726-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI37703</ELocationID><ELocationID EIdType="pii" ValidYN="Y">37703</ELocationID><Abstract><AbstractText>Bipolar disorder (BPD) is a devastating illness that is characterized by recurrent episodes of mania and depression. In addition to these cyclic episodes, individuals with BPD exhibit changes in psychovegetative function, cognitive performance, and general health and well being. In this article we draw from neuroimaging findings in humans, postmortem data, and human genetic and pharmacological studies as well as data from animal models of behavior to discuss the neurobiology of BPD. We conclude with a synthesis of where the field stands and with suggestions and strategies for future areas of study to further increase our conceptual understanding of this complex illness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martinowich</LastName><ForeName>Keri</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Johnson &amp; Johnson Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, E32000, Titusville, New Jersey 08560, USA. hmanji@its.jnj.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schloesser</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Manji</LastName><ForeName>Husseini K</ForeName><Initials>HK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001519" MajorTopicYN="N">Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005818" MajorTopicYN="N">Genetic Engineering</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>138</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>4</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>4</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19339764</ArticleId><ArticleId IdType="pii">37703</ArticleId><ArticleId IdType="doi">10.1172/JCI37703</ArticleId><ArticleId IdType="pmc">PMC2662565</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain Res Bull. 2001 Jul 15;55(5):569-78</Citation><ArticleIdList><ArticleId IdType="pubmed">11576753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Oct 7;356(9237):1241-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11072948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2000 Mar 3;100(5):525-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10721990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2003 Aug 29;278(35):33067-77</Citation><ArticleIdList><ArticleId IdType="pubmed">12796505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebrovasc Dis. 2006;22(2-3):83-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16685119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1981 Aug 29;2(8244):470</Citation><ArticleIdList><ArticleId IdType="pubmed">6115222</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Soc Symp. 1999;65:101-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10320935</ArticleId></ArticleIdList></Reference><Reference><Citation>J Affect Disord. 2000 Sep;59 Suppl 1:S5-S30</Citation><ArticleIdList><ArticleId IdType="pubmed">11121824</ArticleId></ArticleIdList></Reference><Reference><Citation>Perspect Dev Neurobiol. 1992;1(1):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1364285</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Aug;152(8):1139-44</Citation><ArticleIdList><ArticleId IdType="pubmed">7625460</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2002 Feb 15;114(1):51-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11864809</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 Jun 1;53(11):1059-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2004 Feb;58(1):82-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14678462</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1994 Jun;151(6):842-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8184992</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurochem Res. 2007 Apr-May;32(4-5):707-15</Citation><ArticleIdList><ArticleId IdType="pubmed">17024568</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2004 Jul 29;351(5):476-86</Citation><ArticleIdList><ArticleId IdType="pubmed">15282355</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychobiology. 2001;43(4):242-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11340363</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2004 Jul 28;24(30):6791-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15282284</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2002 Apr;4(2):105-16</Citation><ArticleIdList><ArticleId IdType="pubmed">12071508</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1980 Nov 25;255(22):10896-901</Citation><ArticleIdList><ArticleId IdType="pubmed">6253491</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Med. 1995 May;25(3):557-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7480436</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2007 Jul 18;27(29):7860-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17634380</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Feb 10;311(5762):864-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16469931</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Res. 2001 Feb 28;106(1):25-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11231097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Neurobiol. 2007 May;27(3):351-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17235693</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1977 Jul 28;268(5618):327-9</Citation><ArticleIdList><ArticleId IdType="pubmed">887159</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 1999 Feb;72(2):879-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9930766</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Neurobiol. 2004;16(1-2):83-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15581403</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2005 Jul;30(7):1223-37</Citation><ArticleIdList><ArticleId IdType="pubmed">15827567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2000 Mar 3;100(5):495-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10721986</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Brain Behav. 2006 Feb;5(1):85-95</Citation><ArticleIdList><ArticleId IdType="pubmed">16436192</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2003 May 15;53(10):906-13</Citation><ArticleIdList><ArticleId IdType="pubmed">12742678</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Mol Brain Res. 1998 Sep 18;60(1):50-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9748499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2002 Dec;4(6):378-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12519097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1989 Nov 3;59(3):411-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2553271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Feb;13(2):197-207</Citation><ArticleIdList><ArticleId IdType="pubmed">17486107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Sep;13(9):858-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18332879</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Mar;61(3):300-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14993118</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):751-6</Citation><ArticleIdList><ArticleId IdType="pubmed">18178625</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2001 Jan 26;280(3):720-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11162580</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Sep 15;48(6):505-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11018223</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2005 May 25;293(20):2528-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15914754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2006 Apr;8(2):133-43</Citation><ArticleIdList><ArticleId IdType="pubmed">16542183</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacology (Berl). 2002 May;161(2):160-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11981596</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychiatry Clin Neurosci. 2007 Feb;61(1):3-19</Citation><ArticleIdList><ArticleId IdType="pubmed">17239033</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 2003 Winter;37(1):47-63</Citation><ArticleIdList><ArticleId IdType="pubmed">14561948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2000 Mar;5(2):142-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10822341</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2004 Apr 15;55(8):781-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15050857</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2002 Apr 15;22(8):3251-61</Citation><ArticleIdList><ArticleId IdType="pubmed">11943826</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Neurother. 2008 Jan;8(1):93-110</Citation><ArticleIdList><ArticleId IdType="pubmed">18088203</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2000 Dec 29;275(52):41340-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11007782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1995 Mar;15(3 Pt 1):1768-77</Citation><ArticleIdList><ArticleId IdType="pubmed">7891134</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Mar 1;61(5):640-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16950219</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2006 Jun 15;59(12):1116-27</Citation><ArticleIdList><ArticleId IdType="pubmed">16631126</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1999 Dec;156(12):1986-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10588416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2005 Oct;32(2):173-202</Citation><ArticleIdList><ArticleId IdType="pubmed">16215281</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2002 Sep 15;52(6):503-28</Citation><ArticleIdList><ArticleId IdType="pubmed">12361666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2008 Jun;13(6):558-69</Citation><ArticleIdList><ArticleId IdType="pubmed">18317468</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2006 Jun 3;170(1):126-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16546269</ArticleId></ArticleIdList></Reference><Reference><Citation>FASEB J. 2008 Sep;22(9):3129-34</Citation><ArticleIdList><ArticleId IdType="pubmed">18492725</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurochem. 2000 Oct;75(4):1729-34</Citation><ArticleIdList><ArticleId IdType="pubmed">10987856</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychologia. 1987;25(2):359-65</Citation><ArticleIdList><ArticleId IdType="pubmed">3601041</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11851-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15280545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2002 Oct;96(1):45-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12441177</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Oct 15;48(8):766-77</Citation><ArticleIdList><ArticleId IdType="pubmed">11063973</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Neurosci. 2000;11(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10716655</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2005 May 4;25(18):4493-502</Citation><ArticleIdList><ArticleId IdType="pubmed">15872096</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Mar 15;47(6):475-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10715353</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Brain Res. 2005 Dec 7;165(2):172-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16095731</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13290-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9789081</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 1977 Apr;130:330-51</Citation><ArticleIdList><ArticleId IdType="pubmed">558030</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2008 Jan;33(1):110-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17912251</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Biochem Eng Biotechnol. 1998;62:75-105</Citation><ArticleIdList><ArticleId IdType="pubmed">9755641</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Psychiatry. 2001 Feb;178:172-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11157432</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):401-12</Citation><ArticleIdList><ArticleId IdType="pubmed">16080015</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1995 Jun;152(6):915-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7755123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Neurosci. 2007 May;8(5):355-67</Citation><ArticleIdList><ArticleId IdType="pubmed">17453016</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3480-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16484373</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med Genet. 2002 May 8;114(4):391-406</Citation><ArticleIdList><ArticleId IdType="pubmed">11992561</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereb Cortex. 2002 Apr;12(4):386-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11884354</ArticleId></ArticleIdList></Reference><Reference><Citation>NeuroRx. 2006 Jan;3(1):22-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16490411</ArticleId></ArticleIdList></Reference><Reference><Citation>Behav Pharmacol. 2007 Sep;18(5-6):391-418</Citation><ArticleIdList><ArticleId IdType="pubmed">17762509</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2007 Jan 17;27(3):684-91</Citation><ArticleIdList><ArticleId IdType="pubmed">17234600</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2000 May;21(5):832-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10815657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2005 Oct;7(5):449-55</Citation><ArticleIdList><ArticleId IdType="pubmed">16176438</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2004 Jul;61(7):705-13</Citation><ArticleIdList><ArticleId IdType="pubmed">15237082</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2007 Jul 1;62(1):4-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17572175</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10827-32</Citation><ArticleIdList><ArticleId IdType="pubmed">15249684</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 1997 Aug 29;26(2-3):85-92</Citation><ArticleIdList><ArticleId IdType="pubmed">9323337</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Neuropsychopharmacol. 1995;5 Suppl:89-93</Citation><ArticleIdList><ArticleId IdType="pubmed">8775765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2002 Apr;4(2):137-44</Citation><ArticleIdList><ArticleId IdType="pubmed">12071511</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem J. 2000 Oct 1;351(Pt 1):95-105</Citation><ArticleIdList><ArticleId IdType="pubmed">10998351</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2004 Aug;7(8):847-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15220929</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 2000 Jan;57(1):95-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10632242</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Sci. 1998 May;111 ( Pt 10):1351-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9570753</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Psychol. 1967 May;74(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6032570</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophr Res. 2004 Apr 1;67(2-3):269-75</Citation><ArticleIdList><ArticleId IdType="pubmed">14984887</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pharmacol. 2007 Feb;7(1):22-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17055337</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2007 Jan 10;411(2):123-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17095155</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Psychiatry. 2002;7(6):571-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12140780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 Jun 7;447(7145):661-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17554300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mt Sinai J Med. 2008 May-Jun;75(3):226-47</Citation><ArticleIdList><ArticleId IdType="pubmed">18704977</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8745-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10411946</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2001 May 1;49(9):741-52</Citation><ArticleIdList><ArticleId IdType="pubmed">11331082</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1998;248(6):289-95</Citation><ArticleIdList><ArticleId IdType="pubmed">9928907</ArticleId></ArticleIdList></Reference><Reference><Citation>Philos Trans R Soc Lond B Biol Sci. 1999 Feb 28;354(1381):269-79</Citation><ArticleIdList><ArticleId IdType="pubmed">10212475</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2008 Oct;33(11):2551-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18235426</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2000 Jul 1;48(1):1-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10913502</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Psychiatry. 1982 Nov;43(11):439-41</Citation><ArticleIdList><ArticleId IdType="pubmed">7174617</ArticleId></ArticleIdList></Reference><Reference><Citation>Compr Psychiatry. 2002 Sep-Oct;43(5):361-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12216011</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1998;248(1):53-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9561353</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2008 Mar;33(4):933-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17507910</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8766-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18562287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2007 Sep;9(6):561-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17845270</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 Oct 27;437(7063):1370-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16251967</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2002 Nov;27(5):792-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12431853</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Aug 8;301(5634):805-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12907793</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 2003 May;160(5):873-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12727690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bipolar Disord. 2002 Dec;4(6):357-65</Citation><ArticleIdList><ArticleId IdType="pubmed">12519095</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11</Citation><ArticleIdList><ArticleId IdType="pubmed">17379666</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Arch Psychiatry Clin Neurosci. 1998;248(6):301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9928909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Neurobiol. 2005 Sep;25(6):973-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16392030</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2003 Jan 1;23(1):349-57</Citation><ArticleIdList><ArticleId IdType="pubmed">12514234</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8358-62</Citation><ArticleIdList><ArticleId IdType="pubmed">8078888</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 May 16;417(6886):292-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12015604</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 1995 May;12(3):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7612155</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Biochem Psychopharmacol. 1995;49:43-66</Citation><ArticleIdList><ArticleId IdType="pubmed">7653334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Genet Metab. 2004 May;82(1):87-92</Citation><ArticleIdList><ArticleId IdType="pubmed">15110328</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gen Psychiatry. 1999 Feb;56(2):162-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10025441</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropsychopharmacology. 2007 Oct;32(10):2173-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17299510</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2006 Sep;23(3):587-94</Citation><ArticleIdList><ArticleId IdType="pubmed">16843000</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Neuropsychopharmacol. 2004 Dec;7(4):387-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15315719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2008 Sep;40(9):1056-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18711365</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1986 Feb;36(2):212-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3945393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1997 Apr 24;386(6627):824-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9126739</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Psychiatry. 2002 Mar 1;51(5):377-86</Citation><ArticleIdList><ArticleId IdType="pubmed">11904132</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Genet Dev. 2008 Jun;18(3):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18657615</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26417754</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0353-5053</ISSN><JournalIssue CitedMedium="Print"><Volume>27 Suppl 1</Volume><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Psychiatria Danubina</Title><ISOAbbreviation>Psychiatr Danub</ISOAbbreviation></Journal><ArticleTitle>Are there different genotypes in Bipolar II and Bipolar I disorder and if so, why then do we tend to observe Unipolar Depression converting to Bipolar II and then converting to Bipolar I?</ArticleTitle><Pagination><MedlinePgn>S160-9</MedlinePgn></Pagination><Abstract><AbstractText>We review the recent literature in order to establish the importance of a spectrum for bipolar affective disorder, and that unipolar depression, bipolar II and bipolar I are discrete entities that may however evolve in sequence. We discuss clinical, genetic and neurobiological data which illustrate the differences between bipolar I and bipolar II. To fit the data we suggest a series of multiple mood disorder genotypes, some of which evolve into other conditions on the bipolar spectrum. Thence we discuss the nature of the bipolar spectrum and demonstrate how this concept can be used as the basis of a staging model for bipolar disorder. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fawcett</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emmanuel College Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agius</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Croatia</Country><MedlineTA>Psychiatr Danub</MedlineTA><NlmUniqueID>9424753</NlmUniqueID><ISSNLinking>0353-5053</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008487" MajorTopicYN="N">Medical History Taking</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26417754</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17064222</PMID><DateCompleted><Year>2007</Year><Month>01</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1744-7623</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2006</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Expert opinion on emerging drugs</Title><ISOAbbreviation>Expert Opin Emerg Drugs</ISOAbbreviation></Journal><ArticleTitle>Emerging drugs for bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>621-34</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a relatively common condition characterised by recurrent episodes of mania and depression, and associated with high levels of morbidity and mortality. Although there have been substantial advances in the pharmacotherapeutics of this condition over the last 10-15 years, the benefits have been predominantly in terms of tolerability and safety, with no new treatments being demonstrated to be more effective than lithium--the prototype mood stabiliser. This article reviews current and emerging medications for bipolar disorder. Most of the emerging treatments in pharmaceutical industry developmental programmes are new or modified anticonvulsants or atypical antipsychotics. A number of possible future directions and challenges for the field are discussed. The treatment of bipolar disorder is unlikely to advance substantially until the causative pathogenetic molecular processes are elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Philip B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>School of Psychiatry, University of New South Wales, Black Dog Institute, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia. phil.mitchell@unsw.edu.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malhi</LastName><ForeName>Gin S</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Emerg Drugs</MedlineTA><NlmUniqueID>101135662</NlmUniqueID><ISSNLinking>1472-8214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015507">Drugs, Investigational</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015507" MajorTopicYN="N">Drugs, Investigational</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>105</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17064222</ArticleId><ArticleId IdType="doi">10.1517/14728214.11.4.621</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23681714</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-3522</ISSN><JournalIssue CitedMedium="Internet"><Volume>81 Suppl 1</Volume><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Fortschritte der Neurologie-Psychiatrie</Title><ISOAbbreviation>Fortschr Neurol Psychiatr</ISOAbbreviation></Journal><ArticleTitle>[Differential diagnosis of and pharmacotherapy for bipolar disorder].</ArticleTitle><Pagination><MedlinePgn>S3-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0033-1335240</ELocationID><Abstract><AbstractText>Bipolar disorders constitute a group of frequent, chronic psychiatric illnesses with a most severe impact on the patient's life. The course can be very individual and heterogeneous, the best known and most frequent manifestations include the classical bipolar I and bipolar II disorders. However, in Germany even typical bipolar I disorders are underdiagnosed and, consequently, undertreated. This is true despite the fact that the number of pharmacological treatment options has rapidly increased during recent years, both in the field of anticonvulsants and atypical antipsychotics. This supplies us today with new therapeutic strategies, not only for acute mania, but also for bipolar depression and maintenance treatment, and it is feasible to assume that there will be more options available within the next few years.</AbstractText><CopyrightInformation>© Georg Thieme Verlag KG Stuttgart · New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grunze</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Academic Psychiatry, Institute of Neuroscience, Newcastle upon Tyne, UK. Heinz.Grunze@newcastle.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunze</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Amann</LastName><ForeName>B L</ForeName><Initials>BL</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Differenzialdiagnostik und Psychopharmakotherapie bipolarer Störungen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Fortschr Neurol Psychiatr</MedlineTA><NlmUniqueID>8103137</NlmUniqueID><ISSNLinking>0720-4299</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018692">Antimanic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018692" MajorTopicYN="N">Antimanic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23681714</ArticleId><ArticleId IdType="doi">10.1055/s-0033-1335240</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30182740</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1665</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists</Title><ISOAbbreviation>Australas Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Mixed states in bipolar disorder: modelling, measuring and managing.</ArticleTitle><Pagination><MedlinePgn>69-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1039856218794883</ELocationID><Abstract><AbstractText Label="OBJECTIVE:" NlmCategory="UNASSIGNED">To consider whether consensus exists in recommendations for managing bipolar mixed states published in recent reviews and treatment guidelines, and to summarise what might be their best management.</AbstractText><AbstractText Label="CONCLUSION:" NlmCategory="UNASSIGNED">Limitations to and changes in the definition of mixed states compromise diagnosis and management. The striking comparison between DSM-IV and DSM-5 criteria sets risks under-diagnosis and over-diagnosis. Current reviews and guidelines offer limited evidence to guide treatment; however, management should involve addressing the contribution of any antidepressant medication, and the introduction of a second-generation antipsychotic medication to stabilise the condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Scientia Professor, School of Psychiatry, University of New South Wales; Black Dog Institute, Randwick, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricciardi</LastName><ForeName>Tahlia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Officer, School of Psychiatry, University of New South Wales; Black Dog Institute, Randwick, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Australas Psychiatry</MedlineTA><NlmUniqueID>9613603</NlmUniqueID><ISSNLinking>1039-8562</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038801" MajorTopicYN="N">International Classification of Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bipolar disorder</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">mixed states</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30182740</ArticleId><ArticleId IdType="doi">10.1177/1039856218794883</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12957718</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0924-977X</ISSN><JournalIssue CitedMedium="Print"><Volume>13 Suppl 2</Volume><PubDate><Year>2003</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</Title><ISOAbbreviation>Eur Neuropsychopharmacol</ISOAbbreviation></Journal><ArticleTitle>Issues in the treatment of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>S37-42</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder is a chronic, recurring illness that requires long-term prophylactic treatment. However, treatment is often complicated by misdiagnosis and inappropriate medication selection. A number of therapies are available for the treatment of bipolar disorder and the ultimate therapeutic choice depends on the individual patient's current symptoms, disease history, and comorbid illnesses. However, research is needed to improve the overall prognosis for patients with bipolar depression, particularly because approximately 20% of patients commit suicide. Mania is the most dramatic expression of bipolar disorder and may overshadow the impact of the depressive phase of the illness. Compared with mania, episodes of bipolar depression are more frequent, of longer duration, and are associated with higher rates of morbidity and mortality. Therefore, successful treatment and prevention of bipolar depression remains an essential treatment goal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kasper</LastName><ForeName>Siegfried</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Psychiatry, University Hospital for Psychiatry, Währinger Gürtel 18-20, 1090 Vienna, Austria. siegfried.kasper@akh-wien.ac.at</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur Neuropsychopharmacol</MedlineTA><NlmUniqueID>9111390</NlmUniqueID><ISSNLinking>0924-977X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>70</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12957718</ArticleId><ArticleId IdType="pii">S0924977X03000762</ArticleId><ArticleId IdType="doi">10.1016/s0924-977x(03)00076-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11400596</PMID><DateCompleted><Year>2001</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2200</ISSN><JournalIssue CitedMedium="Print"><Volume>108</Volume><Issue>5</Issue><PubDate><Year>2001</Year><Month>May</Month></PubDate></JournalIssue><Title>Nederlands tijdschrift voor tandheelkunde</Title><ISOAbbreviation>Ned Tijdschr Tandheelkd</ISOAbbreviation></Journal><ArticleTitle>[Bipolar disorder].</ArticleTitle><Pagination><MedlinePgn>193-4</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bol</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Arts-epidemioloog Faculteit Civiele techniek en Geowetenschappen Sectie Gezondheidstechniek TU Delft Postbus 5048 2600 GA Delft.</Affiliation></AffiliationInfo></Author></AuthorList><Language>dut</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Bipolaire stemmingsstoornis.</VernacularTitle></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ned Tijdschr Tandheelkd</MedlineTA><NlmUniqueID>0400771</NlmUniqueID><ISSNLinking>0028-2200</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>13</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>8</Month><Day>31</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>6</Month><Day>13</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11400596</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">23477848</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>148</Volume><Issue>2-3</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Prevalence, chronicity, burden and borders of bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>161-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2013.02.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(13)00114-6</ELocationID><Abstract><AbstractText>Bipolar disorder (BD) has traditionally been thought of as an episodic condition, characterized by periods of hypomania/mania and depression. However, evidence is accumulating to suggest that this condition is associated with significant chronicity. For a large proportion of patients with BD, residual, sub-syndromal symptoms persist between major syndromal episodes, and studies have shown that many patients with bipolar disorder are symptomatic for approximately 50% of the time over follow-up periods of greater than 10 years. Moreover, while the prevalence of BD has been estimated to be around 1-2%, there is growing evidence that this may be a substantial underestimation. There are a number of reasons for this potential underestimation, including difficulties in diagnosis. Adding to the burden of BD is the issue of comorbidity, with an increased prevalence of many chronic conditions in those with a primary diagnosis of BD. Conversely, for many patients with chronic conditions, both medical and psychiatric, BD frequently exists as a comorbid secondary diagnosis. This issue of comorbidity complicates estimates of use of pharmaceutical agents for BD, such as mood stabilizers, which are known to be used off-label in conditions such as borderline personality or substance use disorder. We speculate that such off-label prescribing may not be truly off-label but may be instead fully justified by an overlooked secondary diagnosis of BD. Finally, we discuss the association of bipolar disorder with a significant economic burden, to the individual and to society, both due to the direct costs of medical expenditure and indirect costs such as loss of productivity and increased mortality.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fagiolini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Siena, Department of Molecular Medicine and Clinical (DAI) Department of Mental Health, Viale Bracci 1, Siena 53100, Italy. andreafagiolini@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forgione</LastName><ForeName>Rocco</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Maccari</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cuomo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Morana</LastName><ForeName>Benedetto</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Dell'Osso</LastName><ForeName>Mario Catena</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Pellegrini</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>10</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>02</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23477848</ArticleId><ArticleId IdType="pii">S0165-0327(13)00114-6</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2013.02.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1625657</PMID><DateCompleted><Year>1992</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0193-9416</ISSN><JournalIssue CitedMedium="Print"><Issue>54</Issue><PubDate><Year>1992</Year><Season>Summer</Season></PubDate></JournalIssue><Title>New directions for mental health services</Title><ISOAbbreviation>New Dir Ment Health Serv</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>35-8</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strober</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, Los Angeles.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>New Dir Ment Health Serv</MedlineTA><NlmUniqueID>7905590</NlmUniqueID><ISSNLinking>0193-9416</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>4</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1625657</ArticleId><ArticleId IdType="doi">10.1002/yd.23319925408</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15253674</PMID><DateCompleted><Year>2005</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1089-5159</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Alternative medicine review : a journal of clinical therapeutic</Title><ISOAbbreviation>Altern Med Rev</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder and cell membrane dysfunction. Progress toward integrative management.</ArticleTitle><Pagination><MedlinePgn>107-35</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder (BD) is characterized by periods of abnormally elevated mood (mania) that cycle with abnormally lowered mood (depression). Multiple structural, metabolic, and biochemical abnormalities are evident in the brain's cortex, subcortex, and deeper regions. This disorder is highly genetically conditioned but also highly susceptible to environmental stressors: prenatal or perinatal insults, childhood sexual or physical abuse, challenging life events, substance abuse, and other toxic chemical exposures. Its high morbidity, lost productivity, and suicide risk place a great toll on society. Since World War II, BD has been steadily worsening with earlier age of onset, greater intensity of symptoms, and development of drug resistance. Incidence in children is rising and misdiagnosis is common. Disciplined management of the many risk factors is essential, including cognitive psychotherapy and support from family and community. Lithium has been the foundational treatment, followed by valproate and other mood stabilizers, antidepressants, and anticonvulsants. Several single-nutrient and multinutrient supplements have also proven beneficial. Controlled, double-blind trials show multinutrient combinations of vitamins, minerals, orthomolecules, herbals, and the omega-3 fatty acids EPA and DHA to be effective monotherapy. The molecular action of lithium and valproate converge with nutrients on the level of the cell membrane and its molecular signal transduction systems. This emergent, unified rationale presages effective integrative management of bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kidd</LastName><ForeName>Parris M</ForeName><Initials>PM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Altern Med Rev</MedlineTA><NlmUniqueID>9705340</NlmUniqueID><ISSNLinking>1089-5159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical><Chemical><RegistryNumber>57WA9QZ5WH</RegistryNumber><NameOfSubstance UI="D009553">Nimodipine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>K</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009553" MajorTopicYN="N">Nimodipine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>142</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>4</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15253674</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15679203</PMID><DateCompleted><Year>2005</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0706-7437</ISSN><JournalIssue CitedMedium="Print"><Volume>49</Volume><Issue>12</Issue><PubDate><Year>2004</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Canadian journal of psychiatry. Revue canadienne de psychiatrie</Title><ISOAbbreviation>Can J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar II disorder: an overview of recent developments.</ArticleTitle><Pagination><MedlinePgn>802-12</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Recent research on the epidemiology, clinical course, diagnosis, and treatment of bipolar II disorder (BD II) stands to have a considerable impact on clinical practice. This paper reviews these developments.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We conducted a Pubmed search, focusing on the period from January 1, 1994, to August 31, 2004. Articles deemed directly relevant to the epidemiology, course, diagnosis, and management of BD II were considered.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of BD II is likely higher than previously suggested. Systematic probing for particular clinical features and use of screening tools allow for a more timely and accurate detection of the disorder. There is a paucity of good quality data to guide clinicians treating BD II.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Significant progress has been made in clarifying diagnostic and treatment issues in BD II. Neither strong nor broad treatment recommendations can be made; a cautious interpretation of available data suggests that lithium or lamotrigine are fairly reasonable first-line choices. More well-designed studies with larger samples are needed to improve the evidence base for managing this disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hadjipavlou</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of British Columbia, Vancouver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mok</LastName><ForeName>Hiram</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Yatham</LastName><ForeName>Lakshmi N</ForeName><Initials>LN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Psychiatry</MedlineTA><NlmUniqueID>7904187</NlmUniqueID><ISSNLinking>0706-7437</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010554" MajorTopicYN="N">Personality Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>98</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>2</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>2</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15679203</ArticleId><ArticleId IdType="doi">10.1177/070674370404901203</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7608043</PMID><DateCompleted><Year>1995</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0890-8567</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>6</Issue><PubDate><Year>1995</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of the American Academy of Child and Adolescent Psychiatry</Title><ISOAbbreviation>J Am Acad Child Adolesc Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder in children: misdiagnosis, underdiagnosis, and future directions.</ArticleTitle><Pagination><MedlinePgn>709-14</MedlinePgn></Pagination><Abstract><AbstractText>Bipolar disorder has not been well studied in prepubertal children, despite its potentially debilitating effects on growth and development. However, there have been case reports of mania in this age group dating back to Esquirol in the mid-19th century. Despite anecdotal case reports, explicit criteria to diagnose mania in children were not used until 1960. Since 1980 the DSM-III/DSM-III-R criteria have indicated adult criteria can be used to diagnose childhood mania, with some modifications to adjust for age differences. Bipolar disorder has not been frequently considered in the psychiatric differential diagnosis of children. However, if a diagnosis of mania is made, clinical rating scales can be used to rate the severity of manic symptoms and to monitor treatment. A manic child should be treated using a biopsychosocial approach. To date, lithium carbonate has been the most commonly used psychopharmacological treatment, but results have been variable. Additional research is needed, including double-blind, placebo-controlled studies to document the beneficial effects of mood-stabilizing medications. Also, diagnostic instruments should be refined to improve their utility. Finally, children at high risk for developing mania should be studied to identify predictors of bipolar disorder in children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weller</LastName><ForeName>E B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Ohio State University, Columbus, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weller</LastName><ForeName>R A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Fristad</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Child Adolesc Psychiatry</MedlineTA><NlmUniqueID>8704565</NlmUniqueID><ISSNLinking>0890-8567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010553" MajorTopicYN="N">Personality Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>40</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1995</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1995</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1995</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7608043</ArticleId><ArticleId IdType="pii">S0890-8567(09)63568-1</ArticleId><ArticleId IdType="doi">10.1097/00004583-199506000-00010</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26531027</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2402</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Biological psychiatry</Title><ISOAbbreviation>Biol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Toward a Valid Animal Model of Bipolar Disorder: How the Research Domain Criteria Help Bridge the Clinical-Basic Science Divide.</ArticleTitle><Pagination><MedlinePgn>62-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopsych.2015.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0006-3223(15)00736-2</ELocationID><Abstract><AbstractText>Bipolar disorder is a diagnostically heterogeneous disorder, although mania emerges as a distinct phenotype characterized by elevated mood and increased activity or energy. While bipolar disorder's cyclicity is difficult to represent in animals, models of mania have begun to decode its fundamental underlying neurobiology. When psychostimulants such as amphetamine or cocaine are administered to rodents, a resulting upsurge of motor activity is thought to share face and predictive validity with mania in humans. Studying black Swiss mice, which inherently exhibit proclivity for reward seeking and risk taking, also has yielded some insight. Further, translating the biology of bipolar disorder in humans into animal models has led to greater understanding of roles for candidate biological systems such as the GRIK2 and CLOCK genes, as well as the extracellular signal-related kinase pathway involved in the pathophysiology of the illness. The National Institute of Mental Health Research Domain Criteria initiative seeks to identify building blocks of complex illnesses like bipolar disorder in hopes of uncovering the neurobiology of each, as well as how each fits together to produce syndromes like bipolar disorder or why so many mental illnesses co-occur together. Research Domain Criteria-driven preclinical models of isolated behaviors and domains involved in mania and bipolar disorder will ultimately inform movement toward nosology supported by neurobiology.</AbstractText><CopyrightInformation>Copyright © 2016 Society of Biological Psychiatry. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cosgrove</LastName><ForeName>Victoria E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford; Veterans Affairs Palo Alto Health Care System, Palo Alto. Electronic address: veileen@stanford.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelsoe</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of California San Diego, San Diego, La Jolla, California; Veterans Affairs San Diego Healthcare System, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suppes</LastName><ForeName>Trisha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford; Veterans Affairs Palo Alto Health Care System, Palo Alto.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biol Psychiatry</MedlineTA><NlmUniqueID>0213264</NlmUniqueID><ISSNLinking>0006-3223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Medical Research</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal models</Keyword><Keyword MajorTopicYN="N">Bipolar disorder</Keyword><Keyword MajorTopicYN="N">CLOCK</Keyword><Keyword MajorTopicYN="N">ERK</Keyword><Keyword MajorTopicYN="N">Mania</Keyword><Keyword MajorTopicYN="N">RDoC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>09</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26531027</ArticleId><ArticleId IdType="pii">S0006-3223(15)00736-2</ArticleId><ArticleId IdType="doi">10.1016/j.biopsych.2015.09.002</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23749629</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2013</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-960X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Evidence-based mental health</Title><ISOAbbreviation>Evid Based Ment Health</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder and disruptive mood dysregulation in children and adolescents: assessment, diagnosis and treatment.</ArticleTitle><Pagination><MedlinePgn>93-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/eb-2013-101400</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krieger</LastName><ForeName>Fernanda Valle</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of São Paulo, , São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stringaris</LastName><ForeName>Argyris</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Evid Based Ment Health</MedlineTA><NlmUniqueID>100883413</NlmUniqueID><ISSNLinking>1362-0347</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000339" MajorTopicYN="N">Affect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019958" MajorTopicYN="N">Attention Deficit and Disruptive Behavior Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23749629</ArticleId><ArticleId IdType="pii">eb-2013-101400</ArticleId><ArticleId IdType="doi">10.1136/eb-2013-101400</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23567604</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1809-452X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)</Title><ISOAbbreviation>Braz J Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Staging and neuroprogression in bipolar disorder: a systematic review of the literature.</ArticleTitle><Pagination><MedlinePgn>70-4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1516-44462013000100013</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The use of clinical staging models is emerging as a novel and useful paradigm for diagnosing severe mental disorders. The term "neuroprogression" has been used to define the pathological reorganization of the central nervous system along the course of severe mental disorders. In bipolar disorder (BD), neural substrate reactivity is changed by repeated mood episodes, promoting a brain rewiring that leads to an increased vulnerability to life stress.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A search in the PubMed database was performed with the following terms: "staging", "neuroprogression", "serum", "plasma", "blood", "neuroimaging", "PET scan", "fMRI", "neurotrophins", "inflammatory markers" and "oxidative stress markers", which were individually crossed with "cognition", "functionality", "response to treatments" and "bipolar disorder". The inclusion criteria comprised original papers in the English language. Abstracts from scientific meetings were not included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We divided the results according to the available evidence of serum biomarkers as potential mediators of neuroprogression, with brain imaging, cognition, functioning and response to treatments considered as consequences.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The challenge in BD treatment is translating the knowledge of neuronal plasticity and neurobiology into clinical practice. Neuroprogression and staging can have important clinical implications, given that early and late stages of the disorder appear to present different biological features and therefore may require different treatment strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Clarissa Severino</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Brazil. clarissasgama@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunz</LastName><ForeName>Maurício</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Magalhães</LastName><ForeName>Pedro V S</ForeName><Initials>PV</Initials></Author><Author ValidYN="Y"><LastName>Kapczinski</LastName><ForeName>Flavio</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Psychiatry</MedlineTA><NlmUniqueID>100895975</NlmUniqueID><ISSNLinking>1516-4446</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23567604</ArticleId><ArticleId IdType="pii">S1516-44462013000100013</ArticleId><ArticleId IdType="doi">10.1016/j.rbp.2012.09.001</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18330746</PMID><DateCompleted><Year>2008</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2008</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1300-2163</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2008</Year><Season>Spring</Season></PubDate></JournalIssue><Title>Turk psikiyatri dergisi = Turkish journal of psychiatry</Title><ISOAbbreviation>Turk Psikiyatri Derg</ISOAbbreviation></Journal><ArticleTitle>[The role and importance of cognitive symptoms in bipolar disorder].</ArticleTitle><Pagination><MedlinePgn>81-93</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our aim was to review evidence of the role of cognitive deficits in bipolar disorder and their relationship to other factors, such as disorder variables, treatment, additional diagnoses, genetic risk, and brain imaging findings.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Studies that examined cognitive dysfunction in bipolar disorder and its relationship to the variables of clinical, genetic, and bipolar disorder subtypes, as well as neuro-anatomical and neuro-functional evidence have been reviewed. Findings from our own studies have also been used while conducting the review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In bipolar disorder, deficits in executive functions, memory, and attention persist in the euthymic state. The number of episodes and the course of the disorder seem to be related to the severity of memory dysfunction and psychomotor slowness. However, symptoms of cognitive dysfunction are present at the onset of the disorder. Moreover, cognitive dysfunction has been observed in the healthy relatives of bipolar disorder patients. Cognitive dysfunction in bipolar disorder is associated with functional and possibly structural anomalies in some parts of the brain, such as the frontal and cingulate cortex. Some recent studies reported a relationship between symptoms of cognitive dysfunction and genetic variations in bipolar disorder.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Today, the presence of cognitive deficits in bipolar disorder is widely accepted; however, evidence of the neurobiological and clinical correlates of cognitive symptoms is still limited. More studies are needed to investigate the relationship between cognitive dysfunction in bipolar disorder and risk. Genetic studies are just now amending our body of knowledge. There have been many conflicting results reported by brain imaging studies. Different brain imaging approaches and genetic methods should be used with more specific cognitive and social-emotional tasks for increasing our knowledge about the nature of cognitive deficit in bipolar disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bora</LastName><ForeName>Emre</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Melbourne, Melbourne Neuropsychiatry Centre, Melbourne. Emrebora@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahip</LastName><ForeName>Simavi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Akdeniz</LastName><ForeName>Fisun</ForeName><Initials>F</Initials></Author></AuthorList><Language>tur</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Bipolar bozuklukta bilişsel belirtilerin doğasi ve önemi.</VernacularTitle></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turk Psikiyatri Derg</MedlineTA><NlmUniqueID>9425936</NlmUniqueID><ISSNLinking>1300-2163</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>90</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>3</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>7</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>3</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18330746</ArticleId><ArticleId IdType="pii">617</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18466044</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Is bipolar disorder overdiagnosed?</ArticleTitle><Pagination><MedlinePgn>935-40</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Bipolar disorder, a serious illness resulting in significant psychosocial morbidity and excess mortality, has been reported to be frequently underdiagnosed. However, during the past few years we have observed the emergence of an opposite phenomenon--the overdiagnosis of bipolar disorder. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we empirically examined whether bipolar disorder is overdiagnosed.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Seven hundred psychiatric outpatients were interviewed with the Structured Clinical Interview for DSM-IV (SCID) and completed a self-administered questionnaire, which asked the patients whether they had been previously diagnosed with bipolar or manic-depressive disorder by a health care professional. Family history information was obtained from the patient regarding first-degree relatives. Diagnoses were blind to the results of the self-administered scale. The study was conducted from May 2001 to March 2005.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fewer than half the patients who reported that they had been previously diagnosed with bipolar disorder received a diagnosis of bipolar disorder based on the SCID. Patients with SCID-diagnosed bipolar disorder had a significantly higher morbid risk of bipolar disorder than patients who self-reported a previous diagnosis of bipolar disorder that was not confirmed by the SCID (p &lt; .02). Patients who self-reported a previous diagnosis of bipolar disorder that was not confirmed by the SCID did not have a significantly higher morbid risk for bipolar disorder than the patients who were negative for bipolar disorder by self-report and the SCID.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Not only is there a problem with underdiagnosis of bipolar disorder, but also an equal if not greater problem exists with overdiagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Human Behavior, Brown Medical School, and Rhode Island Hospital, Providence, RI, USA. mzimmerman@lifespan.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggero</LastName><ForeName>Camilo J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Chelminski</LastName><ForeName>Iwona</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Psychiatry. 2009 Jan;70(1):143; author reply 144</RefSource><PMID Version="1">19222987</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Psychiatry. 2009 Apr;70(4):603; author reply 603-4</RefSource><PMID Version="1">19403101</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039721" MajorTopicYN="N">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>5</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>5</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18466044</ArticleId><ArticleId IdType="pii">ej07m03888</ArticleId><ArticleId IdType="doi">10.4088/jcp.v69n0608</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18052572</PMID><DateCompleted><Year>2008</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-2101</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>11</Issue><PubDate><Year>2007</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of clinical psychiatry</Title><ISOAbbreviation>J Clin Psychiatry</ISOAbbreviation></Journal><ArticleTitle>A systematic review of rates and diagnostic validity of comorbid adult attention-deficit/hyperactivity disorder and bipolar disorder.</ArticleTitle><Pagination><MedlinePgn>1776-84</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Adult attention-deficit/hyperactivity disorder (ADHD) is increasingly recognized and reported to frequently coexist with bipolar disorder. Concurrent diagnosis of adult ADHD and bipolar disorder remains controversial. In this study, we conducted a systematic review to examine the rates and diagnostic validity of the concept of comorbid adult ADHD and bipolar disorder.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">MEDLINE, Embase, PsycInfo, and Cochrane databases were searched for articles published before March 30, 2007, using the keywords manic, bipolar, attention deficit hyperactivity, and adult. The computer search was supplemented with bibliographic cross-referencing.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Exclusion criteria were studies with only pediatric subjects, childhood ADHD only but not adult ADHD, and either bipolar disorder or ADHD only, but not both; review articles, case reports; letters to the editor; and book chapters. Of the 262 citations found, 12 studies met our inclusion criteria.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Specific diagnostic validating criteria examined were phenomenology, course of illness, heredity, biological markers, and treatment response. There were 6 studies on comorbid rates, 4 on phenomenology, 3 on course of illness, 2 on heredity, none on biological markers, and 1 on treatment response.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">The proposed comorbid syndrome is fairly common (present in up to 47% of adult ADHD and 21% of bipolar disorder populations), with a more severe course of illness compared with that of bipolar disorder alone, and high rates of comorbidity with other psychiatric disorders. Its treatment appears to require initial mood stabilization.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Comorbid adult ADHD and bipolar disorder has been insufficiently studied, with more emphasis on comorbidity rates and few data on course, neurobiology, heredity, and treatment. The diagnostic validity of adult ADHD/ bipolar disorder as a true comorbidity is not well-established on the basis of this equivocal and insufficient literature. More studies are greatly needed to further clarify its diagnostic validity and treatment approach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wingo</LastName><ForeName>Aliza P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Bipolar Disorder Research Program, Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Ga. 30322, USA. anpham@emory.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaemi</LastName><ForeName>S Nassir</ForeName><Initials>SN</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MH-64189</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Psychiatry</MedlineTA><NlmUniqueID>7801243</NlmUniqueID><ISSNLinking>0160-6689</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001289" MajorTopicYN="N">Attention Deficit Disorder with Hyperactivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>31</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>4</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18052572</ArticleId><ArticleId IdType="doi">10.4088/jcp.v68n1118</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9686750</PMID><DateCompleted><Year>1998</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0891-9887</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>1998</Year><Season>Spring</Season></PubDate></JournalIssue><Title>Journal of geriatric psychiatry and neurology</Title><ISOAbbreviation>J Geriatr Psychiatry Neurol</ISOAbbreviation></Journal><ArticleTitle>Bipolar disorder in late life: a review.</ArticleTitle><Pagination><MedlinePgn>29-35</MedlinePgn></Pagination><Abstract><AbstractText>Although there is a broad base of literature on depression among elderly patients and on mania in younger patients, there is a relative paucity of information on bipolar disorder in the elderly population. While the quantities of data reflect the relative prevalences of these illnesses, there is evidence to suggest that classification of mania in the elderly with respect to age of onset, natural course, family history, and pathophysiology may be useful in understanding the heterogeneous etiologies of this syndrome. This paper presents a review of the literature on the incidence and course of illness in late-life bipolar disorder. Further, dilemmas of diagnostic classification in relation to associated risk factors will be discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>S T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles, California 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altshuler</LastName><ForeName>L L</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Spar</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Geriatr Psychiatry Neurol</MedlineTA><NlmUniqueID>8805645</NlmUniqueID><ISSNLinking>0891-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>51</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9686750</ArticleId><ArticleId IdType="doi">10.1177/089198879801100107</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>